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Cre recombinase, a member of the tyrosine recombinase (YR) family of site-specific recombinases catalyzes
DNA rearrangements using phosphoryl transfer chemistry that is identical to that used by the type IB
topoisomerases (TopIBs). In this dissertation, the requirements for YR catalysis and the relationship between
the YRs and the TopIBs are explored. I have analyzed the in vivo and in vitro recombination activities of all
possible substitutions of the seven active site residues in Cre recombinase. To facilitate the interpretation
mutant activities, I also determined the structure of a vanadate transition state mimic for the Cre-loxP reaction
that allows for a comparison with similar structures from the related TopIBs. The results demonstrate that
active site residues shared by the TopIBs are most sensitive to substitution. Two of the conserved active site
residues in YRs have no equivalent in TopIBs. I have concluded that Glu176 and His289 in Cre evolved to
have functional roles in site-specific recombination, that are unnecessary for relaxation by TopIB. His289 is
not essential for cleavage of DNA, but accelerates water mediated hydrolysis of the 3'-phosphotyrosine
covalent intermediate. Glu176 serves a structural role in facilitating the activation of Cre for cleavage by
helping position the general acid, K201 in the active site. These residues may compensate for activity lost
during the evolution of allosteric regulation required for recombination. Examination of two regions involved
in protein:protein interactions in the Cre-DNA tetramer complex has led to the characterization of two modes
of allosteric regulation. The first involves a C-terminal helix (hN), which binds in the pocket of a neighboring
Cre monomer to serve as a regulatory switch by acting as a tether to position the tyrosine nucleophile (Y324).
The second regulatory module involves the mobile β2-β3 hairpin carrying the general acid, K201. This hairpin
must form synapsis dependent contacts to efficiently position K201 near O5' of the scissile phosphate. Cre has
evolved to modulate the positions of critical residues for catalysis, which is an effective and highly sensitive
mechanism of regulation of catalysis not shared by TopIBs.
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ABSTRACT
REQUIREMENTS FOR CATALYSIS IN CRE RECOMBINASE
Bryan P.S. Gibb
Gregory Van Duyne, Ph.D., Thesis Advisor
Cre recombinase, a member of the tyrosine recombinase (YR) family of site-specific
recombinases catalyzes DNA rearrangements using phosphoryl transfer chemistry that is
identical to that used by the type IB topoisomerases (TopIBs).  In this dissertation, the
requirements for YR catalysis and the relationship between the YRs and the TopIBs are explored.
I have analyzed the in vivo and in vitro recombination activities of all possible substitutions of the
seven active site residues in Cre recombinase. To facilitate the interpretation mutant activities, I
also determined the structure of a vanadate transition state mimic for the Cre-loxP reaction that
allows for a comparison with similar structures from the related TopIBs. The results demonstrate
that active site residues shared by the TopIBs are most sensitive to substitution.  Two of the
conserved active site residues in YRs have no equivalent in TopIBs. I have concluded that Glu176
and His289 in Cre evolved to have functional roles in site-specific recombination, that are
unnecessary for relaxation by TopIB. His289 is not essential for cleavage of DNA, but accelerates
water mediated hydrolysis of the 3'-phosphotyrosine covalent intermediate. Glu176 serves a
structural role in facilitating the activation of Cre for cleavage by helping position the general acid,
K201 in the active site.  These residues may compensate for activity lost during the evolution of
allosteric regulation required for recombination. Examination of two regions involved in
protein:protein interactions in the Cre-DNA tetramer complex has led to the characterization of
two modes of allosteric regulation. The first involves a C-terminal helix (hN), which binds in the
pocket of a neighboring Cre monomer to serve as a regulatory switch by acting as a tether to
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position the tyrosine nucleophile (Y324). The second regulatory module involves the mobile β2-β3
hairpin carrying the general acid, K201. This hairpin must form synapsis dependent contacts to
efficiently position K201 near O5' of the scissile phosphate. Cre has evolved to modulate the
positions of critical residues for catalysis, which is an effective and highly sensitive mechanism of
regulation of catalysis not shared by TopIBs. 
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Chapter  1. Introduction
1.1 Site specific recombination
Site-specific recombination is a form of DNA rearrangement that involves reciprocal
exchange between defined DNA sites. The products are rearranged versions of the starting DNA
substrates that may have altered topology and sequences. Site-specific recombination enzymes
that catalyze these DNA rearrangements are commonly found in prokaryotic systems and in
some cases in yeast, where they perform various functions such as mediating the integration and
excision of viral genomes into and out of host chromosomes, resolving multimeric plasmids to
monomers in order to ensure faithful partitioning at cell division, regulating the copy number of
yeast 2 μm circles, and switching on and off expression of genes (Craig, Gragie, Gellert &
Lambowitz, 2002).
Site-specific recombination involves two DNA sites that are recognized by a specialized
recombinase that mediates DNA breakage and reunion of the phosphodiester backbone through
a mechanism that does not require high-energy cofactors such as ATP. The orientation and
topology of the recombination sites in the originating DNA molecules dictate one of three possible
DNA rearrangements that are depicted in Fig. 1.1. Intramolecular recombination where the sites
are in a direct (head-to-tail) orientation will result in the excision of the region flanked between the
two sites. Resolution is a special form of excision where the substrate is a circular DNA molecule
which is resolved to form two individual circular products. The reverse reaction, intermolecular
recombination of sites located on two separate DNA molecules, will result in the integration of the
two segments. Inversion is a form of intramolecular recombination where the two recombinase
sites are oriented as inverted repeats (head-to-head) (for reviews see (Nash, 1996), (Van Duyne,
2008)). 
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Many site-specific recombination systems have been identified that perform these DNA
rearrangements in a variety of biological roles, but nearly all can be grouped into one of two
families; tyrosine recombinases (YR) and serine recombinases. These two families are capable of
all three types of DNA rearrangements, but are unrelated by sequence or structure and have very
different functional mechanisms. The serine recombinases are also known as the
resolvase/invertase family and are defined by a catalytic serine nucleophile that is responsible for
attacking the scissile phosphate to form a 5'-phosphoserine linkage. The proposed mechanism
for serine recombinases involves concomitant cleavage of all four DNA strands by a tetramer of
recombinase protomers to introduce double strand breaks at crossover in both recombination
sites before strand exchange. Although the exact mechanistic details are not completely
understood, a large rotation is thought to swap the strands for ligation to generate products
(reviewed in (Grindley, Whiteson & Rice, 2006), (Van Duyne, 2008)). The tyrosine recombinases
utilize a different mechanism. This family is also known as the lambda integrase family (λ-int) for
the recombinase encoded by bacteriophage λ that controls integration and excision of phage
DNA into and out of the bacterial genome. This family is defined by a conserved tyrosine
nucleophile that attacks the scissile phosphate to form a 3'-phosphotyrosine linkage to the DNA.  
YRs bind to a core site where cleavage and strand exchange reactions are catalyzed. The
core sites contain two recombinase binding elements (RBEs) that vary in size and are usually but
not always, inverted repeats that flank a short 6-8 bp central crossover region where cleavage
and strand exchange occur (Fig. 1.2B). Like the serine recombinases, strand exchange occurs in
a tetrameric complex of recombinase proteins containing two core DNA sites. However, unlike the
serine recombinases, YRs perform cleavage in a stepwise manner with only two of the four
recombinase subunits active at a time. Cleavage results in a 3'-phosphotyrosine covalent
intermediate and release of a 5' hydroxyl group as shown schematically in Fig. 1.2A. Exchange of
the cleaved strands and subsequent ligation forms a Holiday junction (HJ) intermediate.
Isomerization of the HJ activates the second pair of recombinases for cleavage, strand exchange
and ligation on the complementary set of strands to form products (Van Duyne, 2002). 
2
3Figure 1.1  Examples of site-specific recombination
A. Intermolecular recombination as mediated by λ-int
B. Resolution, a form of intramolecular recombination occurs between two core sites in direct repeat (head-to-tail
orientation), as observed for Cre,  XerC/D, and Flp
C. Inversion is another form of intramolecular recombination that occurs between core sites oriented as inverted repeats
(head-to-head orientation) as observed in Flp recombination. 
Adapted from: (Van Duyne, 2008)
4Figure 1.2  Reaction mechanisms
A. Recombination pathway for YRs as modeled after structures of Cre-DNA reaction intermediates.
B. The loxP site contains two 13 bp inverted repeat recombinase binding sites that flank an 8 bp central crossover
region where cleavage and strand exchange take place. This central region contains asymmetry that confers
directionality to the site by defining a top strand (TS) where cleavage is between an A·T base step AT, and a bottom
strand (BS) where cleavage take place between G·C base step. 
C. Schematic of topoisomerase reaction. The cleavage and ligation steps are mechanistically related to the equivalent
step in the YR recombination pathway, except topoisomerase achieves relaxation as a monomer. 
The mechanism of cleavage and ligation in YRs is shared by the type IB topoisomerases
(TopIB), and the catalytic domains of YRs are also closely related to those found in the type IB
topoisomerases. However, unlike YRs, TopIBs act as monomers to relax supercoiled DNA
through the formation of a covalent 3' phosphotyrosine intermediate (Fig. 1.2C). The similarity of
mechanism and active site residues in the catalytic domain led to speculation that
topoisomerases and YRs are evolutionarily related, possibly sharing a common ancestor
(reviewed in (Dong & Berger, 2008)). 
1.2 Tyrosine recombinase family members
The YR family has been thoroughly studied through molecular genetics, biochemistry and
structural biology. PsiBlast (Altschul et al., 1997) searches indicate that the family consists of over
10,000 members (this work), however most of the knowledge regarding mechanism has been
garnered from studies of λ-int, XerC, XerD, Flp and Cre recombinases (for reviews see, (Azaro &
Landy, 2002),(Barre & Sherratt, 2002),(Jayaram, Grainge & Tribble, 2002),(Van Duyne, 2002)).
Extensive mutagenesis and biochemistry performed on the type IB topoisomerase enzymes has
contributed significantly to the understanding of the YRs. Consequently, the YRs can be broken
down into  three groups that correlate with the reaction complexity of the system. 
The type IB topoisomerases, acting as monomers, make up the most basic group. The
second group consists of recombinases that are often referred to as 'simple' members because
they carry out site-specific recombination functions on simple substrates without the need for
accessory factors or auxiliary DNA sequences. This group is best exemplified by the Cre and Flp
recombinases. The third group consists of recombinases that require or exploit accessory
proteins and auxiliary DNA sites for regulatory control of site-specific recombination. λ-int and
XerCD are two well studied examples of 'complex' recombination systems. 
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1.2.1 Type Ib topoisomerases
Type IB topoisomerases (TopIB) (for reviews see, (Dong & Berger, 2008) and (Champoux,
2001)) function as monomers to relax both positive and negative supercoils. This is done by
introduction of transient breaks in one strand of the DNA duplex, allowing rotation about the intact
strand. These enzymes have critical roles in cellular processes by relieving stress built up by
overwinding or underwinding the DNA duplex that occurs during transcription, replication, and
DNA repair. The type IB subfamily shows no sequence or structural homology to other known
topoisomerases and is functionally distinct from the type IA subfamily. The TopIB family consists
of eukaryotic cellular TopIBs, topoisomerases encoded by poxviruses, and a small number of
bacterial TopIBs. 
The eukaryotic TopIB enzymes are quite large, varying in size from 765 to 1019 amino acids.
These enzymes contain an N-terminal domain which is dispensable for relaxation activity, but
contains signals for nuclear localization and sites for regulatory interactions with other cellular
proteins such as nucleolin, SV40, T-antigen, and a number of transcription factors. A central
domain called  the capping lobe is involved with mediating contacts with the DNA. The C-terminal
catalytic domain contains the active site residues responsible for phosphoryl-transfer chemistry,
but is split in half by a large helical domain. 
The poxvirus topoisomerases are much smaller and more highly conserved, typically 314 to
333 amino acids in length. These topoisomerases share a similar domain architecture by
retaining the capping lobe and a highly conserved catalytic domain, however they lack the N-
terminal regulatory domain as well as the helical insertion in the catalytic domain found in the
eukaryotic TopIBs. This has led to the suggestion that the viral TopIBs are minimal functional
topoisomerases and have been the focus of extensive study. 
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Another interesting difference between eukaryotic and viral TopIB enzymes is that the
poxvirus family exhibits a high degree of sequence specificity that has made the system
amenable to detailed kinetic analysis. Recent structural studies of both eukaryotic and viral
topoisomerases have explained the observed differences in binding specificity as well as
similarities in the mechanism of relaxation with detailed views of the active site. 
1.2.2 Cre and Flp: Simple YRs
Cre recombinase (causes recombination) is a 38 kDa protein encoded by bacteriophage P1,
and represents one of the simplest members of the YR family (Sternberg, Sauer, Hoess &
Abremski, 1986). Cre recognizes and mediates recombination between two 34 bp sites called
loxP (locus of X-over, phage; Fig. 1.2B) (Hoess & Abremski, 1984),(Hoess, Ziese & Sternberg,
1982) . LoxP contains two 13 bp inverted repeats that serve as recombinase binding elements
that flank an 8 bp asymmetric central cross over region that imparts directionality to the site. The
protein consists of two domains, an N-terminal domain responsible for binding DNA and a C-
terminal domain that contains all of the active site residues (Guo, Gopaul & van Duyne, 1997). 
Cre has two roles in the biology of phage P1 (Sternberg et al., 1981). First, Cre ensures that
the 100-kb cyclically permuted and linear redundant genome is circularized after infection into
E.coli. Generally, the host homologous recombination system fulfills this role, but should this
system fail, Cre will efficiently circularize the infecting DNA at loxP sites located in the terminal
redundancies.
The second role for Cre in P1 is to ensure maintenance of the P1 DNA in lysogens
(Sternberg et al., 1981). The prophage genomes of many varieties of bacteriophages, including λ
and P2 are normally integrated into the host chromosome. The bacteriophage P1 genome
resides primarily as a unit copy plasmid as a lysogen. Homologous recombination can generate
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dimers of the P1 genome after replication. To ensure fidelity in the progeny, the dimers are
resolved efficiently by Cre mediated excision at loxP sites to provide monomers that are able to
properly segregate. 
The recombinase encoded by Saccharomyces cerevisiae, Flp, also functions without a
requirement for accessory cofactors and binding sites (reviewed in, (Sadowski, 1995) and
(Jayaram et al., 2002)). Flp recognizes two 34 bp sites called frt sites, that are arranged in head-
to-head (inverted) orientation on the multicopy 2 μm plasmid. If missegration during cell division
causes the plasmid copy number to drop, Flp mediated inversion of the intervening region of DNA
between frt sites alters the direction of replication forks, resulting in the increased plasmid
replication of the copy number amplification of the S. cerevisae 2 μm circle. Flp then resolves the
resulting tandemly repeated products that have frt sites oriented in direct repeats to monomers.
Cre acts primarily as a resolvase, while Flp can function both as a resolvase and invertase, but
neither functions well as an integrase since intramolecular recombination is the natural reaction.  
1.2.3 λ-int and XerCD: Complex YRs
λ-int from bacteriophage lambda serves as the paradigm for the family (reviewed in (Azaro &
Landy, 2002)). The recombinase is responsible for integration and excision of the phage λ DNA
into and out of the infected cells' genome. During integration, recombination takes place between
a site on the viral genome called attP and a site on the bacterial genome called attB. The attB site
is a minimal recombination site similar to those found in simple recombinases, however attP is far
more complex. In addition to containing a simple core recombination site, attP  contains more
than 200 bp of additional DNA that contains accessory sites for proteins that regulate the activity
of λ-int. Integration of phage DNA between attB and attP generates hybrid sites, attL and attR,
which are substrates for excision. Included on attP are additional λ-int binding modules called
ARM sites (labeled as P and P' in Fig. 1.3).  
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9Figure 1.3  Site specific recombination by λ-integrase
During infection λ-int mediates recombination between core sites, attP on the phage lambda genome and E.coli site
attB generating hybrid sites, attL and attR to integrate into the host genome. Excision of the lambda genome requires
recombination between attL and attR to regenerate attP and attB. The integration and excision reactions are highly
regulated requiring proteins IHF in integration and excision, Xis in exision, which is further stimulated by Fis. ARM
binding sites are labeled P and P', IHF binding sites H , Xis binding as X and Fis binding site F. Black symbols indicate
sites that are used in integration (top) or excision (bottom).
Adapted from: (Van Duyne, 2008)
Unlike Cre and many other YRs, λ-int contains an additional domain found at the N-terminus
that binds to the regulatory ARM sites found in attP. The central core binding (CB) domain and
catalytic domain of λ-int are homologous to those in other YR homologs, which are responsible
for binding the core DNA sites where recombination takes place. This makes λ-int heterobivalent
in that it independently binds two distal regions of DNA using the same protein subunit. The
binding of ARM DNA by λ-int is required for efficient synapsis and regulating recombination. The
directionality of recombination of λ-int is highly regulated by a number of accessory DNA binding
proteins that alter the topology of the synaptic complex, either activating or repressing integration
or excision. Bacterially encoded integration host factor (IHF) binds attP at several sites and
induces a sharp bend in the DNA to alter the topology of the site, possibly to allow λ-int to
physically interact with both core site and P site DNA, simultaneously. The phage encodes the
accessory protein Xis, which binds to sites on attP and alters the topology of the synaptic
complex such that it promotes excision of the viral genome and inhibits integration. The bacterial
host encoded protein Fis also binds to attP and stimulates excision of lambda from the host
genome. All of these cofactors combine to make λ-int one of the more complex YR systems. 
The E.coli XerC and XerD recombinases have homologs that are found in most eubacteria
and have an important role in chromosome segregation at cell division (reviewed in (Barre &
Sherratt, 2002). The system is unique in that two separate recombinase proteins are used to
complete a full recombination reaction. Of the commonly studied YRs, XerC and XerD are the
most closely related with 37% sequence identity (Barre & Sherratt, 2002). These two
recombinases recognize a 28  bp site on the bacterial genome called dif, which contains specific
RBEs for each recombinase. During replication, homologous recombination generates
chromosome dimers for approximately 15% of cell divisions (Barre & Sherratt, 2002). XerC and
XerD interact with the protein FtsK, a membrane associated DNA translocase located at the
septum during cell division, to resolve chromosome dimers to monomers at the dif recombination
sites. The XerC/D system is also involved in resolving multimers of multicopy plasmids, pColE1
and pSC101, at two dif-like recombination sites called, cer and psi, respectively. Both of these
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sites contain more than 100 bp of accessory DNA that include binding sites for host encoded
arginine repressor (ArgR) and leucine aminopeptidase (PepA) at cer and aerobic respiration
control protein (ArcA) and PepA at psi. These accessory proteins bind and bend DNA specifically,
creating a 'topological filter' that ensures that only intermolecular recombination will occur.  
1.3 Recombinases as tools for DNA manipulation
Simple YRs, such as Cre and Flp recombinases were found to have robust activity in vitro as
well as in bacterial and eukaryotic systems (Dale & Ow, 1990; Sauer, 1987). The minimal
requirements for activity of Cre combined with the high specificity for loxP allowed for
development of Cre as a tool used in DNA manipulations and genome engineering (Kilby, Snaith
& Murray, 1993). 
In a cell-free system, purified Cre can simplify the introduction and manipulation of genes
into and out of plasmids and large viral genomes (Gage, Sauer, Levine & Glorioso, 1992;
Peakman, Harris & Gewert, 1992). The use of specific recombination sites eliminates steps
involved in complicated subcloning, bypassing the need for restriction enzymes and appropriately
placed restriction sites (Liu et al., 1998; Liu, Li, Liu & Elledge, 2000). 
In addition to applications in vitro, Cre and Flp are extraordinarily useful as tools in vivo
(reviewed in (Sauer, 2002)). Cre is commonly used to perform recombination events such as
gene knock-outs, knock-ins or inversions in eukaryotic systems such as mice. A gene or genes of
interest can be bracketed by recombination sites. Depending on the orientation, expression of
Cre will either excise or invert the intervening region containing either a gene, promoter or
terminator. Since the expression of Cre can be controlled in a time and tissue specific manner,
this offers a unique and effective way to study the effects of transgenes in ways not possible by
other traditional methods.
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Combining multiple recombinases, each with a unique recombination site or mutated
derivatives of the same recombinase that recognize novel sites have both been used successfully
to expand the number of genome manipulations that can be performed in a single experiment
(Birling, Gofflot & Warot, 2009; Buchholz & Stewart, 2001; Livet et al., 2007). 
1.4 Mechanism of recombination
Decades of biochemistry in YRs and TopIBs (primarily vaccinia virus topoisomerase), have
contributed greatly to understanding the mechanism of recombination. More recently, crystal
structures of YRs and TopIBs have greatly advanced the understanding of tyrosine recombinases
(reviewed in (Chen & Rice, 2003c) and (Van Duyne, 2008) and (Dong & Berger, 2008)). Among
the most revealing structures are those that capture recombinase-DNA complexes as 'snapshots'
of  mechanistic steps in the pathway. In particular, multiple Cre-loxP structures have captured
views of the pre-cleavage synaptic complex, the post-cleavage covalent intermediate bearing a
3'-phosphotyrosine linkage, and the Holiday Junction intermediate (Fig. 1.7). Structures at
recombination reaction intermediates have also been captured for Flp and λ-int (Biswas et al.,
2005; Chen et al., 2000) (Fig. 1.8). In addition to revealing the overall architecture, the structures
also have made important contributions to understanding phosphoryl transfer chemistry both at
the level of catalysis within the active site and with respect to the mechanism of strand exchange
within the assembled recombination complexes. 
1.4.1 Phosphoryl-transfer chemistry
The mechanism of cleavage and ligation with the formation of a 3'-phosphotyrosine
intermediate is conserved within the YRs and shared with TopIBs. The reaction has been shown
to be SN2-like, proceeding through a pentacoordinate phosphorane transition state intermediate
in which the tyrosine nucleophile and the O5' leaving group form axial ligands (Grindley et al.,
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2006; Shuman, 1998). The reaction has been proposed to utilize an acid/base mechanism where
in the cleavage reaction, a base is responsible for accepting a proton from the tyrosine, and an
acid donates a proton to the O5' leaving group. In the ligation reaction the roles are reversed
where the acid accepts a proton from the incoming 5' OH and the base donates a proton to the
tyrosine leaving group (Fig.  1.4).
Structural and biochemical work in YRs and TopIBs has helped identify residues that aid in
activation of the scissile phosphate and stabilize the transition state in the phosphoryl transfer
reaction (Fig. 1.5). In addition to non-covalent and covalent intermediate structures that revealed
the active sites of YRs and TopIBs, recent structures of TopIB captured a covalent complex with
vanadate and DNA (Davies et al., 2006; Perry et al., 2010). Vanadate forms a trigonal bipyramidal
geometry that mimics the transition state of the phosphodiester backbone as it is attacked by the
catalytic tyrosine. These structures have aided the understanding and function of residues in the
active site of TopIB, however no equivalent structure exists for YRs (Fig. 1.6). 
The YR active site is composed of seven conserved residues (Table 1.1).  In addition to the
tyrosine nucleophile, one lysine and two arginine residues are thought to be essential for efficient
recombination.  Two histidine residues are also found in most YR active sites; one of these
(His/Trp III) is tryptophan in the Cre and Flp recombinases.  The seventh active site residue is
either Glu or Asp in the YR enzymes.  A comparison of ~100 tyrosine recombinases in 1998
revealed aspects of the protein sequences that were strongly conserved, that were similar, and
that differed among family members (Nunes-Düby et al., 1998).  To obtain an updated estimate of
the degree of conservation of the active site residues that includes data from microbial genomes
sequenced over the past decade, we analyzed over 12,000 PsiBlast (Altschul et al., 1997) hits
from the NCBI RefSeq protein database (Pruitt, Tatusova & Maglott, 2007) using the Cre
recombinase catalytic domain as a query sequence (method details described in Chapter 2).  As
shown in Table 1.1, conservation ranges from the more variable box I histidine (87%) to the highly
conserved catalytic tyrosine (99.6%) and box II arginine (99.1%).  Two residues (His/Trp III and
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Glu/Asp I) are present as one of two alternative amino acid types in the YR enzymes.  TopIBs
have a similar active site, sharing five of the conserved residues with YRs. TopIBs lack the
strongly conserved histidine and the acidic residue (glutamic acid or aspartic acid). 
The properties of a number of YR (and TopIB) active site mutants have been described in
the literature, including their ability to catalyze recombination (relaxation) in vivo or in vitro and to
carry out specific catalytic activities such as binding, cleavage, and ligation.  We have compiled a
summary of these results in a table found in Appendix A, that augments a similar compilation
reported by Nunes-Duby et al. (Nunes-Duby et al., 1998).
Studies performed in vaccinia virus topoisomerase and Cre have demonstrated that the
invariant lysine (K201 in Cre), acts as a general acid to protonate the leaving 5' hydroxyl during
cleavage (Krogh & Shuman, 2000). Two arginine residues interact with the scissile phosphate,
likely having a role in charge stabilization. Work with TopIB demonstrated that R130 (R173 in Cre)
may assist in general acid catalysis, acting in a proton shuttle with the catalytic lysine, lowering
the pKa of the lysine, or possibly participating as the sole proton donor to 5'OH (Krogh &
Shuman, 2002; Nagarajan et al., 2005; Stivers et al., 2000). 
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Table 1.1: Tyrosine recombinase and topoisomerase IB active site residues
aResidue numbers refer to the vaccinia/variola virus topoisomerases.  bA lysine residue is located in
this position of the sequence in the TopIB enzymes, but is directed away from the active site.    cThe
values given are based on analysis PSI-BLAST hits from the NCBI RefSeq database using the Cre
catalytic domain as query.  The percentages for the catalytic lysine are estimates, as described in
Methods.  DRoles of active site residues in catalysis, based on published biochemical and structural
data and on the work described here.  TS=transition state stabilization; S=structural; GAB=general
acid/base catalysis; N=nucleophile.
Arg I Glu/Asp I Lys His II Arg II His/Trp III Tyr
P1 Cre R173 E176 K201 H289 R292 W315 Y324
λ Int R212 D215 K235 H308 R311 H333 Y342
S. cerevisiae Flp R191 D194 K223 H305 R308 W330 Y343
E.coli XerC/D R148 D151 K172 H240/244 R243/247 H243/247 Y275/279
R130 None K167 R223 H265 Y274
TS S GAB TS, GAB TS S, TS N
Poxvirus TopIBa Noneb
Conservationc 
91.2% R
1.1% K
79% E
16.4% D
94.7% K
3.8% R
87.3% H
6.8% Y
99.1% R
0.5% K
92% H
4% W
99.6% Y
Functionsd
Figure 1.4  Proposed mechanism of phosphoryl transfer in YRs and TopIB
Active site interactions depicting mechanistic states in phosphoryl transfer in YRs and TopIB enzymes as derived from structural snapshots and supported with
biochemistry. (A) Precleavage. (B) transition state. (C) Covalent intermediate. A constellation of conserved active site residues surround the scissile phosphate. The
reaction proceeds through an SN2 like mechanism where attack by the tyrosine nucleophile, assisted by a general base generates a pentavalent transition state as
observed in TopIB structure (pdb 3IGC). The two strictly conserved arginines stabilize negative charge on the scissile phosphate in the transition state and the
conserved Trp/His III donates a hydrogen bond to a nonbridging oxygen O1 of the phosphate. The conserved lysine acts as a general acid to donate a proton to O5' of
the leaving strand, generating a 3'phosphotyrosine covalent intermediate (C). Ligation is the reverse of cleavage. The 5'OH of the original strand or in the case of YRs,
from a partner site is activated by the lysine, now acting as a base, for attack on the 3'-phosphotyrosine generating the transition state where the a base, now acting as an
acid donates a proton to the tyrosine leaving group generating intact DNA and noncovalently attached enzyme as in (A).
                                                              16
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Figure 1.5  Pre-cleavage and covalent intermediate active sites of Cre and TopIB.
Structural snapshots depicting the arrangement of active site residues of Cre (top, A and B) and V. topoisomerase
(bottom, C and D). With the exception of E176, H289 the active sites are nearly superimposable. In place of E176,
TopIB has two well ordered water molecules providing similar interactions as E176 with Arginine and Lysine. K220 in
topoisomerase is the equivalent of H289, but is oriented away from the active site making an interaction if a
phosphoate. In the precleavage (C) and transition state mimic (not shown) structures of TopIB, two well ordered water
molecules  occupy the space as histidine. Similar well ordered water is not observed in the TopIB covalent intermediate
structure (2H7F), possibly due to the 2.7 Å resolution. 
18
Figure 1.6  Active site of Variola topoisomerase transition state intermediate
The active site of Variola (smallpox) topoisomerase active site as viewed in the transition state where the scissile
phosphate has been replaced with vanadium (pdb 3IGC).  Notice the well ordered water in B,located 2.7 Å from
phenolic oxygen of Y274 in the same approximate location as Nε of H289 in Cre in the covalent complex (1CRX – see
figure 1.5). 
The identification of a general base responsible for activation of the catalytic tyrosine has
remained elusive in both families of enzymes. The conserved histidine in YRs, H289 in Cre, is a
lysine in the TopIB enzymes. In structures of YRs, the histidine is positioned next to the catalytic
tyrosine leading to the suggestion that the histidine could act as a general base to activate the
tyrosine for attack on the scissile phosphate (Guo et al., 1997). However, mutagenesis of this
histidine is not as deleterious to recombination as mutations at the catalytic lysine (Ghosh, Lau,
Gupta & Van Duyne, 2005a; Parsons, Prasad, Harshey & Jayaram, 1988; Whiteson et al., 2007)
(Appendix A). Surprisingly, the lysine of TopIB forms an interaction with the phosphate backbone
of DNA away from the active site. The equivalent space is instead occupied by two well ordered
water molecules that have been proposed to assist in the activation of tyrosine (Davies et al.,
2006). It remains an open question why YRs have a conserved histidine when TopIB enzymes
have no equivalent residue. 
Another notable difference in active sites between YRs and TopIBs is the conservation of an
acidic residue, E176 in Cre with no structural equivalent in TopIB (Nunes-Düby et al., 1998). In
Cre, E176 accepts hydrogen bonds from the backbone amide nitrogens of K201 and R173 in
addition to Nη1 of R173 (Ghosh et al., 2007; Ghosh et al., 2005b; Guo et al., 1997). As with the
histidine, water fills this space in TopIB structures. Although aspartate in the equivalent as Cre
E176 has been studied in Flp and λ-int (Chen et al., 1992a; Nunes-Düby et al., 1998), no specific
function has been suggested that would explain why this residue is conserved in YRs. E176 has
essentially been ignored and until now, has not been considered among the conserved active site
residues in YRs (Azaro & Landy, 2002; Chen & Rice, 2003b). 
The specific roles of all conserved active site residues are explored further in Chapter 2 of
this thesis. 
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1.4.2 Architecture
Crystal structures of YRs have had a tremendous impact in the understanding the assembly
of the activated tetramer and the process of strand exchange that defines the recombination
pathway (reviewed in (Van Duyne, 2008; Van Duyne, 2002)). Structures are available for isolated
domains, unliganded protomers and complete tetrameric protein-DNA complexes. 
The tetrameric complex consisting of two sets of recombinase dimers bound to the core
site are brought together in a process called synapsis. It is within this tetramer that cleavage,
strand exchange and ligation take place, forming a HJ intermediate (Fig. 1.2A). Crystal structures
of Cre have captured the pre-cleavage synaptic complex, the post-cleavage covalent
intermediate and the HJ intermediate providing visual snapshots of several crucial steps in the
recombination pathway (Gopaul, Guo & Van Duyne, 1998; Guo et al., 1997; Guo, Gopaul & Van
Duyne, 1999) (Fig. 1.7). The structures of a Flp HJ complex (Chen et al., 2000) and λ-int HJ and
synaptic intermediates (Biswas et al., 2005) have also been determined, providing a means of
directly comparing a number of YRs to understand conserved and variable features of the
recombinase-DNA assemblies (Fig. 1.8).
Strikingly, the structures of Cre in the three states are almost superimposable, exhibiting a
pseudo four-fold symmetry with the largest differences being in the connectivity of the DNA in the
cross-over region. Each subunit makes extensive protein:protein interactions, burying nearly 3400
Å2 of surface area per subunit.  The N-terminal domains on one side of the DNA plane form a set
of interactions separate from those of the C-terminal catalytic domains (Fig. 1.7 and 1.8). The
very C-terminus of Cre forms a helix (hN) that exchanges in a cyclical manner with neighboring
subunits in the tetramer. The similarity in the three states suggest the entire recombination
pathway occurs with little change in the overall architecture. 
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The inter-subunit interfaces observed in the Cre tetramers differ in the corresponding Flp
and λ-int complexes. The Cre complex is the most rigid of the three, with λ-int forming very few
interactions between the CB and catalytic domains (Biswas et al., 2005; Chen & Rice, 2003c)(Fig.
1.8). This observation is consistent with the fact that λ-int exhibits weak binding specificity to core
sites and requires binding of P site DNA to the ARM-domain for efficient synapsis. Interestingly,
the ARM domains are cyclically exchanged in the integrase tetramer (Fig. 1.8).  
The pseudo four-fold symmetry observed in the tetrameric complexes reveals two distinct
interfaces. At the start of the reaction, synapsed sites form a pair of interfaces between two
recombinases bound to the same core site (the dimer interface). A second interface is formed
between recombinases bound to different core sites (a synaptic interface) (Van Duyne, 2002). HJ
isomerization swaps these interfaces for the second half of cleavage and strand exchange.
Differences in the protein:protein interfaces formed by the catalytic domains at dimer and synaptic
interfaces are at least partially responsible for activating only two of the four recombinases for
cleavage in the tetramer.  The mechanism of activation in Cre is not completely understood,
however regions containing the active site lysine and tyrosine in Cre are involved in
protein:protein interfaces at the synaptic and dimer interfaces. 
The catalytic lysine is located in a loop between two well conserved β-strands in YRs and
TopIB enzymes. However, the size of this loop and placement of the lysine in the loop is variable.
In Cre, this element appears to be quite mobile, as the lysine is poorly ordered or misoriented in
all but the activated subunits. In the active subunit, this region forms inter-subunit interactions at
the synaptic interface, while the region is displaced from the active sites of inactive subunits
mediated by the dimer interface. Therefore, it seems possible that this region could act as a form
of allosteric control to regulate the activity of the recombinase by delivery of lysine to the active
site. Since this interaction is mediated through a synaptic partner, this would imply that synapsis
may be required for cleavage. 
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Figure 1.7  Crystal structures of higher-order Cre-DNA complexes. 
Cre subunits are colored green and purple. The DNA is yellow. The tyrosine nucleophile is colored red and represented
as spheres.  The architecture of the tetramer does not change significantly in the three states with exception of the
central DNA region where cleavage and strand exchange occur.
(A) Pre-cleavage synaptic complex. (B) Covalent intermediate structure (C)  A HJ intermediate structure.
The C-terminal region of Cre adopts a very different conformation between the two
interfaces. In the dimer interface, hN of an active Cre subunit is donated to the catalytic domain of
an inactive subunit. However, hN of inactive subunits is donated across the synaptic interface to
the catalytic pocket of an active subunit. Although hN binding is similar in both instances, the
position of hM, Y324, and the hM-hN linker, is different, suggesting a role for the C-terminus of
Cre in regulating activity by modulating the position of Y324 (Gopaul et al., 1998). This region is
not conserved within the YR family. Flp for instance, exchanges the equivalent of hM with the
catalytic tyrosine to a neighboring subunit and the equivalent of hN returns to the original subunit.
Thus, the active site of Flp is composed of residues from two subunits (Chen & Rice, 2003b).
Since the tyrosine is donated to a neighboring subunit, cleavage in Flp occurs in trans, as
opposed to other YRs such as Cre, λ-int and XerCD that construct an active site entirely from the
same subunit where cleavage occurs in cis. The C-terminal residues of λ-int are exchanged in a
cyclical manner similar to Cre, however the element exchanged forms a β-strand and binds a
different region of the catalytic domain (Biswas et al., 2005). The only structural information from
the XerCD system is of unliganded XerD, however biochemical studies investigating the C-
terminus indicate that this region is important for activity and is likely to be structurally similar to
Cre (Hallet, Arciszewska & Sherratt, 1999; Kazmierczak et al., 2002; Spiers & Sherratt, 1999;
Tekle et al., 2002). 
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Figure 1.8  HJ intermediate structures of YRs
Comparison of YRs structures captured in the same mechanistic state of HJ intermediate. Cre (3CRX) makes extensive
protein:protein contacts at the interfaces of subunits, while Flp (1FLO) and λ-int (1Z1G) have far fewer interactions.
The cyclic exchange of  N-domains interacting with ARM site DNA are visible for λ-int (C, right). 
1.5 Thesis objectives
The overall goal of this thesis is to understand the mechanism of Cre-loxP recombination.
Despite the extensive biochemical and structural studies that have been reported in Cre, TopIB
and other YR systems, a number of crucial questions remain. 
YRs contain seven active site residues. How conserved are these
residues and how tolerant is Cre to change at each of these conserved
positions?
Although each of the conserved YR active site residues has been studied previously, no
more than seven of the nineteen possible substitutions have been tested. In some cases, a clear
understanding of the function has been derived from this limited set of mutants, however the
function for others remains unclear. To understand why these seven residues are conserved in
YRs, all nineteen single site variants were constructed in Cre and tested for the ability to support
recombination. To further aid the analysis of the active site and requirements for catalysis, I
determined the structure of Cre-DNA-vanadate complex, trapped as a transition state mimic,
where the scissile phosphate has been replaced by pentavalent vanadium. This structure
represents the first such intermediate for a YR system and complements a similar set of
structures of TopIB (Davies et al., 2006; Perry et al., 2010) to aid in understanding the
evolutionary relationship between YRs and TopIBs. 
Why do YRs contain two highly conserved active site residues that are
not found in TopIB enzymes?
YRs and TopIB share a similar mechanism of phosphoryl transfer and active site with two
exceptions. H289 and E176 in Cre are well conserved residues in YRs with undefined function,
but well positioned to serve important catalytic roles. The equivalent space in the TopIB active site
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is replaced with water.  I performed detailed biochemical analysis of mutants at H289 and E176 to
better understand the catalytic function of these residues and suggest why they are not found in
TopIB. 
Given similarities to TopIB enzymes that function as monomers, how
does Cre, perhaps the most simple YR, regulate activity to prevent
uncontrolled cleavage of DNA? 
TopIB enzymes efficiently cleave and ligate DNA as monomers, in some cases with limited
DNA specificity. Cre and other YRs systems regulate their activities to prevent undesirable
cleavage of DNA with potentially devastating consequences. Complex YR systems such as λ-int
and XerC/D use accessory factors to regulate activity. However, the mechanisms controlling
simple recombinases such as Cre are poorly understood. Work described in this thesis defines
the minimally active Cre complex, and investigates the regulatory function of the C-terminal helix
(hN). 
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Chapter  2. Requirements for catalysis in the Cre active
site (adapted from Gibb, B. et al. Nucleic Acids Research. 2010.)
2.1 Introduction
Members of the tyrosine recombinase (YR) family of site-specific recombinases catalyze
DNA rearrangements using phosphoryl transfer chemistry that is identical to that used by the type
IB topoisomerases (TopIBs). This similarity also extends to the level of structure, as the TopIB
enzymes have similar catalytic domain folds to YRs and share a subset of the YR active site
residues (Cheng, Kussie, Pavletich & Shuman, 1998).
The YR active site is composed of seven conserved residues (Table 2.1).  In addition to the
tyrosine nucleophile, one lysine and two arginine residues are thought to be essential for efficient
recombination.  Two histidine residues are also found in most YR active sites; one of these
(His/Trp III) is a tryptophan in the Cre and Flp recombinases.  The seventh active site residue is
either Glu or Asp in the YR enzymes.  A comparison of ~100 tyrosine recombinases in 1998
revealed aspects of the protein sequences that were strongly conserved, that were similar, and
that differed among family members (Nunes-Düby et al., 1998).  To obtain an updated estimate of
the degree of conservation of the active site residues that includes data from microbial genomes
sequenced over the past decade, we analyzed over 12,000 PsiBlast (Altschul et al., 1997) hits
from the NCBI RefSeq protein database (Pruitt et al., 2007) using the Cre recombinase catalytic
domain as a query sequence.  As shown in Table 2.1, conservation ranges from the more variable
box I histidine (87%) to the highly conserved catalytic tyrosine (99.6%) and box II arginine
(99.1%).  Two residues (His/Trp III and Glu/Asp I) are present as one of two alternative amino
acid types in the YR enzymes.  Four of the seven active site residues listed in Table 2.1 are
strictly conserved among the TopIBs.
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Table 2.1: Tyrosine recombinase and topoisomerase IB active site residues
aResidue numbers refer to the vaccinia/variola virus topoisomerases.  bA lysine residue is located in
this position of the sequence in the TopIB enzymes, but is directed away from the active site.    cThe
values given are based on analysis PSI-BLAST hits from the NCBI RefSeq database using the Cre
catalytic domain as query.  The percentages for the catalytic lysine are estimates, as described in
Methods.  DRoles of active site residues in catalysis, based on published biochemical and structural
data and on the work described here.  TS=transition state stabilization; S=structural; GAB=general
acid/base catalysis; N=nucleophile.
Arg I Glu/Asp I Lys His II Arg II His/Trp III Tyr
P1 Cre R173 E176 K201 H289 R292 W315 Y324
λ Int R212 D215 K235 H308 R311 H333 Y342
S. cerevisiae Flp R191 D194 K223 H305 R308 W330 Y343
E.coli XerC/D R148 D151 K172 H240/244 R243/247 H243/247 Y275/279
R130 None K167 R223 H265 Y274
TS S GAB TS, GAB TS S, TS N
Poxvirus TopIBa Noneb
Conservationc 
91.2% R
1.1% K
79% E
16.4% D
94.7% K
3.8% R
87.3% H
6.8% Y
99.1% R
0.5% K
92% H
4% W
99.6% Y
Functionsd
A number of active site mutants have been previously described for YR and TopIB enzymes
(summarized in Appendix I).  Even when the data for all YR enzymes are combined, however, the
substitutions that have been studied for a given active site residue number only 6-7 at most out of
the 19 alternatives and in some cases relatively conservative substitutions have not been
reported.  
As is the case for the YRs (Van Duyne, 2008), there are now several high resolution crystal
structures available for TopIBs bound to DNA substrates, providing a corresponding set of
snapshots of the enzyme active sites at different steps in the phosphoryl transfer reaction (Dong
& Berger, 2008).  One such model is a vanadate transition state mimic for both trypanosomal and
variola virus TopIB (Davies et al., 2006; Perry et al., 2010), which has provided additional insight
into the nature of TopIB catalysis.  A corresponding transition state mimic structure for a YR
system has not yet been reported.
To better understand the requirements for YR catalysis and the relationship between the YRs
and the TopIBs, I have analyzed the in vivo and in vitro recombination activities of all substitutions
of the seven active site residues in Cre recombinase.  I have also determined the structure of a
Cre-loxP reaction intermediate trapped as a transition state mimic with vanadate that facilitates
interpretation of mutant activities and allows for a comparison with similar structures from the
related topoisomerases.  The findings indicate that active site residues shared by YRs and TopIBs
are most sensitive to substitution.  Only two residues, the tyrosine nucleophile and a conserved
lysine residue that activates the 5'-hydroxyl group leaving group, are strictly required to achieve
greater than 5% of wild-type activity.  The two conserved arginine residues each tolerate one
substitution that results in modest  recombination activity and the remaining three active site
positions can be substituted with several alternative amino acids while retaining a significant
amount of activity.  The results in this chapter are discussed in the context of YR and TopIB
structural models and data from related YR systems.
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2.2 Structure of a Cre-loxP transition state mimic
To trap a vanadate transition state mimic for the Cre-loxP reaction, we used a symmetric
version of the loxP site where the scissile phosphates are missing in both the top and bottom
strand cleavage positions (Fig. 2.1A).  I chose to symmetrize the more G·C rich half-site of loxP
for these experiments (resulting in a site which I refer to as loxS1 (Ghosh et al., 2007)), which
provides a transition state model depicting the DNA functional groups that would be present in the
initial cleavage step of the reaction (Hoess, Wierzbicki & Abremski, 1987), as opposed to the HJ-
resolution step later in the pathway.  When activated potassium orthovanadate was added to the
Cre-loxS1 complex, one VO2+ equivalent was incorporated into the active site and covalent
linkages were formed with O3', O5', and Tyr324 as observed in the related TopIB transition state
mimic structures (Davies et al., 2006; Perry et al., 2010).
Crystals of the Cre-loxS1-vanadate complex were grown from hanging drops using
conditions similar to those used previously for several Cre-DNA structures (Gopaul et al., 1998;
Guo et al., 1997; Guo et al., 1999) and diffracted to 2.3 Å resolution at synchrotron sources.  The
structure was determined by molecular replacement using the synaptic Cre-DNA complex
(Ghosh et al., 2007) lacking active site residues as a search model.  A summary of diffraction data
and refinement results is given in Table 2.1 and electron density within the active site following
refinement is shown in Fig. 2.1B.  
The overall structure is similar to that observed in the pre-cleavage and covalent
intermediate Cre-DNA structures previously described (Ghosh et al., 2007; Guo et al., 1997), with
a tetramer of interlocked Cre subunits bound to two bent DNA substrates (Fig. 2.1C-D).  With the
exception of the active sites, the protein subunits in the current structure superimpose with an
r.m.s.d of 2 Å to those in the synaptic complex and covalent intermediate structures, with no
significant differences observed.  My discussion of the transition state mimic structure will
therefore focus only on the active site of the enzyme.
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Figure 2.1  Structure of Cre-DNA-vanadate transition state mimic.
(a) Sequence of the DNA substrate used, with vanadium incorporation indicated by 'v'.  The 14 bp recombinase binding
elements that surround the central 6 bp crossover region are shaded.  The '+1' and '-1' base-pair labels are used to
facilitate comparison with related TopIB structures.  (b) Weighted 2Fo-Fc electron density following refinement at 2.3
Å resolution.  The map is contoured at 1.2 σ.  Glu176 and His289 are not visible in this view.  (c) Overall structure of
the synaptic complex, viewed from the N-terminal domains of the recombinase subunits.  The activated subunits
containing vanadate linkages are colored green.  (d) View of a single Cre subunit bound to a loxP half-site within the
tetrameric complex, rotated from the boxed subunit in (c).  The tyrosine linkage to vanadate is circled.
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Table 2.2: Crystallographic data for the Cre-DNA-vanadate transition state
mimic
Values in parentheses refers to the highest resolution shell (2.38-2.30 Å).
Rsym  =  ∑h| Ih - ‹I›h | / ∑ Ih , where ‹I›h is the average intensity over the symmetry equivalents. 
Rwork includes 95% of the reflection data used in refinement.
Rfree  includes 5% of the reflection data excluded from refinement.
Diffraction Data Cre-Vanadate-DNA Complex
Resolution (Å) 2.3 Å
Space Group
Unit Cell
a = b = 136.046 Å
c = 218.431 Å
0.53
Wavelength (Å) 1
Completeness (%) 97.2(95.4)
0.103(0.462)
Total Reflections 775,986
Unique Reflections 102,079
16.17 (4.15)
Redundancy 7.6(7.3)
Refinement
0.222(0.285)
0.193(0.238)
Number of atoms 13,407
   Protein 10,204
   DNA 2859
   Water 346
   Protein 27.75
   DNA 36.75
   Water 25.6
   Bond lengths (Å) 0.01
1.62
P322
1
Mosaicity
R
merge
I/σ
R
free
R
work
Average B factors (Å2)
Rmsd
   Bond angles (o)
In principle, vanadate could be incorporated into each of the four active sites present in the
Cre-loxS1 complex shown in Fig. 2.1C.  In the Cre-DNA reaction intermediate structures that
have been reported, two of the active sites in the Cre tetramer adopt  'active' configurations that
are poised for catalysis of strand exchange (referred to here as the 'activated sites') and the other
two are in 'inactive' configurations ('inactive sites') that are not competent to catalyze cleavage of
the DNA (Van Duyne, 2001).  In the current structure, vanadium is incorporated only into the
activated sites, reflecting the inability of the remaining two subunits to stabilize a transition state
configuration.  With the exception of Tyr324 and Lys201, the protein and DNA residues involved
in coordinating vanadium in the activated sites (Fig. 2.2) adopt similar positions in the inactive
sites of the Cre-loxS1 complex.  Tyr324 is shifted by 3.5 Å in the inactive site relative to the
activated site position and Lys201 is withdrawn from the minor groove. These alternative
configurations for Tyr324 and Lys201 are typical of those observed in the inactive sites of other
Cre reaction intermediates and I assume that these effects are also responsible for preventing
stable incorporation of penta-coordinate vanadium in the inactive sites of the Cre-DNA complex
described here.
In the activated sites, vanadium is coordinated by five oxygen atoms in a trigonal bipyramidal
arrangement with Tyr324-Oη and O5' in the axial positions and with O3' and the two non-bridging
oxygen atoms in equatorial positions (Fig. 2.2).  The two conserved arginine residues each make
double hydrogen bonding interactions; Arg173 hydrogen bonds to O5' and the non-bridging
oxygen corresponding to O2P and Arg292 hydrogen bonds to the Tyr324 phenolic oxygen and to
O1P.  Lys201 is within close hydrogen bonding distance of four groups: O5' of the -1 sugar, N3 of
the +1 guanine base, O4' of the -1 sugar, and a tightly bound water molecule.  Each of these
features is also found in the trypanosomal and viral TopIB transition state structures (Davies et
al., 2006; Perry et al., 2010), supporting the close mechanistic and evolutionary relationship
between the two enzyme families.  Several other aspects of the Cre active site differ from the
TopIB enzymes and will be discussed below in the context of the specific residues. A comparison
of the Cre and TopIB active sites trapped in the transition state is shown in Fig. 2.3.
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Figure 2.2  The Cre-DNA-vanadate transition state mimic active site. 
(a) Stereo view of the 'activated' site where vanadate has been incorporated.    (b) Schematic of the activated site with
additional residues and hydrogen bonding interactions indicated.  Well-ordered water molecules  are drawn as red
spheres in (a) and (b).
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Figure 2.3  Cre and TopIB active sites in the transition state
The active sites of Cre and TopIB vanadate complexes are compared. A and C. Cre pdb 3MGV (this work). B and D.
Variola topoisomerase, pdb 3IGC (Perry, Hwang, Bushman & Van Duyne, 2010).
2.3 Comprehensive analysis of Cre active site substitutions
 To establish which Cre active site substitutions would support recombination, I generated all
single site variants for the residues shown in Table 2.1 and measured their ability to catalyze
recombination in vivo and in vitro.
To test for recombination activity in bacterial cells, I designed the single copy reporter shown
schematically in Fig. 2.4A.  The aadA streptomycin resistance and lacZYA genes located on an F'
episome are transcribed from a strong promoter when an intervening transcriptional terminator
has been excised by Cre-loxP recombination, but full-length transcripts are only produced  at low
levels when the terminator is present.  Cells that are Lac- and harbor the reporter F' will be
sensitive to streptomycin and Lac- in the absence of active Cre but will become streptomycin
resistant and Lac+ when active Cre is present.  For the experiments described here, I used
streptomycin resistance and β-galactosidase activity to score for Cre-mediated site-specific
recombination (Fig. 2.4B).  Growth on minimal lactose plates can also be used  and is more
effective in identifying mutants with very low activity.
To assay for in vivo Cre activity, I transformed E. coli strain CSH142 containing the reporter
F' with a plasmid containing a Cre coding sequence (described below) and compared the number
of colonies that formed on plates containing 20 µg/ml streptomycin to the number that formed on
plates lacking streptomycin.  Approximately 45 min is required for expression of the aadA gene
(data not shown).  A sixty minute outgrowth prior to plating therefore provided a ~15 min time
window for recombination to occur.  To facilitate in vitro mutagenesis and limit in vivo expression, I
cloned the wild-type Cre coding sequence into pBluescriptIIKS+ where it is oriented opposite that
of the lac and bla promoters.  Due to the high plasmid copy number, this promoter-less construct
still provides moderate levels of constitutively expressed Cre.   When I compared Cre expression
from this plasmid to basal Cre expression from uninduced pET21a (T7/lac promoter) and to a P1
lysogen by western blotting, I were not able to detect Cre in lysates from the P1 lysogen but could
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detect small amounts from pET21a and larger amounts from pBluescriptIIKS+ .  Electrophoretic
mobility shift assays (EMSA) confirmed that active Cre is present in all three cases and allowed
us to estimate the relative concentrations (Fig. 2.5).  Thus, the plasmid used for Cre expression
provides protein levels that are higher than that found in a P1 lysogen, but much lower than would
be produced by a promoter-driven expression system.
Using the pBluescriptII-Cre plasmid as template, I generated all nineteen amino acid
substitutions at each of the seven active site residues shown in Table 2.2.  Four of these (Arg173,
Lys201, Arg292, and Tyr324) are strongly conserved among both the YRs and the TopIB
enzymes.  Trp315 is most often a histidine in the YRs and is always histidine for the TopIBs.  The
final two residues are Glu176 and His289, both of which are unique to the YR enzymes.
Glutamic acid is favored in the Glu176 position, although a significant number of family members
use aspartic acid.   His289 is moderately conserved among the YRs but is absent from the TopIB
proteins.  The results of in vivo recombination for the 134 Cre variants are summarized in Fig.
2.4C.  I found a surprising range of flexibility at several active site positions, including a number of
mutants that I had not predicted would be active.  
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Figure 2.4  In vivo recombination activities of Cre active site mutants.
 (a) F' reporter used to score  in vivo activity.  If Cre excises a transcriptional terminator located downstream of the
promoter,  the streptomycin resistance and LacZYA gene products are expressed.  (b) example data from in vivo
recombination. After a 60 minute outgrowth, cells are plated on non-selective plates and selective plats containing
20ug/ml streptomycin (+strep). (c) in vivo recombination results for Cre active site substitutions.   Activity
definitions:  0: no activity observed; +: <5% wild-type, ++: 5-50% wild-type, +++: >50% wild-type.
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Figure 2.5  Cre concentration in vivo
Dilution of Cre lysate and purifed Cre were tested for binding in vitro to compare the expression levels of WT Cre on
from the highcopy Bluscript vector used for the characterization of Cre mutants compared with  the expression  of
uninduced  Cre from pET21A and Cre expression in a P1 lysogen. Comparing the intensity of the shifted probe to that
of purified Cre, allows for a determination of the concentration of Cre in the undiluted lysate. Based on the comparison
to purified Cre, the approximate concentrations of Cre in the undiluted lysates are ~250 nM from the Bluescript vector,
~5 nM from pET21A, and >1 nM Cre from phage P1. 
2.4 In vitro recombination of Cre mutants
To determine if any of the active site substitutions disrupt the ability of Cre to bind to the loxP
site, I used a gel-shift assay to test cleared lysates from the transformed reporter strain (Fig. 2.6).
The lysates in these experiments were diluted in binding buffer so that wild-type Cre lysate had
similar binding activity as that of a 4 nM Cre control.  This allowed a qualitative comparison of
DNA-binding activities in the lysates relative to wild-type Cre.  As shown in Fig. 2.6, the lysates for
all substitutions at His289 contain DNA-binding activities similar to wild-type Cre.  Out of all 134
Cre variants tested, only the Y324T mutant displayed a significant loxP-binding defect, where the
apparent KD  is more than 10-fold greater than wild-type Cre. For the remaining mutants, these
results indicate that the Cre variants are being produced in a soluble form that bind to loxP site
DNA, eliminating expression, folding, or gross DNA-binding defects as explanations for a lack of
recombination activity.  For many of the mutants, I noticed a small, but reproducible variation in
mobility of the shifted EMSA bands that may be caused by subtle differences in DNA-bending. 
To confirm and extend our findings from the in vivo recombination experiments, I tested each
Cre mutant for in vitro recombination, again using lysates from the transfected reporter strain.  In
this assay, Cre excises a 334 bp segment flanked by loxP sites in a labeled, linear substrate,
producing an unlabeled 368 bp circle and a labeled 234 bp linear product (Fig. 2.7A).  The results
of in vitro recombination for the H289 panel are shown in Fig. 2.7B and a summary of results for
all of the active site substitutions is shown in Fig. 2.7C.  In general, there is good agreement
between in vitro and in vivo recombination, but for mutants with higher levels of activity the in
vitro assay provides better discrimination.  For example, the W315F and W315Y substitutions
have near wild-type activity in the in vivo assay, but are shown have less than 50% wild-type
activity in the in vitro excision assay.  The in vitro recombination experiments also identified active
site mutants that accumulate covalent and/or HJ intermediates in excess of wild-type Cre.  These
results are summarized in Table 2.3 and in Fig. 2.8.
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Figure 2.6  In vitro loxP-binding for Cre H289 substitutions.
 A 64 bp loxP-containing probe for electrophoretic mobility shift assays using lysates that had been diluted 50-fold to
give an apparent concentration of 5 nM for wild-type Cre based on gel shift assays of further serial dilutions and the
known binding affinity to the loxP site. Assignment of the shifted bands was based on preliminary experiments where
purified Cre was analyzed in the same gels for comparison. The additional band between the singly and doubly bound
species is lysate-dependent and could be due to Cre degradation products (observed in Western blots) or to bacterial
components in the lysates.
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Figure 2.7  In vitro recombination activities of Cre active site mutants.
 (a) Schematic of the excision assay.  (b) Native PAGE of in vitro recombination reactions following protein digestion
for the H289 panel of substitutions.  In addition to the 602 bp substrate (labeled 'S') and the 234 bp product (labeled
'P'), a band corresponding to a covalent Cre-DNA intermediate can be observed migrating slightly above the product
band for some mutants .  This is a nicked 234 bp   covalent 3'-phosphotyrosine adduct.  The corresponding covalent
intermediate associated with the substrate is not well-resolved.  Identification of covalent and HJ intermediate bands
are described in more detail in Figure S2.  (c) in vitro recombination results. Activity definitions:  0: no activity
observed; +: <5% wild-type, ++: 5-50% wild-type, +++: >50% wild-type.
Table 2.3: Accumulation of Holliday junction and covalent intermediates during in vitro recombination
Key:  + indicates levels similar to wild-type Cre; ++ indicates greater than 2x wild-type; +++ indicates greater than 4x wild-type.  Levels
reported are after a 60 min reaction.
A C D E F G H I K L M N P Q R S T V W Y
Y324
HJ +
cov +
K201
HJ +
cov +
R173
HJ ++ +
cov ++ +
R292
HJ ++ + +
cov +++ +
W315
HJ +++ + +++
cov + +
H289
HJ ++ + + ++ + + + ++ + + + + +
cov + ++ + + ++
E176
HJ +++ +++ +++ + +++ +++ + ++ ++ ++ + + +++ ++ +
cov + + + +
                                                              43
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Figure 2.8  Identification of intermediates formed during in vitro recombination. 
Legend on next page.
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Figure 2.8 continued. Legend
(a) Expanded view of the 6% acrylamide gel in Fig. 2.5b.  HJ intermediates do not migrate far into the gel matrix, but
nicked 3'-phosphotyrosine linked products resulting from digestion of covalent Cre-DNA intermedates are resolved
from product bands. (b) in vitro recombination reactions with Cre WT, Y324F, A312T and H289Q were incubated for
60 minutes, quenched, and then separated on a 4% acrylamide gel. Cre A312T accumulates HJ intermediates (1). The
reactions were quenched with either SDS/Proteinase K or Phenol/Chloroform. Covalent intermediates partition into the
organic phase during extraction with phenol/chloroform.  The DNA substrate contains a central BsrGI site; digestion
results in the formation of 389 bp and 234 bp bands. Digestion of the HJ α-intermediate (III in panel e.) yields a χ-
structure with increased mobility (III-A in panel e.). Covalent intermediates formed during HJ resolution are identified
by comparing samples quenched with SDS/Proteinase K vs. Phenol/Chloroform. (c and d) In vitro recombination
reactions with Cre WT and H289Q were quenched after 60 min with SDS/Proteinase K and separated by native PAGE
(c) or by denaturing PAGE in 7 M Urea (d). The denatured, digested covalent intermediate is separated into a labeled
114 -mer containing a covalently attached tyrosine and a labeled 234-mer that is uncleaved. (e) Schematic of the
reaction showing intermediates that are formed. 
2.5 Results and discussion of the active site
2.5.1 Tyr324 substitutions
As anticipated, Tyr324 is strictly required for recombination.  None of the nineteen alternative
residues showed any detectable recombination activity in vivo or in vitro.  As noted above, Cre
Y324T was the only mutant identified that is substantially defective in DNA-binding (Fig. 2.9B).
Western blot analysis indicates that this mutant is expressed in a full-length, soluble form and at
levels comparable to wild-type Cre (Fig. 2.9A).  It is possible that this mutant is misfolded or
adopts an alternative structure that is not competent to bind to the loxP site.
The requirement for tyrosine in this position of the active site is evident from Fig. 2.2.
Whereas some substitutions could in principle fulfill a role as nucleophile (e.g., serine, cysteine,
lysine, histidine), the length and shape of the tyrosine side chain is unique.  Indeed, a large
superfamily of site-specific recombinases use serine rather than tyrosine as a nucleophile to
catalyze strand exchange by a related phosphoryl transfer mechanism (Grindley et al., 2006).
However, even if a suitable general base were present to activate a serine residue for
nucleophilic attack in the Cre active site, it is clear that the  side chain of a Y324S substitution is
too short reach the scissile phosphate.
The requirement for tyrosine in the YR and TopIB active sites may also extend to the identity
of the phenolic hydroxyl group.  Semi-synthetic vaccinia virus TopIB mutants with the tyrosine
oxygen replaced by nitrogen (tyramine) or sulfur (thio-tyrosine) are both inactive, suggesting a
unique requirement for tyrosine in the cleavage and ligation chemistry catalyzed by this enzyme
superfamily (Gao et al., 2005). 
46
47
Figure 2.9  Y324T defective in binding, but soluble.
Cre Y324T was the only mutant to display a significant deficiency in binding with soluble lysates. 
A. 20 ul of cleared Cre lysate (grown to 1 OD) run on SDS-PAGE for western analysis and detected with Cre specific
antibody. 'No Cre Lys', contains Bluescript vector lacking Cre insert. 
B. Cre binding assay with 1:50 dilution of  cleared lysate. Probe contains labeled substrate in binding buffer, 'No Cre
Lys', contains Bluescript vector lacking Cre insert. 
2.5.2 Arg173 substitutions
The results of substitutions at Arg173 were surprising.  For the Cre R173K mutant, previous
studies showed no in vitro cleavage or recombination activity using linear substrates (Chapter 5).
It was expected that no substitutions at Arg173 would result in recombination activity above the
threshold of our in vivo assay.  However, the R173K mutant is clearly active for recombination in
vivo.  Cre R173K was previously shown to be severely defective in synapsis of loxP sites (Ghosh
et al., 2007) and the corresponding R191K mutant in Flp shows altered patterns of DNA-bending
(Friesen & Sadowski, 1992).   It is conceivable that substrate supercoiling or other differences in
the in vivo reaction (Adams, Bliska & Cozzarelli, 1992) are able to compensate to some extent for
these deficiencies.
The second surprise was the relatively high activity observed for R173H, a mutant that to our
knowledge has not been described for the tyrosine recombinases or the TopIB enzymes.  Unlike
R173K, which showed no in vitro recombination activity, the R173H mutant showed robust activity
both in vivo and  in vitro.  These results suggest that a lack of interaction with the O5' leaving
group is unlikely to be responsible for the devastating loss of activity observed in other
substitutions at this position (e.g., R173A).  The hydrogen bond to O5' made by R173 is via the
η2-nitrogen, at the very end of the arginine side chain (Fig. 2.2A).  At best, the shorter histidine
side chain in this position would be capable of a long-range interaction with O5' via its ε-nitrogen.
The more likely active site configuration for Cre R173H is one where His173 hydrogen bonds to
the O2P non-bridging oxygen via Nε, just as Arg173 does in all Cre-DNA crystal structures that
have been reported.  Thus, the activity of R173H is most likely due to its ability to stabilize a
buildup of negative charge on O2P rather than its ability to activate O5'.    
The R173H mutant also accumulates more HJ and covalent intermediates of the reaction
than are observed for wild-type Cre.  Accumulation of covalent intermediate implies that Keq =
kclv/klig (where kclv and klig are the first-order rate constants for cleavage and ligation,
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respectively) has increased for the covalent intermediates in the recombination pathway.
Although Arg173 has been implicated in activation of the O5' leaving group, the same interaction
may also play a role in guiding O5' into position for efficient ligation.  Loss of this contribution
could explain the mild ligation defect observed in the R173H mutant.  Interestingly, the Flp R191K
mutant also accumulates covalent intermediates in vitro, but in this case the ligation defect is
more severe and no recombinant products are formed (Friesen & Sadowski, 1992).
Arg173 is strongly conserved among the tyrosine recombinase and TopIB enzymes and
conservative lysine substitutions in this position show greatly diminished in vitro catalytic activity
in the systems that have been tested (Appendix A). The Cre-DNA transition state mimic structure
shows this catalytic arginine making hydrogen bonding interactions with both a non-bridging
phosphate (vanadate) oxygen and with the O5' leaving group (Fig. 2.2).  Thus, Arg173 plays a
dual role in the transition state of the cleavage and ligation reactions.
2.5.3 Lys201 substitutions
Lys201 is located in the loop that connects conserved β-strands 2 & 3 in the YRs and in the
TopIBs, where it is inserted into the minor groove near the cleavage site and hydrogen bonds to
the +1 base (Guo et al., 1997; Redinbo et al., 1998).  Although Lys201 appears to be strongly
conserved among the YRs, its position in a variable-length loop creates challenges for identifying
the corresponding residue in large alignments of YR sequences (see Experimental Methods).
None of the Lys201 substitutions in Cre resulted in high recombination activity.  However,
several substitutions did have a low level of recombination activity in vivo, including the K201R
mutant.  Since the pKs of lysine and arginine differ by roughly two log orders, the arginine
substitution would be expected to result in a 100-fold decrease in cleavage rate based only on its
ability to activate the O5'-leaving group.  This  prediction holds true for poxvirus TopIB (Krogh &
Shuman, 2000) and appears to be approximately true for Flp (Chen & Rice, 2003a) and for Cre
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(this work).   However, the Ala and Asn substitutions at this position also have weak in vivo
activity, despite their lack of ability to participate in general acid catalysis.  None of the K201
substitutions showed measurable in vitro recombination activity.  
The important catalytic role of this conserved lysine was first demonstrated for poxvirus
TopIB, where 5'-bridging phosphorothiolate DNA substrates were used to show that this residue is
the general acid responsible for activation of the O5' leaving group during the cleavage step of
the reaction (Krogh & Shuman, 2000).  The same conclusion was later reached for Cre, using a
similar approach (also Chapter 5) (Ghosh et al., 2005a).  Accordingly, the Cre K201A mutant and
the corresponding  mutants in Flp and Xer are inactive (Cao & Hayes, 1999; Chen & Rice, 2003a;
Lee & Sadowski, 2003).
The Cre transition state mimic structure strongly supports the biochemical data and related
structural results from the TopIB systems regarding the active site lysine (Fig. 2.3) (Davies et al.,
2006; Perry et al., 2010; Krogh & Shuman, 2000; Krogh & Shuman, 2002).  Lys201 hydrogen
bonds directly to the O5' leaving group as well as to the +1 base, O4' of the -1 sugar, and a well-
ordered water molecule that is also found in the TopIB transition state mimic structures (Fig. 2.3).
The lysine side chain adopts a fully extended form, with all four side chain dihedral angles near
180°.  This may explain in part why histidine is ineffective in this position; even if the bulkier
imidazole ring could be accommodated in the minor groove, the ε-nitrogen would fall well short of
forming effective hydrogen-bonding interactions with O5'.  Although the weak activity of the
arginine substitution can be rationalized, it is not clear why the Ala and Asn substitutions have a
comparable level of activity in vivo.  
2.5.4 Substitutions at Arg292
Sequence alignments indicate that Arg292 is as conserved as Y324, with only a small
number of lysine substitutions represented (Table 2.2).  Structures of  Cre-DNA (Van Duyne,
2008),  λ Int-DNA (Aihara et al., 2003a; Biswas et al., 2005), and Flp-DNA (Chen & Rice, 2003b)
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complexes all show this side chain hydrogen-bonding to the O1P non-bridging oxygen via Nη2.
Since lysine in this position should also be capable of interacting with O1P (based on modeling),
it is not surprising that the corresponding R223K mutant in vaccinia virus TopIB retains ~10%
activity (Cheng, Wang, Sekiguchi & Shuman, 1997).  I also found that the R292K mutant was
moderately active.  In addition, I identified nine different substitutions for Arg292 that are  weakly
active in vivo.  Of these, only the histidine mutant shows detectable recombination in vitro.  The
R292K substitution, on the other hand, is active both in vivo and in vitro.  This mutant also
accumulates the most covalent intermediate of any single active site substitution that I have
studied (Table 2.3), indicating a substantial defect in substrate ligation.  Similar observations have
been reported for the corresponding mutants in vaccinia virus TopoIB (Cheng et al., 1997),  and
XerCD (Arciszewska, Baker, Hallet & Sherratt, 2000).
The Cre-DNA-vanadate structure reveals a potentially important interaction involving
Arg292 that was not evident in earlier recombinase-DNA crystal structures.  In addition to forming
a hydrogen bond with O1P, the arginine side chain hydrogen-bonds to the Tyr324 phenolic
oxygen via Nε, forming a double hydrogen-bonding contact resembling that observed for Arg173
(but to different functional groups).  A similar interaction was observed in the TopIB-vanadate
structures (Fig. 2.3) (Davies et al., 2006; Perry et al., 2010), indicating that this is a conserved
feature of the transition state in the YR and TopIB enzymes.  As noted for the TopIB enzyme
(Yakovleva, Chen, Hecht & Shuman, 2008), the interaction of Arg292 with the Tyr324 oxygen
suggests that Arg292 could play a functional role in stabilizing the buildup of negative charge of
the phenolate form of the active site tyrosine during the transition state of the reaction.   The
accumulation of covalent intermediate by the R292K mutant would be consistent with a role for
Arg292 in activation of the tyrosine leaving group during the ligation reaction, since lysine in this
position would not be expected to form optimal interactions with either the Tyr324 oxygen or with
O1P for the same reasons discussed above for the R173K mutant. during the ligation reaction,
since lysine in this position would not be expected to form optimal interactions with either the
Tyr324 oxygen or with O1P for the same reasons discussed above for the R173K mutant.
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2.5.5 Substitutions at Trp315
Trp315 is an outlier among the YR enzymes in that greater than 90% of family members
have histidine in this position (Table 2.1).  In the Cre-DNA-vanadate structure Trp315 hydrogen
bonds to O1P phosphate oxygen via the indole nitrogen. A similar interaction was observed with
the equivalent histidine in λ-integrase  (Aihara et al., 2003a) and for the TopIB enzymes (Perry,
Hwang, Bushman & Van Duyne, 2006; Redinbo et al., 1998). The results of substitutions at Cre
Trp315 found that His is not as effective when substituted for tryptophan in Cre than Phe or Tyr. In
addition, Ala, Gly, Leu and Met substitutions all have weak in vivo recombination activity. Of the
weaker substitutions, His, Leu and Met have detectable recombination activity in vitro but the
smaller Gly and Ala substitutions do not.  The finding that W315M has recombination activity
comparable to W315H further underscores the need for a large hydrophobic residue in this
position.  The in vivo activity of W315A and W315G would appear to contradict this model, but it
is possible that these mutants adopt an alternative conformation in this region of the enzyme that
is somehow able to partially compensate for the loss of W315.  
The positions of Trp315 and Tyr324 in the transition state mimic structure (Fig. 2.2) provide
an opportunity to carefully examine the contacts that are present at this crucial stage of the
reaction.  Trp315 is located on a turn between the αL and αM helices, where it provides a
substantial amount of hydrophobic surface onto which the αM helix docks via van der Waals
interactions with Ile320 and Val321.  Tyr324 is located at the carboxyl-terminus of αM, where the
tyrosine ring 'sits' on top of Trp315.  Each of the carbon atoms in the Tyr324 phenyl ring contacts
Cζ of Trp315 with a distance of 3.5-4 Å.  Although the Phe and Tyr substitutions are predicted to
be less effective than Trp in supporting the Tyr324 ring system, it is clear from modeling that a
similar set of substantial contacts could be made in the transition state in both cases.  Indeed, the
structure of the Flp W330F/DNA complex shows that this is the case when the catalytic tyrosine
has not yet attacked the scissile phosphate (Chen & Rice, 2003a).  On the other hand, the
smaller histidine in this position does not appear to be capable of forming similar contacts.  I note
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that both the Phe and Tyr substitutions at Trp315 cause substantial accumulations of HJ
intermediates (Table 2.3), suggesting that repacking this hydrophobic region of the enzyme may
also lead to conformational changes that influence aspects of the reaction pathway other than
catalysis.
If Trp315 plays a crucial role in positioning the active site nucleophile, then it is instructive
to consider how the majority of tyrosine recombinases are able to function with histidine in this
position.  In both Cre and Flp (and most other YRs that use Trp in this position), glycine is located
two residues before His/Trp III.  A side chain in this position would occupy the same space as the
tryptophan side chain in the absence of large structural changes in the αL-αM turn.  This residue
is normally Leu, Met, or Val in most of the YR enzymes, each of which would likely be able to
fulfill the role of the active site tryptophan in Cre and Flp.  In λ integrase, for example, a leucine
side chain in this position packs against the catalytic tyrosine (Aihara et al., 2003a).
In those cases where a smaller side chain is located two residues preceding His/Trp III, a
large hydrophobic side chain is present four residues after Arg292 in the αK helix.  This residue is
normally an alanine in most YRs, but a larger side chain would also project into the space
occupied by the bulky Trp side chain in Cre and Flp.  Thus, there appear to be a number of
solutions for stabilizing the local structure and defining the position of the active site nucleophile
in the YR enzymes (Ma et al., 2007).  In vaccinia virus TopIB, the corresponding His265 can be
substituted by Asn or Gln with only a modest loss of activity (Petersen & Shuman, 1997b).  In this
case, the helix containing Tyr274 is anchored adjacent to the active site via direct contacts to the
DNA backbone and to bases downstream of the cleavage site (Perry et al., 2010), so the role of
this catalytic residue for the TopIBs appears to primarily involve transition state stabilization and
not positioning of the active site tyrosine.  In the Flp recombinase, the W330A mutant shows an
unexpected thio-effect on 5'-bridging phosphorothiolate substrates, suggesting a role in leaving
group activation (Ma et al., 2007).  This observation cannot be readily explained based on the Cre
transition state mimic structure.
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2.5.6 His289 is unique to tyrosine recombinases
I found that all but five substitutions (Asp, Glu, Lys, Arg, and Trp) at His289 in Cre are active
for recombination in vivo.  Of these, Ile and Pro show only weak activity but several are nearly as
efficient as wild-type Cre.  All of the mutants that were active in vivo also showed detectable in
vitro activity (Fig. 2.7).  Two of the active mutants, H289A and H289N, have been previously
studied (Gelato, Martin & Baldwin, 2005).  In the transition state mimic structure, His289 adopts a
curious hydrogen-bonding arrangement, with the Nε hydrogen directed midway between non-
bridging O2P and the attacking/leaving oxygen of Tyr324.  Thus, His289 is positioned in such a
way that it could stabilize the buildup of negative charge on O2P and serve as a proton
donor/acceptor for the Tyr324 phenol oxygen.  A well ordered water molecule (B-factor ~ 18 Å2)
hydrogen bonds to Nδ of His289, an anchoring interaction that was also observed in the covalent
intermediate structure.  
The TopIB enzymes have no equivalent to His289 in their active sites.  Although lysine
precedes Arg223 by three residues in vaccinia and variola virus TopIB, differences in local
structure allow Lys220 to be directed away from the scissile phosphate, where it instead interacts
with the upstream (+1) phosphate on the cleaved strand (Fig. 1.5 and Fig 1.6)(Perry et al., 2006).
Consequently, the space occupied by His289 in the YRs is filled with water molecules in the
TopIB structures.  His289 is less strongly conserved among the tyrosine recombinases compared
to the active site arginines and the tyrosine (~87%), with ~7% of sequences showing Tyr in this
position and ~1% with Gln.  The original covalent Cre-DNA structure prompted the suggestion
that His289 could be responsible for activation of Tyr324 during cleavage and ligation (Guo et al.,
1997; Sherratt & Wigley, 1998).  Indeed, subsequent crystal structures of Cre-DNA, Flp-DNA and
λ Int-DNA complexes supported this idea.  Biochemical evidence for a role in general acid/base
catalysis has come from the Flp system, where synthetic peptides with increased nucleophilicity
of the catalytic tyrosine were shown to rescue cleavage activity of the His305Q mutant (Whiteson
et al., 2007).
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The variety of amino acid substitutions at His289 that are active for recombination
indicates that although moderately conserved, this active site residue is not strictly required for
catalysis.  This idea is consistent with the absence of an equivalent residue in the TopIB
enzymes.  Glutamine is probably the most conservative substitution for His289 in terms of size
and ability to hydrogen bond, yet the Met substitution has similar activity in vivo and nearly the
same activity in vitro.  Even the Gly substitution is moderately active.  As shown in Fig. 2.5B and
Table 2.3, both the Gln and Leu substitutions at His289 lead to an accumulation of covalent
intermediate.  This effect was also observed for several His305 mutants in Flp, including H305L
(Parsons et al., 1988).  Although one might conclude from an analysis of these substitutions alone
that His289 is required for efficient ligation, the data indicate that covalent intermediate
accumulation is not a general property of His289 mutants.  The Ala, Gly, Met, and Asn
substitutions are all moderately active, yet none of them appears to have shifted the cleavage-
ligation balance in favor of cleavage.  The H289M mutant does, however, accumulate a
significant amount of HJ intermediate, with lesser amounts produced by the Ala and Gly
substitutions.  Interestingly, the Cre H289A mutant has also been shown to have an altered
preference for the strand of loxP that is initially exchanged during recombination (Gelato et al.,
2005). The functional role of His289 in Cre is explored in detail in Chapter 4. 
Of the inactive substitutions at His289, modeling indicates that Trp is too bulky to be
accommodated in the active site without major changes in the positions of catalytic residues.  Asp
and Glu would in principle be capable of performing general acid/base catalysis, but the negative
charges associated with the carboxylate side chains are clearly detrimental to recombination,
presumably by destabilizing the transition state.  The lack of detectable activity for the Lys and
Arg substitutions was somewhat surprising.  One possible explanation is that these side chains
compete with Tyr324 for the same position adjacent to the scissile phosphate and sterically block
the nucleophile.  A large conformational change that occurs in helix-M and Tyr324 relative to the
inactive active sites in the Cre tetramer suggests that this explanation is plausible.  Alternatively,
the side chains may simply be too long to be accommodated in the active site.  It does not appear
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possible for Lys289 or Arg289 to adopt conformations that resemble Lys220 in the viral TopIB
structures due to steric interference with the inter-domain linker that is quite different in Cre
compared to the viral TopIB protein.
2.5.7 Glu176 organizes the active site
Glu176 does not interact directly with the scissile phosphate, but plays a role in organizing
the Cre active site.  Although Glu is favored in this position of the YR family (79%), Asp is also
highly represented (16.4%), with over 95% using one or the other acidic side chain (Table 2.1).
Fifteen substitutions for Glu176 in Cre were active for recombination in vivo, although the His,
Met, Pro, Val, Trp, and Tyr substitutions were very weak.  In vitro, the His, Trp, and Tyr mutants
showed no detectable activity.  Surprisingly, the strongest substitutions were Asn and Thr, each of
which showed high in vitro recombination activity.  The conservative E176D mutant was
somewhat less active and the E176Q mutant showed no measurable activity at all in the in vitro
assay.  The behavior of E176Q was unexpected; presumably this residue  stabilizes an
alternative, but unproductive arrangement of active site residues.   The modest activities resulting
from Ala and Gly substitutions indicate that loss of the interactions involving Arg173 and Lys201
diminishes, but does not destroy catalysis in this system.  The functional role of Glu176 and the
interactions made with Arg173 and Lys201 are explored in detail in Chapter 5. 
Several substitutions for the corresponding Asp194 in Flp recombinase have also been
studied (Appendix A).  Of these, it is interesting to note that the D194N mutant is deficient for
cleavage of DNA half-sites (Chen et al., 1992a).  As noted above, the corresponding conversion
from acid to amide in Cre is also defective.  Although none of the Cre Glu176 mutants accumulate
significant amounts of covalent intermediate, many of them do accumulate Holliday
intermediates.  
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 In the transition state mimic structure, Glu176 accepts three hydrogen bonds from catalytic
residues.  The side chain carboxylate forms a hydrogen-bonding bridge between the backbone
amide and Nη1 of Arg173, appearing to lock this key residue into a conformation that is optimal
for catalysis.  The Glu176 carboxylate also hydrogen bonds to the backbone amide of Lys201,
helping to position the β2-β3 loop in the minor groove adjacent to the active site.  
Both λ integrase and Flp recombinase have aspartic acid in this position.  In the λ Int-
DNA complex, Asp215 anchors the β2-β3 loop by hydrogen bonding with the backbone amide  of
Ser234 (which precedes the conserved active site Lys235) and makes a long-range interaction
with Arg212- Nη1 (Aihara et al., 2003a; Biswas et al., 2005).  In the Flp-DNA complex, Asp194
hydrogen bonds to the backbone amide of Arg191 and interacts with the amide of Lys223
indirectly via bridging water molecules (Chen et al., 2000).  Thus, Asp and Glu in this position of
the YR enzymes carry out similar structural roles, but the detailed interactions differ among the
individual systems.  The TopIB enzymes do not have a residue corresponding to Glu176 in Cre.
Instead, tightly bound water molecules in the active site make a similar set of interactions with
Arg130 and the Lys167 backbone (Fig. 2.3) (Davies et al., 2006; Perry et al., 2010).
2.6 Discussion
The Cre active site residues can be grouped into three categories based on their tolerance
to substitution.  In the first category, Tyr324 and Lys201 are essential for catalysis; I found no
active substitutions of Tyr324 and only very weak ones for Lys201.  Thus, a nucleophile and a
general acid catalyst to activate the 5'-hydroxyl leaving group play the most unique and essential
roles in the reaction.  In the second group, Arg173 and Arg292 each play dual roles in catalysis
and are symmetrically organized in the transition state with respect to cleavage and ligation.  Both
residues stabilize the buildup of negative charge by hydrogen-bonding to a non-bridging
phosphate oxygen.  These residues also hydrogen bond to the nucleophile and leaving groups of
the reaction: Arg173 to O5' and Arg292 to the Tyr324 hydroxyl.  Thus, the roles of the two
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residues become interchanged during cleavage vs. ligation.  The third category includes Trp315,
His289, and Glu176, each of which is tolerant to substitutions that result in moderate to high
levels of recombination activity, with additional substitutions that have lower levels of activity.  No
active site substitution resulted in an increase in in vivo or in vitro recombination activity relative to
wild-type Cre.
For most active site residues, there is a high correlation between the degree of
substitution allowed and the diversity of residues identified at the corresponding position in the
protein database.  The exception is Arg173, which is present as Arg in only 91% of the YR protein
sequences.  Interestingly, the lysine substitution is found in only ~1% of the sequences and the
remainder are distributed among Ala, Ser, and other residues.  One explanation could be that
there are alternative active site compositions and/or geometries that do not require the box I
arginine for activity.  Alternatively, the YRs lacking Arg I may represent a group that is catalytically
inactive, but has nonetheless retained Arg II and the active site tyrosine.
The active site residues most sensitive to substitution are those shared by the TopIB
enzymes, which catalyze the same basic phosphoryl transfer reactions very efficiently without
His289 and Glu176 equivalents.  Why, then, is His II moderately conserved in the YR family and
why are Asp and Glu nearly always found in the position corresponding to Glu176?  Part of the
answer may be related to the differences between the reactions catalyzed by the YR and TopIB
enzymes.  The TopIBs cleave their targets to form covalent 3'-phosphotyrosine intermediates and
allow rotation of DNA downstream of the cleavage site  about the site of the nick.  TopIB evolution
has presumably tuned the relative rates of cleavage and ligation to strike a balance between
allowing escape of the 5'-nucleoside (and subsequent relaxation of supercoils) and minimizing
exposure of the nicked chromosome to potentially damaging processes.  In contrast, the YR
enzymes need to coordinate the cleavage, exchange, and ligation of DNA strands between two
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active sites in the recombinase tetramer, while rendering the other two sites inactive.  In the
absence of such allosteric regulation, YR enzymes could generate double-strand breaks across
the 6-8 bp overlap region.
The details of the inter-subunit interactions responsible for coordinating cleavage in the
YR systems differ considerably among the Cre, λ integrase, and Flp systems.  However, one
general feature in common to each of these systems involves positioning of the active site
tyrosine, where availability of the nucleophile for catalysis is strongly influenced by interactions
with the neighboring subunit (Discussed in Chapter 6) (Aihara et al., 2003a; Arciszewska et al.,
2000; Chen & Rice, 2003b; Van Duyne, 2001).  For Flp recombinase, the active site tyrosine is
donated in trans from an adjacent subunit (Chen, Lee & Jayaram, 1992b).  An additional source
of regulation may involve positioning of the active site lysine, which is also influenced by inter-
subunit contacts.  One consequence of evolving a regulated recombinase active site from an
ancestral topoisomerase may therefore have been a loss of some catalytic power, as the
dynamics of active site residues were modified in order to allow allosteric control of their
positions.  I suggest that the YR active site residues corresponding to His289 and Glu176 in Cre
were added in order to compensate for this loss in activity.   Indeed, loss of either of these
residues in Cre to generate a more 'Topo-like' active site results in a decrease in recombination
activity and for those mutants in Cre and other systems where cleavage has been assayed
specifically, a decrease in cleavage rates have been reported (Appendix B).
Ironically, a comparison of the static transition state models between the TopIB and YR
enzymes might lead to the conclusion that the YRs should be more efficient in catalyzing
cleavage and ligation.  In the Cre transition state mimic structure, His289 provides both additional
transition state stabilization and a potential activating function for Tyr324.  Glu176 plays a
structural role in positioning Arg173 and Lys201.  In the corresponding variola virus and
trypanosomal TopIB transition state mimics, these functional roles appear to be carried out by
ordered water molecules (Fig. 2.3).  However, estimates of the pseudo-first order cleavage rate
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constants for half-site and full-site DNA substrates for Cre range from 0.001-0.003 s-1 (Gelato et
al., 2005; Ghosh et al., 2005a; Ma et al., 2009a), compared to 0.3-0.7 s-1 for vaccinia virus TopIB
(Krogh & Shuman, 2000; Stivers et al., 2000).  Flp recombinase, on the other hand, cleaves half-
site and full-site DNA at rates that are closer to that of the TopIB enzymes (Ma et al., 2009b).
Thus, the additional active site residues found in the YR enzymes do not appear to provide a
substantial increase in their ability to cleave and ligate DNA substrates relative to their TopIB
cousins.
The active site substitutions that I have described, when combined with transition state
mimic structures of Cre and TopIB, provide a useful foundation for comparing the two systems
and for understanding the requirements for catalysis during Cre-loxP recombination and
presumably in the other YR family members as well.  In the YR systems, however, it is an
oversimplification to think of the active site as being devoted entirely to catalysis of cleavage and
ligation.  The Cre R173K and H289A mutants are examples where this is clearly the case.  Cre
R173K is defective in synapsis of loxP sites, which may contribute to the lack of in vitro activity for
this mutant.   In the structure of the pre-cleavage synaptic Cre-loxP complex (using the Cre
K201A mutant), Arg173 hydrogen bonds to the scissile phosphate in the inactive sites, stabilizing
a phosphate backbone conformation adjacent to the asymmetric loxP bend (Ghosh et al., 2007).
The H289A mutant has the unexpected property of promoting a top-strand-first order of loxP
strand exchanges during recombination, the opposite of that preferred by wild-type Cre (Gelato et
al., 2005).  His289 also plays an important role in the inactive site of the synaptic complex,
nucleating a hydrogen-bonding network involving the Arg173 backbone, two water molecules,
and the active site phosphate (Ghosh et al., 2007).  Related allosteric effects have been reported
in the Xer system, where an R148K mutant in XerC is able to stimulate the catalytic activity of
XerD on HJ substrates and vice versa (Arciszewska et al., 2000).  Thus, active site residues can
also strongly influence the reaction via interactions involving the half-sites not undergoing
catalysis.  
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Efforts thus far to correlate biochemical activities with structural models in the Cre, Flp,
and λ Int systems indicate that while the YRs have evolved strategies for inter-subunit
communication that share some overall themes, they do differ considerably in their molecular
details.  This is especially apparent when comparing Flp recombinase to the bacterial YRs, where
the inter-subunit contacts in the recombinase tetramers are quite different.  Consequently, the
roles of active site residues in mediating the allosteric regulation of cleavage and ligation in these
enzymes are likely to differ as well.  An example of this can be seen in a comparison of the Cre
H289Q mutant with the corresponding H305Q mutant in Flp.  The Cre mutant is nearly as active
as wild-type Cre (this work and Chapter 4), yet the Flp H305Q mutant is severely defective
(Parsons et al., 1988).   Dissection of active site contributions to chemical catalysis vs. mediating
the conformational changes and dynamics of the recombinase tetramer through the
recombination pathway may therefore prove to be challenging.  
2.7 Methods
Reagents and strains
Reagents were obtained from Sigma, unless otherwise noted.  Strains CSH100 (F'
lacproA+,B+(lacIq lacPL8)/ara Δ(gpt-lac)5 ) and CSH142 (F-/ara Δ(gpt-lac)5 ) were obtained from
the E. coli Genetic Stock Center (CGSC8105 and CGSC8083) at Yale University.  Plasmids
pFW11 and pTSA29 were gifts from Dr. Fred Whipple and Dr. Gregory Phillips, respectively.
 Crystallization and diffraction data 
Cre was over-expressed and purified as previously described (Ghosh & Van Duyne, 2002).
Oligonucleotides were synthesized by the Keck Biotechnology Facility at Yale University and
purified by ion-exchange chromatography.  Sodium orthovanadate (Sigma) was activated as
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described (Gordon, 1991) and added to a premixed solution containing  40 μM Cre, 75 μM half-
site DNA, 20 mM CaCl2, 20 mM sodium acetate, pH 5.6, 1 mM dithiothreitol, and 25% 2-methyl-
2,4-pentanediol (MPD) to a final concentration of 2 mM.  Crystals were grown by hanging drop
vapor diffusion against a well reservoir of 20 mM sodium acetate, pH 5.0, 20 mM CaCl2, and 30-
45% MPD.  Crystals were flash frozen in liquid nitrogen prior to data collection.  Diffraction data
were measured at the Advanced Light Source beamline 8.2.1  and processed using HKL2000
(Otwinowski & Minor, 1997). 
Structure solution and refinement 
The structure was determined by molecular replacement with AMORE (18), using a search
model based on the pre-cleavage synaptic complex (pdb entry 2HOI) where crossover region
DNA and all active site residues had been removed.  Initial rounds of refinement were performed
with CNS (Brünger et al., 1998) following model building and adjustment with COOT (Emsley &
Cowtan, 2004).  Final refinements were performed with REFMAC (Murshudov, Vagin & Dodson,
1997).  Active site residues, the vanadate linkage, and omitted DNA residues were fit into clear,
unbiased electron density.  Vanadate geometry was restrained during refinement as described for
the viral TopIB-DNA complex (Perry et al., 2010).  Coordinates for the refined structure have been
deposited with the Protein Data Bank with accession code 3MGV.
Generation of active site mutants
An XbaI-HindIII fragment containing the wild-type Cre coding sequence was cloned into the
same sites of pBluescriptIIKS+ (Stratagene) and used as a template for PCR-based mutagenesis
using a modified version of the Phusion protocol (New England Biolabs; NEB).  Most substitutions
were generated using primers with degenerate codons and those remaining following initial
sequencing were obtained using specific primers.  In both cases, only the primer containing the
altered active site codon was phosphorylated during oligonucleotide synthesis (Integrated DNA
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Technologies; IDT) and a 1 hour DpnI digestion following ligation of the PCR products was used
to remove the template.  All mutant plasmids were sequenced twice to verify the correct
substitution.
In vivo recombination reporter 
A single copy reporter was generated by homologous recombination of an intermediate
plasmid based on pFW11 into an F' containing an intact lac operon (Whipple, 1998).  A modified
sulA promoter (Dmitrova et al., 1998) was cloned into the EcoRI and BamHI sites of pFW11 using
oligonuclotides P1 and P2 (Table 2.4) and a fragment containing the aadA coding sequence with
a 5'-KpnI site was amplified using primers P3 and P4 and ligated into the BamHI and SalI sites of
sulA-FW11 to give pGV1026.  A terminator cassette that could be excised by Cre was generated
by inserting the E. coli rpoC terminator (Brosius, 1984) amplified using primers P5 and P6 into the
BsrGI and HincII sites of pGV697, a pBluescript derivative containing directly repeating loxP sites
flanking an 867 bp segment (GV, unpublished), to generate pGV1025.  The resulting construct
contains loxP sites flanking a 920 bp segment containing TrpoC.  The excisable element was then
inserted into the BamHI-KpnI sites of pGV1026 to give pGV1035.  pGV1035 was then
transformed into CSH100 and double crossovers were selected following transfer of the
recombinant episome into CSH142/pTSA29 by conjugation as described (Whipple, 1998).
pTSA29 provides ampicillin resistance and a temperature sensitive pSC101 origin, allowing facile
removal following incubation at 42°C (Phillips, 1999).  The relevant segment of the resulting F'
(pGV1048) is shown schematically in Fig. 2.4A.   
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Table 2.4: Oligonucleotide sequences used in construction of in vivo recombination
reporter 
Restriction sites are underlined
P1: 5'-AATTCAATAGGGTTGATCTTTGTTGTCACTGGATGTACCGTACATCCATACAGTAACTCAC-AGGGCTG-3'
P2: 5'-GATCCAGCCCTGTGAGTTACTGTATGGATGTACGGTACATCCAGTGACAACAAAGATCAAC-CCTATTG-3'
P3:
P4:
P5:
P6: 5'-CTGACAAATGCTCTTTCCCTAAACTC-3'
5'-GTCAGTGGATCCTAGGTACCGAAAAAGGAAGAGTATGAGGG-3'
5'-GTCAGTGTCGACTTATTTGCCGACTACCTTGG-3'
5'-GTCAGTTGTACACGTGCTGCGGGTGAAGC-3'
In vivo recombination 
Cre mutant plasmids were transformed into chemically competent CSH142/pGV1048 cells
and after a one hour incubation at 37°C  were plated on LB containing ampicillin (100 µg/ml),
kanamycin (35 µg/ml), and X-gal (20 µg/ml).  An equal volume was plated on LB containing the
same components plus 20 µg/ml streptomycin.  Activity was recorded as the ratio of the number
of colonies after 16 hours at 37° on the streptomycin plate divided by the number on the plate
lacking streptomycin.  For wild-type Cre,  this ratio was reproducibly close to 1, with a colony
count of ~1000.  For the empty pBluescript and Cre Y324F negative controls, the background
was zero; no streptomycin resistant colonies were observed in multiple experiments and colonies
on the non-selection plate were white.   For weakly active mutants where a small number of
colonies were observed on the streptomycin plate, in vivo activity was corroborated by the
appearance of blue colonies in the absence of streptomycin selection.  in vivo assays were
repeated 3-4 times and the results were tabulated as a percentage of wild-type activity with
typical standard deviations of 9% for the most weakly active mutants.
In vitro Recombination Assay
The substrate for in vitro recombination was a linear 602 bp DNA fragment digested from
pBG1701, dephosphorylated, and 32P end-labeled with polynucleotide kinase.  pBG1701 was
constructed by ligation of a DNA segment containing  two loxP sites flanking a 334 bp spacer,
shown schematically in Fig. 2.7A.  Cre-containing lysates were prepared from CSH142/pGV1048
transformants by sonication of cells from 2 ml culture grown at 37° to an optical density of ~1.0 in
100 µl lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 2mM dithiothreitol, 1 mM EDTA, 0.5%
Triton-X100 and protease inhibitors).  Cleared lysates were diluted in lysis buffer and used
directly for in vitro binding and recombination assays. Recombination reactions were carried out
in  25 µl assay buffer (50 mM Tris pH 7.4, 150 mM NaCl, 2mM dithiothreitol, 1 mM EDTA, 50
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µg/ml sheared salmon DNA) containing 200 pM labeled substrate and a 50-fold dilution of lysate.
After incubation at 37°C for 1 hour, reactions were quenched with 0.5% SDS, heated at 70°C for
1 minute, and digested with proteinase K for one hour at 37°C.  Reactions were analyzed on a
6% acrylamide gel in 1X TBE  for 2 hours at 10 V/cm. Gels were dried and quantified on a
Phosphorimager.  Errors for the in vitro recombination assays were estimated at 5-10% of wild-
type activity based on multiple repetitions of a subset of weak and moderately active mutants.
In vitro loxP binding
The probe for electrophoretic mobility shift assays was a 64-mer duplex containing the loxP
site flanked by 15 bp G·C-rich segments.  10 pmol of PAGE-purified top strand was 32P end-
labeled with polynucleotide kinase and annealed to a purified, unlabeled bottom strand. Cleared
lysate was added (50:1 final dilution) to 200 pM labeled substrate in assay buffer and the
reactions were incubated for 30 min at 20°.  Binding reactions were electrophoresed on a 6%
polyacrylamide gel (29:1 acrylamide:bisacrylamide) in TBE that was pre-run for 10 V/cm for 45
min at  20 °C prior to loading. The gel was run at 13 V/cm for two hours at  20°C, dried, and
analyzed with a phosphoimager. 
Tyrosine recombinase sequence alignments 
the Cre catalytic domain (residues 134-343) was used as a query sequence for three
iterations of PSI-BLAST (Altschul et al., 1997) searching of the NCBI RefSeq database (Pruitt et
al., 2007) and 12,049 alignments (maximum E-value = 0.01) that included all seven active site
residues were analyzed by quantifying the amino acid frequency at each of the seven positions.
The catalytic lysine is not well-aligned due to its position in a loop of variable size and sequence.
For this residue, we counted lysine (or arginine) as present at this site if it was located within five
residues of Cre Lys201 in the alignment. We obtained similar results when the λ integrase
catalytic domain was used as a search query.  
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Identification of covalent intermediate 
Purified Cre (wild-type and H289Q) was added to recombination substrate in assay buffer to
50 nM concentration and the reaction carried out as described in the main text. Following
proteinase K digestion, one half of the reaction was ethanol precipitated, resuspended and
denatured in formamide, and loaded on a 4% (19:1) 7M Urea-TBE gel (19:1
acrylamide:bisacrylamide) that was pre-run for 45 min at 7 watts. The samples were
electrophoresed for 2 hours at 7 W, the gels fixed in 10% MeOH/10% Acetic Acid, dried, and
analyzed by phosphoimager analysis. The other half of the reaction was electrophoresed on a
native 6% TBE polyacrylamide gel. 
Identification of HJ intermediate
Recombination reactions were performed with purified wild-type Cre, Cre H289Q and Cre A312T.
The ability of Cre A312T to accumulate intramolecular HJ intermediates and the analysis of the resulting
'alpha' DNA structure has been described (Hoess et al., 1987). Following a one hour incubation at 37°, half
the volume of each reaction was digested with proteinase K and the other half was extracted with phenol-
chloroform. Following ethanol precipitation, samples were resuspended in BsrGI reaction buffer (NEB) and
again divided in half, where one half was digested with BsrGI and one was not. Since the 602 bp
recombination substrate contains an BsrGI site between loxP sites, the HJ intermediate alpha structure is
converted to the open χ form upon digestion. Samples were electrophoresed on a 4% TBE acrylamide gel at
13 V/cm for 100 min. 
Detection of Cre by Western Blot
20 ul of 1OD of cleared lysate prepared as described above, was loaded on SDS-Page and
separated at 20 V/cm for 1 hour. Gels were transferred to nitrocellulose membrane (Bio-Rad)
using a semi-dry transfer apparatus (Bio-Rad)at 17V for 30 minutes. Following transfer, the
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membrane was soaked for 16 hours at 4 °C in TTBS buffer containing 3% BSA and 0.1% Triton.
Membrane was exposed to a 1:5000 dilution  of primary antibody that is specific for Cre
(Novagen) for 1 hour at 20 °C and then washed three time with TTBS. The membrane was then
incubated with a secondary antibody and developed with a chemiluminescent blotting substrate
(Pierce). 
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Chapter  3. A Dual Role in Catalysis for H289 in Cre
3.1 Introduction
Tyrosine recombinases (YR) contain a well conserved histidine that is not conserved in Type
IB topoisomerases. This histidine, H289 in Cre is positioned in the active site proximal to the
catalyic tyrosine nucleophile and is hypothesized to function as a proton acceptor/donor in the
activation of tyrosine during cleavage and ligation reactions. TopIB enzymes have no analogous
residue in their active sites. A lysine, K220 in viral topoisomerases, is related by sequence,
however this lysine is positioned away from the active site making a non-specific interaction with
the phosphate backbone of the cleaved strand. Mutation of K220 to alanine results in a small
deficiency in relaxation and cleavage, which indicates that the interaction made by the lysine is
important but not essential to topoisomerase activity (Cheng et al., 1997). The K220D mutant
however, is defective in relaxation and cleavage, but is capable of binding (Klemperer &
Traktman, 1993). The space corresponding to the histidine is filled by two well ordered water
molecules in TopIB-DNA complex structures (Davies et al., 2006; Perry et al., 2010). 
The work described in Chapter 2 described activities for all nineteen substitutions at Cre
H289. Fifteen of these retained activity in vivo, and all nineteen were capable of binding loxP,
indicating that the mutants inactive for recombination were from a catalytic defect and not from a
folding or solubility artifact. The fifteen active H289 mutants were confirmed for activity in vitro
with soluble lysates. Surprisingly, the H289L and H289Q mutants accumulated a significant
amount of covalent intermediate during in vitro recombination, prompting the suggestion that
these mutations may have a deficiency in ligation. The leucine mutant has been demonstrated to
accumulate covalent intermediate in other YR homologs (Cornet, Hallet & Sherratt, 1997; Lee &
Jayaram, 1993; Vanhooff et al., 2009). The glutamine mutant has also been studied in Flp, where
H305Q could be rescued for cleavage and ligation with peptides containing modified tyrosine
analogs supporting a role for histidine in acid/base catalysis (Whiteson et al., 2007).  The alanine
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and asparagine substitutions of H289 in Cre were found to have an opposite strand bias from WT.
These mutants cleaved the top strand of loxP preferentially and also accumulated Holiday
junctions (Gelato et al., 2005; Martin et al., 2002). 
This chapter examines the role of H289 and attempts to determine the basis for conservation
in YRs but not in TopIB enzymes. Studies of all nineteen mutants of H289 reveal that the histidine
is important but not necessary for recombination, binding, synapsis, and cleavage of loxP.
Detailed investigation of the biochemical activity of the conservative mutant H289Q confirms that
the histidine does not have an essential role in acid-base catalysis. However, mutants at H289
are defective in water mediated hydrolysis of the 3'-phosphotyrosine linkage. Ligation of loxP
DNA appears to be substancially defective in some histidine mutants, including H289Q and
H289L. 
3.2 Studies of all 19 H289 mutants
Fifteen of twenty amino acids at position 289 are active for recombination in vivo, yielding
little direct insight into its conservation. To confirm these previous results and further characterize
H289, all nineteen single site variants at position 289 were subcloned into a T7 expression vector
and purified as described in Methods. The mutants were tested for their ability to bind, synapse,
cleave and mediate recombination. A summary of these results is given in Table 3.1, and results
from individual assays will be described below.
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Table 3.1: H289 mutant activity summary
a) Scoring of in vivo recombination the same as described in Chapter 3. b) In vitro recombination is reported as %excision. c)Synapsis is a qualitative assessment of the
ability to synapse where 3 is WT, 2 is noticeably reduced, 1 is barely visible, and  0 no synapsis. d) Cleavage(suicide cleavage) and Covalent (equilibrium cleavage)
reported as %total covalently bound Cre at 1 hour and 24 hours.
H289 Mutant Binding
WT +++ 44.67 63.04 WT 3 84.40 92.51 8.87 4.91
Y324F 0 0.00 0.00 WT 1 0.55 0.31 0.00 0.00
A +++ 9.42 8.18 WT 3 12.26 60.43 3.72 4.91
C ++ 2.42 0.38 WT 1 4.45 18.11 2.26 3.03
D 0 0.00 0.00 WT 3 0.00 0.00 0.00 0.00
E 0 0.00 0.00 WT 3 0.00 0.00 0.00 0.00
F ++ 0.74 0.18 WT 2 2.55 8.53 1.16 3.10
G +++ 7.40 6.10 WT 3 8.63 37.20 3.56 4.50
I + 0.13 0.07 WT 0 0.93 3.47 0.74 2.12
K 0 0.00 0.00 WT 1 0.72 0.16 0.00 0.00
L ++ 12.89 1.97 WT 2 28.91 46.43 15.19 26.52
M +++ 21.15 25.92 WT 2 18.18 47.59 10.60 12.51
N +++ 30.37 27.11 WT 3 13.40 44.87 3.82 5.62
P + 0.31 0.43 WT 0 3.93 35.35 1.45 2.61
Q +++ 30.90 38.99 WT 3 59.83 80.30 32.26 39.51
R 0 0.09 0.00 WT 2 0.76 1.72 0.00 0.00
S ++ 4.70 1.31 WT 3 7.80 48.10 2.92 4.48
T ++ 1.43 0.41 WT 2 4.16 23.37 2.29 3.96
V ++ 0.26 0.09 WT 0 1.46 14.83 1.10 2.08
W 0 0.00 0.00 WT 1 0.00 0.00 0.27 0.48
F' In vivo assaya
Lysate in vitro 
recombinationb
Pure in vitro 
recombinationb Synapsisc
Cleavaged   
(1‐hour)
Cleavaged   
(24‐hour)
Covalentd 
(1‐hour)
Covalentd 
(24‐hour)
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3.2.1 H289 mutant binding and synapsis
The binding and in vitro recombination activities of the purified H289 mutants agree well with
those obtained from soluble lysates (Chapter 2). Minor differences may be attributed to the
concentration of Cre protein in the lysate or cellular artifacts in the lysates. The binding assay was
performed using a 64 bp loxP substrate at roughly 1 nM (instead of 0.2nM), which permits the
formation of a small amount of synapsis and allows for a crude assessment of the ability of the
H289 mutants to form synaptic complexes. The Cre concentration was 10nM, nearly 50 fold
above KD for binding, where WT Cre is completely bound to loxP as a dimer (Ringrose et al.,
1998). As Fig. 3.1 shows, all mutants at H289 are competent for binding to loxP, but the ability to
synapse varies considerably. Several H289 mutants such as, Asp, Glu, Tyr and Met show a slight
but reproducible change in mobility of the dimer species bound to loxP.  Other mutants also
appear to have altered mobilities, however their change is less apparent. These altered mobilities
suggest that H289 mutants effect bending of loxP  (Lee, Chu & Sadowski, 2003). Eight of the
H289 mutants, Cys, Ile, Lys, Pro, Arg, Thr, Val, and Trp appear to have a severe deficiency in
synapsis. The qualitative assessment of synapsis, shown in Table 3.1, is useful, however, full
synapsis assays titrating loxP concentration would be necessary to be able to make detailed
comparisons.
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Figure 3.1  Binding and synapsis of purified H289 mutants
Binding of 20 nM Cre to 1 nM loxP. All mutants bind loxP without significant deficiency, but some mutants display
altered mobility relative to WT Cre. The mutants at H289 varied in the ability to synapse loxP sites. 
3.2.2 H289 mutants in suicide cleavage
If H289 in Cre is involved in acid-base chemistry during phosphoryl transfer, then mutants at
this position should have deficiencies in the ability to cleave loxP. Cre cleavage activity is
measured using several different substrates shown in Appendix B, and described below.  The
cleavage ability of the H289 mutants was assayed using a suicide substrate that contains a nick
at the +1 base on the bottom strand (BS; loxSS4/5/6; Fig. 3.2A for reaction diagram). The bottom
strand of loxP is defined as the strand containing the cleavage site between C and G while the
top strand (TS) is defined as the strand containing the cleavage site between A and T (Fig. 1.2B).
Cre cleavage of loxSS4/5/6 at the BS results in the dissociation of the +1 Cyt nucleoside,
shortening the crossover region and effectively preventing religation. As a result, the 3'-
phosphotyrosine intermediate is trapped. The TS of this substrate remains intact, so Cre is
capable of cleavage, ligation and strand exchange using this substrate strand. 
Cleavage of the H289 mutants was assayed with loxP concentrations at 50 nM, which favors
synapsis formation and cleavage of the BS (Ghosh et al., 2005a).  Reactions were incubated at
37 °C for 1 hour and 24 hours to allow weakly active mutants to reach completion (Figs. 3.2B and
C). Quenched reactions were separated by SDS-PAGE. Cre covalently bound to the labeled BS
appears as a single band well above unreacted substrate. Cleavage on the intact strand results in
a double strand break separated by 6 bp in the crossover region, which will dissociate forming
two half site duplexes. The first duplex contains the labeled strand with greater mobility than the
unreacted substrate. The second duplex is an unlabeled half site duplex containing covalently
bound Cre to the TS site and is not visible in the gel (Fig 3.2A).  
The H289 mutants active in recombination generated detectable levels of cleavage product
at 1 hour and 24 hour intervals. Most mutants displayed greater cleavage product at 24 hours,
indicating that the reaction at 1 hour was incomplete. Of the nineteen mutants, H289Q was the
most active in cleavage, with near WT activity. The H289L, H289M, and H289Q mutants
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generated TS cleavage product in greater amounts than WT Cre (Fig. 3.2). Cleavage of the intact
TS is in equilbrium between cleavage and ligation, so covalent product accumulation on the TS
means that either the rate of cleavage has increased with respect to the rate of ligation or the rate
of ligation has decreased with respect to the rate of cleavage. Previous reports have observed
that the leucine and glutamine mutants in related YRs also accumulate covalent intermediate,
which is consistent with the histidine being conserved to function in ligation (Cornet et al., 1997;
Pan et al., 1993b; Parsons et al., 1988; Vanhooff et al., 2009; Whiteson et al., 2007). In addition,
these mutants appear to preferentially cleave the TS half site. The observed TS bias could be an
artifact of the nick, however the effect is only observed for a subset of mutants at H289, and the
TS cleavage bias has been observed previously in Cre for H289A and H289N (Gelato et al.,
2005). The strand cleavage preference is examined in greater detail in section 3.3. 
A second observation from the cleavage assays was that the covalent cleavage product for
wildtype Cre disappeared at 24 hours with the concomitant appearance of a unique band with
reduced mobility relative to unreacted substrate (Fig. 3.2).  Of the H289 mutants, only H289C
produced a similar band after 24 hours of incubation. Separate experiments discussed in section
3.3 helped to identify this band as hydrolysis product of the 3'-phosphotyrosine intermediate. WT
Cre efficiently hydrolyzes covalent intermediate, generating nearly 50% of total counts at 1 hour
and essentially 100% after 24 hours.  The hydrolysis reaction is predicted to proceed in a
mechanistic manner similar to that of ligation (Petersen & Shuman, 1997a). Since the H289
mutants are defective in hydrolysis, this provides further evidence that H289 may have a role in
ligation. Hydrolysis is examined further in section 3.3. 
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Figure 3.2  Suicide cleavage of purified H289 mutants at 1 hour and 24 hours.
(A) Schematic showing reaction products generated by Cre with the BS-nicked suicide substrate (loxSS4/5/6)
(B) BS-nicked suicide cleavage substrate loxSS4/5/6 was used to measure cleavage of purified H289 mutants at 1 hour
(C) BS-nicked suicide cleavage substrate loxSS4/5/6 was used to measure cleavage of purified H289 mutants at  24
hours.
Some H289 mutants accumulate cleavage product preferentially on the intact strand corresponding to TS cleavage. WT
Cre hydrolyzes the BS-phosphotyrosine intermediate, which runs as unique band above unreacted substrate. H289C is
the only mutant capable of detectable hydrolysis after 24 hours.
3.2.3 H289 mutants in equilibrium cleavage
Accumulation of covalent intermediate on a natural loxP site offers a way to indirectly
measure Keq and assess the balance of cleavage and ligation. A duplex 64 bp loxP substrate (the
same used to measure binding (loxSS3/6)), was used to assay the accumulation of covalent
intermediate in a method similar to that employed for suicide cleavage at 1 hour and 24 hours for
all H289 mutants (Fig. 3.3). Since the substrate is an intact loxP site, all intermediates in the
recombination pathway are accessible. TS and BS cleavage products are able to be ligated back
to substrate or exchanged to form HJ intermediate and then resolved. However, the starting
substrate is identical to the product of a complete recombination cycle. The 64 bp substrate is
asymmetric, containing flanking DNA of 10 bp and 20 bp on either side of the loxP site. The
asymmetry changes the location of the cleavage sites for TS and BS relative to the DNA such
that covalent TS product is able to be resolved from covalent BS product on an SDS-PAGE Gel. 
All mutants at H289 that were capable of cleavage had detectable levels of covalent
intermediate with WT Cre generating approximately 10%. Most H289 mutants generated covalent
product at levels similar to WT at equilibrium. However, the Met, Leu and Gln mutants
accumulated 3-4 times more covalent intermediate than wild type. This result supports a defect in
ligation and partially explains the accumulation of intact TS cleavage in the suicide cleavage
assay. WT Cre and H289 mutants active on the loxP substrate all appeared to accumulate more
TS covalent complex than BS covalent complex. Since the substrate allows used in this assay
allows the entire recombination reaction to be sampled, it is impossible to assign the observed
strand bias in equilibrium cleavage to a higher Keq for TS or BS. 
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Figure 3.3  Equilibrium cleavage of intact loxP at 1 hour and 24 hours.
(A) Schematic showing cleavage products generated by Cre with the intact loxP substrate, loxSS3/6. 
(B) Covalent product accumulation with intact loxP by WT Cre and H289 mutants at 1 hour.
(C)Covalent product accumulation with intact loxP by WT Cre and H289 mutants at 24 hours.
Reactions at equilibrium (24 hours) are reflective of the relative rates of cleavage and ligation. H289M, H289L and
H289Q accumulate significant covalent product relative to WT Cre, while other mutants do not. 
3.2.4 H289 mutant summary
An amino acid that is branched at Cβ is more defective than one branched at Cγ or not
branched at all. Leu and Met are more active in recombination and cleavage than Ile and Val; Ser
is more active than Thr and Val.  Aromatic substitutions are deficient or inactive, presumably due
to steric bulk. Ala and Gly are modestly active in vitro, possibily due to bound water as observed
in the TopIB-DNA complex structures (Davies et al., 2006; Perry et al., 2010).  The deficiency in
cleavage observed for H289A and H289G suggest that thehistidine may have a role in catalysis
during phosphoryl transfer. The H289Q mutant is the most active of all H289 substitution in
cleavage and recombination, suggesting the histidine is dispensible in acid/base catalysis but the
size and hydrogen bonding potential of histidine are important for Cre activity. 
3.3 Detailed investigation of H289Q and H289A
3.3.1 Synapsis of H289A and H289Q 
Initial binding studies with all nineteen mutants at H289 indicated that both H289A and
H289Q were competent for binding and synapsis. However, the preliminary measurements were
performed well below the KD  for synapsis (Ghosh et al., 2007). To better measure the synapsis
ability of H289Q and H289A, synapsis was assayed at higher concentrations of loxP and in
conditions where Cre is saturating (1 μM). As Fig. 3.4 shows, H289Q forms synaptic complexes
nearly as well as WT Cre, but H289A appears to be as much as 4-fold deficient in synapsis. This
result suggests that the histidine in Cre provides favorable van der Waals surface in addition to
the hydrogen bonding interactions with the scissile phosphate, which Gln is able to mimic, but Ala
does not.  H289Q and H289A were among the more competent substitutions at 289 for synapsis,
indicating that many of the other H289 mutants are more deficient than the H289A mutant.
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3.3.2 Rate of in vitro recombination for H289Q
Time course reactions containing 0.2 nM 32P-labeled recombination substrate in NCB assay
buffer were initiated by addition of 50 nM Cre and time points were quenched in
phenol/chloroform. Figs. 3.5 A and B show representative gels of in vitro recombination for WT
Cre and H289Q. Graphs of product vs. time as well as HJ accumulation vs. time are shown in
Figs. 3.5 C and D. The data fit well to a single exponential where the rates of excision for WT and
H289Q were 0.0065 sec-1 and 0.002 sec-1  (see table 3.2). The minor decrease in recombination
rate for H289Q is not consistent with the histidine functioning in acid/base catalysis in Cre as has
been suggested for H305 in Flp (Whiteson et al., 2007). However, H289Q did not reach the same
maximum extent of excision as WT, indicating that the equilibrium for the recombination reaction
was different. A significant buildup of HJ intermediate was observed for H289Q and H289A (not
shown) suggesting that H289 may have a role in catalytic steps unique to recombination such as
efficient isomerization or activation of Cre in the Holiday intermediate. The accumulation of HJ
intermediate for Cre H289A and H289N had been noted previously (Gelato et al., 2005; Martin et
al., 2002), providing additional evidence of the role of H289 in HJ resolution. 
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Figure 3.4  Synapsis of WT, H289Q and H289A
The first lane of each series contains subsrate alone. Cre at 1 μM to saturate binding to loxP. Synapsis measured at 0.2,
10, 40, and 160 nM total loxP substrate. H289Q is not deficient, but H289A is moderately deficient in synapsis.
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Figure 3.5  In vitro recombination time course
Cre mediated excision of 234 bp linear product from 602 bp substrate as a function of time for WT (A) and
H289Q (B). 
C. Graph of excision for WT and H289Q fit to single exponential (black line). 
D. Graph of HJ intermediate formation as a function of time. H289Q accumulates HJ intermediate in greater
amounts than WT.
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Table 3.2: In vitro recombination rates for WT Cre and H289Q
Rates reported as (sec-1)
WT error H289Q error
Excision 0.39 0.003 0.12 0.021
HJ formation 0.53 0.102 0.45 0.114
3.3.3 pH rate profile of Cleavage
Results from the panel of H289 mutants in recombination and cleavage suggest that the
activation of Y324 does not require assistance from H289. If H289 in Cre functions in a rate
limiting step in acid/base catalysis at cleavage, then the H289Q mutant should have a
significantly different cleavage rate profile than WT Cre as a function of pH. The pH profile of
cleavage for WT Cre and H289Q was measured using a suicide loxP substrate containing a nick
on the bottom strand (loxSS4/5/6). Cleavage at the nick on the BS of loxSS4/5/6 is irreversible,
but cleavage on the intact TS is not. At physiological pH, WT Cre efficiently ligates any cleavage
products on the top strand and rapidly accumulates trapped BS-covalent complex. The trapped
BS-covalent complex is a substrate for water mediated hydrolysis of the phosphotyrosine linkage,
depleting the covalent product (Fig. 3.6).   
The initial velocities of cleavage for Cre WT and H289Q were measured in triplicate with the
BS-nicked substrate under conditions favoring synapsis (50nM substrate) from pH 5.0 to 9.5 (Fig.
3.7). No hydrolysis product was observed in the time interval of the reaction. A plot of log initial
velocity of total cleavage versus pH is shown in Fig.  3.7. The shape of the pH profile for WT is
similar to that of H289Q, which suggests that histidine is not functioning in a rate-limiting step of
cleavage. This is inconsistent with H289 having an essential role as a general base in Cre.
cleavage. The pH dependence of Cre may reflect some other pH sensitive step in cleavage other
than phosphoryl transfer (Ghosh et al., 2007). Sedimentation equilibrium (Ghosh et al., 2007) and
velocity (data not shown) experiments show that Cre is capable of binding loxP over the entire pH
range tested, but synapsis is disrupted at high pH. 
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Figure 3.6  Representative cleavage on BS-nicked substrate at pH 7.5
(A) Schematic of Cre cleavage products generated with BS-nicked loxP suicide substrate loxSS4/5/6.(B)
Representative gel of  WT Cre and Cre H289Q (500 nM) cleavage with loxSS4/5/6 (50 nM)  as a function of time at
pH 7.5. (C) Plots of bottom strand (BS), top strand (TS), and hydrolysis product for WT and H289Q as a function of
time. (D) Plot of total cleavage, which is the sum or TS, BS and Hydrolysis products for WT Cre and H289Q as a
function of time. 
Cre can cleave the BS-nicked substrate (loxSS4/5/6) irreversibly on the BS to trap covalent intermediate (BS-product),
or cleave the intact TS, which is able to be ligated back to starting substrate. The TS cleavage results in a double strand
break since the substrate already contains a nick on the BS. The labeled TS-product, does not contain covalently bound
Cre, but is half of the original substrate. The trapped BS-covalent product is a substrate for water mediated hydrolysis
forming a band with slower mobility than the unreacted substrate. At pH 7.5, hydrolysis of BS-product for WT is
readily apparent for WT, but absent for H289Q. TS-product accumulates more rapidly and to a greater extent for
H289Q than for WT Cre. 
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Figure 3.7  Initial Velocity of Cre Cleavage vs. pH
(A) Diagram of BS-nicked substrate, loxSS4/5/6.
(B and C) Plots of initial velocity vs. pH for WT Cre (B) and Cre H289Q (C). 
The profiles of total cleavage (center) for WT and H289Q look similar, however the relative proportions of TS and BS
product (left) contributing to total cleavage differ substantially between the WT Cre and H289Q. WT is dominated by
TS cleavage at low pH and shifts to primarily BS cleavage above pH 7. H289Q is dominated by TS cleavage over the
entire pH range, with BS-product contributing only minimally to the initial velocity at the higher pH values tested. The
log Vinit of total cleavage (right) was fit to equation log Vinit = log Vinit(max) – log (1 + 10-pKa1/10-pH + 10-pH/10-pKa2)
(Stivers, Shuman & Mildvan, 1994). 
For WT Cre, the TS cleavage rate drops as a function of pH while BS cleavage increases as
a function of pH and the two cross at pH 6.5. H289Q is dominated by TS cleavage through pH 8.0
after which the rate rapidly decreases, and is less efficient at cleaving the BS with only a small
increase in rate at higher pH values. Cleavage pH profiles were also determined for additional
suicide substrates where the nick was moved to the TS (loxSS1/2/3) or the loxP substrate was
intact without a nick using 5'-bridging phosphorothiolate substrates (loxSS7-8/9-10). The pH
profile of total cleavage with these substrates was similar to that observed in Fig. 3.7 with
loxSS4/5/6, but the relative proportions of TS and BS cleavage were different and are discussed
below. 
3.3.4 H289Q strand cleavage preference
In the synaptic complex, loxP is bent asymmetrically at one of the two cleavage sites, where
the site opposite the bend is active for cleavage (Guo et al., 1997). The TS cleavage preference
observed for H289Q with loxSS4/5/6 could be a symptom of alternative bending where H289Q is
better able to bend at the half site with the nick to activate the other half site for cleavage. If
H289Q promotes an alternative bend, moving the nick to the other half site should reverse the
strand preference for H289Q. Alternatively, if H289Q preferentially cleaves the TS, then cleavage
on a substrate with the nick on the TS (loxSS1/2/3) should improve cleavage since it is
irreversible.  WT Cre and H289Q were incubated for 60 minutes with substrate containing a BS-
nick(loxSS4/5/6), TS-nick (loxSS1/2/3), or no nick (5' bridging phosphorothiolate DNA; loxSS7-
8/9-10) (Fig. 3.8). WT Cre efficiently cleaves either substrate on the strand with the nick, however
H289Q preferentially cleaves the TS with both nicked substrates, but is cleaves the TS better
when the nick is on the BS. WT Cre and H289Q cleave more BS than TS with the
phosphorothioate substrate, which is consistent with previous findings, which used the same
substrate (Ghosh et al., 2005a).  
87
88
Figure 3.8  Representative data for strand cleavage preference
(A) Cartoon representation of three cleavage substrates tested. LoxSS4/5/6 contains a BS-nick with intact TS, while
loxSS1/2/3 is the opposite, containing a TS-nick and intact BS. The phosphorothiolate substrate is an intact duplex with
sulfur instead of oxygen at the 5' position of the scissile phosphate. (B and C) Initial velocities for cleavage with each
substrate on TS and BS at pH 7.5 for WT (B) and H289Q (C). Notice the strong reversal in cleavage preference on the
loxSS4/5/6 (BS-nick) substrate for WT and H289Q. When the nick is moved to the TS (loxSS1/2/3), WT cleaves
robustly, but H289Q is deficient. Both WT and H289Q accumulate very little intact BS cleavage product with
loxSS1/2/3. With the phosphorothiolate substrate (PS), BS cleavage is preferred over TS for both WT Cre and H289Q.
3.3.5 pH profile of equilibrium cleavage
To determine if the pH dependence of intact TS cleavage is due to a shift in the equilibrium
cleavage rate constant (Kcl), to favor the ligated state rather than a DNA bending effect, covalent
intermediate was measured for WT and H289Q on a symmetrized and intact loxP site containing
two AT half sites (loxS2) at equilibrium. Since both half sites are identical, any strand bias is
eliminated. WT Cre and H289Q were incubated with loxS2 substrate in different pH buffers for
extended time intervals to allow the system to reach equilibrium. Fig. 3.9A shows a plot of
covalent product versus pH at equilibrium for WT and H289Q with substrate loxS2. The shape of
the pH profile is different for WT Cre and Cre H289Q. Covalent intermediate with WT Cre reaches
a maximum of 35% at pH 5.5 and steadily declines with increasing pH. H289Q accumulates more
covalent intermediate than WT Cre with a maximum of 62% at pH 6.5 or 7.0, and decreases
sharply at higher pH. Since the rate of cleavage by WT Cre does not display a corresponding
drop in cleavage activity with pH, the drop in equilibrium covalent product at higher pH values is
likely due to an increase in the rate of ligation. The shape of the plot in Fig. 3.9A looks nearly
identical to the shape of the initial velocities of TS cleavage determined with loxSS4/5/6 for WT
and H289Q in Fig. 3.7. It is unfair to compare initial velocity with covalent intermediate at
equilibrium. However, cleavage of the intact strand in time course reactions with loxSS4/5/6 and
loxSS1/2/3 did reach equilibrium (Fig. 3.10 for an example) and is plotted in Fig. 3.9B as a
function of pH for H289Q. Though the extent of covalent product is different, the trend in covalent
intermediate as a function of pH is the same, showing a decrease with pH after a maximum at pH
6.5 suggesting the drop of intact strand cleavage at high pH on nicked substrates is due to a pH
dependent increase in ligation relative to the rate of cleavage. WT Cre does not accumulate
significant intact strand product on nicked substrates above pH 6. 
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Figure 3.9   Equilibrium cleavage as a function of pH
A. Cleavage of symmetric substrate loxS2 containing TS halfisites was measured at equilibrium at pH 5.0, 5.5,
6.0,6.5,7.0,7.5,8.0,8.5,9.0 and 9.5 for WT and H289Q. H289Q accumulates more covalent intermediate and the shape
of the curve is shifted to the right where the maximum product is at 6.5 and 7.0 where the maximum for WT is at 5.5.
B. Cleavage of the intact strand of nicked substrates loxSS4/5/6 (intact TS) and loxSS1/2/3 (intact BS). Covalent
product plotted for H289Q at or near equilibrium for intact strand cleavage.  
3.3.6 pH Dependence of Hydrolysis
Water mediated hydrolysis of the trapped covalent intermediate was observed in cleavage
reactions with all three suicide substrates and increased with pH. This reaction is shown
schematically in Fig. 3.6 for loxss4/5/6 where the trapped BS-covalent complex disappears as a
function of time. Fig. 3.10 shows the effect of pH on the rate of hydrolysis catalyzed by WT Cre
compared to H289Q. 
The rate of hydrolysis in the Cre cleavage assays is dependent on the amount of cleavage
product. However, a conservative measure of the hydrolysis rate can be attained by determining
the slope of the linear portion of the hydrolysis product formation curve. As shown in Fig. 3.10, at
pH 9.5 the rate of hydrolysis of the covalent intermediate is linear between the 3 and 15 minute
intervals during the cleavage time course with loxSS4/5/6. The observed rate determined from
the slope during this interval was 0.055% hydrolyzed/sec. This conservative estimate suggests
that Cre mediated hydrolysis at pH 9.5 is more than 600 times faster than topoisomerase
mediated hydrolysis at the same pH (Petersen & Shuman, 1997a). 
H289Q does not catalyze the hydrolysis of covalent intermediate at any pH with any of the
suicide substrates that were tested.  None of the H289 substitutions were capable of hydrolyzing
the covalent intermediate after 24 hours of incubation, where WT Cre had converted nearly 100%
of substrate into hydrolysis product (Fig. 3.2). This suggests that H289 plays a critical role in
promoting hydrolysis. The increased rate of hydrolysis by Cre compared to TopIB further
implicates histidine in hydrolysis, especially since TopIB is faster in cleavage and ligation
chemistry (Krogh & Shuman, 2000). H289 in Cre may therefore have a more important role as a
proton donor to tyrosine in hydrolysis than in ligation.
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Figure 3.10  pH profile of cleavage and hydrolysis timecourse
A. Cleavage reactions measured at 0,1,3,7,15,30,60 and 120 minutes at pH 5.5, 6.5, 7.5, 8.5 and 9.5 for WT and H289Q
on loxSS4/5/6 (BS-nicked) suicide substrate in conditions favoring synapsis (50nM total substrate). BS suicide
cleavage accumulates over time, but is susceptible to hydrolysis at high pH. H289Q does not hydrolyze the BS
cleavage product.
B. Graph of WT BS-covalent product and hydrolysis as a function of time. pH 5.5 not included since no hydrolysis is
observed. 
3.3.7 Activities of H289Q and H289A in ligation
Results of equilibrium cleavage suggested that some mutants at H289, including glutamine,
are partially defective in ligation since they accumulate large amounts of covalent intermediate.
Ligation activity has been measured directly, independent of cleavage in Cre, vaccinia
topoisomerase (Woodfield, Cheng, Shuman & Burgin, 2000)and Flp (Whiteson et al., 2007) by
using a synthetically modified DNA substrate containing a tyrosine analog attached to the 3' end
of a scissile phosphate. The tyrosine analog pNP (para-nitro-phenol) with a pKa of 7.1 was
esterified to the 3' phosphate of either a TS or BS substrate to mimic an activated tyrosyl leaving
group during ligation.  The modified DNA substrate was radiolabeled and annealed to
complementary and adjacent strands, forming a three stranded loxP substrate containing a nick
on either the TS or BS at the scissile phosphate as depicted in Fig. 3.11. Cre catalyzes the
ligation of the two adjacent strands by release of the pNP without the need for Y324 (this work)
(Woodfield et al., 2000).  Fig. 3.11 shows ligation of Cre mutants using TS and BS pNP
substrates at pH 7.5. At this pH, ligation does not require a proton donor to assist the pNP leaving
group.  The 60 minute reactions were quenched with SDS and digested with proteinase K to
remove covalently attached Cre and then separated by denaturing PAGE. The unligated modified
36mer (BS) or 26mer (TS) substrate containing pNP is a single band with greater mobility than
the ligated 64mer loxP product. A second band appears above the unreacted TS substrate for
mutants that contain Y324 but not those containing the Y324F mutation indicating that this
species is the proteinase K digested product of a phosphotyrosine covalent intermediate. The
product of the ligation reaction is an intact loxP site, so active Cre mutants are able to cleave the
ligated loxP product and generate covalent intermediate. However, K201A, which is inactive for
cleavage, accumulates significant amounts of covalent intermediate with the ligation
substrates(data not shown), which suggests that this species is either not covalent intermediate
or is generated by some other mechanism. 
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 The observed covalent intermediate could be due to the direct attack of the pNP by tyrosine
(Fig. 3.11B). If pNP assumes a position in the active site similar to O5' of an intact loxP site, then
tyrosine is able to attack the pNP directly in a mechanism similar to cleavage. K201A is able to
generate covalent intermediate because the pKa of pNP is much lower than 5'-OH, and as has
been determined with 5'-bridging phosphorothiolate substrates (Ghosh et al., 2005a; Krogh &
Shuman, 2000), the leaving group does not require a proton donor. K201A does not generate any
appreciable ligated loxP product, consistent with its role in activating the incoming 5'-OH.  Any
Cre mutants containing Y324 could exploit this secondary pathway to ligated products
complicating analysis. For this reason, any mutants studied by this assay should also mutate
Y324. 
WT Cre and a selection of mutants were tested for BS and TS ligation of pNP modified
substrates under conditions unfavorable (0.2 nM substrate) and favorable (50 nM substrate) for
synapsis  formation. Ligation product was normalized for each mutant to the maximum value
measured with each substrate. The data shown in Fig. 3.11 is consistent with strand preference
observations made for Cre cleavage, where WT Cre and Y324F are highly active on the TS half
site in the absence of synapsis, and only become active at the BS half site in conditions favoring
synapsis (Ghosh et al., 2005a). Congruent with this observation, the A36V mutant, which is
defective in synapsis is robust at ligation of the TS and deficient in BS ligation at both substrate
concentrations. In general, Cre appears less active on the BS ligation substrate than on the TS
substrate. However, time course reactions comparing both substrates demonstrate that ligation is
nearly complete at sixty minutes, indicating that 100% conversion to product will not occur on the
BS substrate (data not shown). Perhaps an artifact during synthesis of the BS-pNP generated a
fraction of unreactive substrate. 
H289Q also appears to be more active on the TS ligation substrate than on the BS ligation
substrate. If the H289Q generated covalent intermediate observed in the TS reaction is from
ligation product that was then a substrate for H289Q cleavage, then the actual extent of ligation
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for H289Q is nearly double that reported in Fig. 3.11.  However, since the H289Q/Y324F double
mutant does not generate this additional ligation product, either Y324 is aiding ligation or the
covalent intermediate generated by direct attack on pNP by Y324. Although H289Q and
H289Q/Y324F have similar extents of ligation, the H289A and H289A/Y324F mutants are
significantly different. The H289A mutant generates ligation product on the order of H289Q,
however the H289A/Y324F double mutant abolishes ligation activity. Perhaps the hydroxyl group
of Y324 aids in stabilization of phosphate in the absence of H289. Alternatively, H289A may have
greater ligation activity on the covalent intermediate than with the pNP substrate. The disruption
of ligation observed with H289A and H289Q, particularly the double mutants with Y324F, support
a role for H289 in ligation. However, since pNP does not require an acid to donate a proton at
physiological pH, these experiments are unable to determine if H289 is acting as a proton donor
in ligation. 
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Figure 3.11  Ligation of pNP modified TS and BS loxP DNA substrates by Cre
A. Bottom strand ligation of labeled 36mer DNA substrate (S) containing a 3'pNP, to an adjacent unlabeled 30mer to
form a full 66mer loxP BS (P).  B. Top strand ligation of labeled 25mer DNA substrate (S) containing 3' pNP, to an
adjacent 40mer to form a full 66mer loxP TS (P). Mutants containing Y324 were found to accumulate Cre covalent
intermediate via a 3'-phosphotyrosine linkage, which when digested with proteinase K runs just above the substrate on
the gel (Cov pTYR). Covalent intermediate can form via two distinct mechanisms. The first involves direct attack of
pNP phosphate by Y324 and the second involves Y324 mediated cleavage of the intact loxP product resulting from
ligation. (A and B) Reactions were performed in conditions favorable (50nM substrate) and unfavorable for synapsis
(0.2 nM substrate). The 60 minute reactions were quenched and separated by UREA Page. Reactions for WT, Y324F
and H289Q are the averaged value of three experiments with associated standard deviation. 
3.4 Discussion
Fifteen amino acid substitutions at 289 are tolerated by Cre as measured by recombination
in vivo and in vitro, which prompted further study to understand the function and reason for
conservation in YRs. The cleavage activity of the purified H289 mutants correlated well with the
observed in vitro recombination activity. Studies of this histidine residue in YRs have suggested a
role in ligation that is primarily based on the accumulation of covalent intermediate by the H305L
in Flp (Pan et al., 1993b; Parsons et al., 1988; Serre & Jayaram, 1992), H240L in XerC and
H244L in XerD (Arciszewska et al., 2000; Cornet et al., 1997),and H234L in TnpI (Vanhooff et al.,
2009). The ligation deficiency of H305Q in Flp was observed directly using synthetic substrates
(Whiteson et al., 2007). All nineteen H289 mutants in Cre were studied for cleavage of an intact
loxP site under equilibrium conditions. The Gln, Leu and Met mutants all accumulated covalent
intermediate at levels above WT, but this does not appear to be a general property, as the other
H289 mutants accumulated covalent intermediate at levels similar to or less than WT Cre.
Accumulation of covalent intermediate under equilibrium conditions suggests that the rate of
cleavage has increased relative to the rate of ligation. Since cleavage by H289Q, H289L and
H289M is slower than WT Cre, a defect in ligation is mostly likely responsible for the buildup of
covalent intermediate. These three mutants are the most competent in suicide cleavage, but
several other mutants that do not accumulate covalent intermediate such as the alanine and
asparagine are nearly as active. 
Leu, Met and Gln are good structural mimics of histidine. Amino acid substitutions at 289
with branch points at Cβ are disruptive to activity. This is evident by comparing the activities of
Leu, Ile and Val as well as Ser and Thr. Modeling suggests that smaller amino acids such as
alanine, asparagine and serine leave enough space to accommodate a water molecule in a
similar position as Nε of histidine as observed in transition state structure of TopIB (Davies et al.,
2006; Perry et al., 2010). H289 may participate in ligation, but solvent can partially or fully
substitute in many H289 mutants, masking potentially significant defects. Leu, Met and Gln fill the
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space occupied by histidine and may prevent solvent from efficiently assisting in ligation.
Structures of the H289A and H289Q mutants done in collaboration with Kushol Gupta in the Van
Duyne group are consistent with this hypothesis and are shown in Fig. 3.12. with statistics
presented in Table. 3.3. Clear density for a well ordered water molecule in H289A is observed in
the same space as the histidine in the active subunit. As expected, glutamine occupies the same
general space as histidine, capable of providing stabilizing hydrogen bonds to the scissile
phosphate, but unable to participate in acid/base catalysis. The density for the glutamine is well-
defined, with no evidence of density corresponding to solvent in this region.  
Despite a possible defect in ligation, H289Q is the most active of all the histidine mutants,
which underscores the importance of stabilizing hydrogen bonds to the scissile phosphate.  The
pH profiles examining cleavage demonstrated that assistance of a general base is not required to
activate the tyrosine for cleavage. This may be due in part to the differences in the pKa of tyrosine
(~10) compared to the 5'-hydroxyl group (~15), and is consistent with observations from model
reactions of nucleophilic substitution at phosphodiester linkages that show a modest dependence
on the basicity of the nucleophile (βnuc ~ 0.2-0.3) but a large dependence on the basicity of the
leaving group (βlg ~ -0.8) (Cassano, Anderson & Harris, 2004; Kirby & Younas, 1970a; Kirby &
Younas, 1970b; Maegley, Admiraal & Herschlag, 1996). Therefore, the dependence on a general
acid to assist the leaving group O5' is more important than a base to aid in the activation of the
tyrosine nucleophile. During ligation, the histidine in YRs or water in TopIB would serve as an acid
to assist in protonating the tyrosine leaving group. Experiments using modified tyrosine peptides
were used to argue that H305 in Flp recombinase is acting as a general base in cleavage and an
acid in ligation (Whiteson et al., 2007).  In these experiments, Flp H305Q was rescued for
cleavage using a modified flourotyrosine peptide with a lower pKa than tyrosine, however Flp
H305A was not rescued. Histidine is perhaps the only amino acid that could provide an important
contribution to stabilization of the transition state and also be able to participate in acid/base
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catalysis. Although water can substitute in acid/base catalysis, other amino acids at this position
are either unable to stabilize the transition state or sterically exclude water from effectively
participating in catalysis. 
3.4.1 Top Strand Bias
H289Q preferentially cleaves the TS half site of nicked suicide substrates. This preference is
more pronounced for cleavage of the intact TS when the nick was located at the BS half site than
when the nick is on the TS half site. This strand bias appears is not observed with the
phosphorothiolate substrate, which lacks a nick. Cleavage of thee phosphorothiolate substrate by
H289Q was similar to that determined for WT Cre, where BS cleavage is slightly preferred to TS
cleavage under conditions favoring synapsis (Ghosh et al., 2005a). This suggests that the H289Q
mutant may have a defect in bending loxP associated with the activation of cleavage. However, if
the defect was strictly a bending artifact, cleavage of the BS should be more pronounced with a
nick on the TS. A bending defect would also likely be apparent in binding and synapsis assays,
but H289Q is unperturbed. This apparent opposite strand bias has been noted previously in Cre
for the H289A and H289N mutants, which preferentially form and resolve TS Holiday junction
intermediates (Gelato et al., 2005; Martin et al., 2002). The H289A-DNA structure (Fig. 3.12) is
clearly a trapped TS-covalent complex, which is suggestive of an altered strand bias. The
mechanism of this altered strand bias is unclear, however other YR systems such as λ-int and
XerCD do not rely on site asymmetry alone to control the direction and order of strand cleavage
during recombination (Azaro & Landy, 2002; Barre & Sherratt, 2002). Therefore the strand bias
observed in Cre is likely only relevant to a small portion of YRs and does not account for
conservation of histidine in the active site of the vast majority of YRs. 
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Figure 3.12  Comparison of structure at H289
A. Cre transition state (pdb 3MGV). H289 makes interaction with O2P and phenolic oxygen of Y324.
B. Smallpox topoisomerase transition state (pdb 3IGC). K220, the equivalent residue is oriented away from the active
site. Two well ordered water molecules replace the nitogens of H289 in Cre making similar bonding interactions.
C. Structure of Cre H289Q mutant in complex with loxP. 2Fo-2Fc electron density is contoured at 1.5 σ. The glutamine
occupies the same space as H289. 
D. Structure of Cre H289A mutant in complex with loxP. 2Fo-2Fc electron density is contoured at 1.5 σ. Clear density
for two water molecules, similar to those observed in TopIB (B) replace the histidine. 
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Table 3.3  Crystal statistics for H289Q and H289A loxP DNA complexes
Diffraction Data Cre H289Q – LoxP Cre H289A – LoxP 
Resolution (Å) 2.6 Å 2.3 Å
Space Group
Unit Cell a = 106.29  Å a = b = 136.2 Å
b = 122.29  Å
c = 178.64 Å c = 217.45 Å
1 0.46
Wavelength (Å) 1 1
Completeness (%) 95.2 (91.9) 94.2(87.6)
0.067(0.584) 0.06(0.55)
12.8 (2.3) 23.4 (3.1)
Redundancy 4.5 (4.5) 2.5 (2.0)
Refinement
0.241(0.289) 0.234(0.284)
49.82 54.36
   Bond lengths (Å) 0.008 0.01
1.303 1.53
C2221 P3221
Mosaicity
R
merge
I/σ
R
free
Average B factors (Å2)
Rmsd
   Bond angles (o)
3.4.2 Hydrolysis
Another interesting observation was made from the pH rate cleavage experiments where WT
Cre hydrolyzed the 3'-phosphotyrosine intermediate efficiently as a function of pH, while H289Q
did not generate any hydrolyzed product. The pH dependence of hydrolysis was observed in
TopIB (Christiansen, Knudsen & Westergaard, 1994; Petersen & Shuman, 1997a) and the
increased rate of hydrolysis was presumed to be due to the hydroxide ion concentration, which
increases in alkaline conditions. Unlike the rates of cleavage and ligation, where TopIB is faster
than Cre, the rate of hydrolysis observed in Cre is faster than TopIB at pH 9.5. This agrees with
published comparisons of hydrolysis measured at pH 7.5 in Cre, Flp and Vaccina
topoisomerase(Ma et al., 2009a; Ma et al., 2007; Ma et al., 2009b; Tian, Claeboe, Hecht &
Shuman, 2003). 
In this published work, the rate of hydrolysis was measured on natural sites as well as
modified DNA substrates containing methylphosphonate in place of either the Sp or Rp oxygen of
the scissile phosphate. The uncharged methylphosphonate abrogates the need for charge
stabilization on the corresponding non-bridging oxygens in the transition state. The rate of
hydrolysis catalyzed by vaccinia virus topoisomerase increased 30,000 fold with the
methylphosphonate DNA substrates (Tian et al., 2003). However, a similar enhancement in the
rate of hydrolysis with methylphosphonate substrates was not observed in Cre and Flp (Ma et al.,
2009a; Ma et al., 2007; Ma et al., 2009b). An explanation for this observed difference may involve
H289. With the methylphosphonate DNA, R223 in TopIB (R292 in Cre) is not required to stabilize
charge on scissile phosphate and is then able to adopt an alternative conformation where Nη1
and Nη2 are positioned in the equivalent space as Nε of H289 in Cre. R223 is more efficient in
activating Y274 which results in an enhancement in the rate of hydrolysis. This mechanism is
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unavailable to Cre (and Flp) since H289 prevents R292 from adopting a similar activating
conformation. If this hypothesis is true, then Cre H289A should see a large rescue in hydrolysis
with methylphosphonate DNA substrates.
The stimulation of water mediated hydrolysis may be a protective mechanism in YRs. A
stalled reaction, trapped as a covalent intermediate is problematic for the integrity of the genome.
Hydrolysis may be used as a means of fixing stalled reactions stuck as covalent intermediates. In
the cell, the 3'-phosphate hydrolysis product can be readily dephosphorylated and ligated to
restore intact DNA with host enzymes such as eukaryotic polynucleotide kinase (Karimi-Busheri,
Lee, Tomkinson & Weinfeld, 1998). The faster rate of hydrolysis in YRs may reflect the complexity
of recombination where there is a greater chance having a stalled reaction. Relaxation catalyzed
by the more efficient TopIB enzymes is a more simple reaction and hydrolysis to scavenge stuck
covalent intermediates is unnecessary.
3.4.3 H289 in ligation
The mechanism of water mediated hydrolysis is similar to that of ligation, where the
incoming 5'-OH is activated for attack on the 3'-phosphotyrosine intermediate. The results from
ligation assays using pNP modified substrates demonstrated that H289Q and H289A were
deficient in ligation at physiological pH. Similar to the results from cleavage assays, H289Q and
H289A generated more TS ligation product than BS ligation product. It was also interesting to
note that the Y324F mutant has ligation activity similar to WT Cre, but the Y324F/H289Q and
Y324F/H289A mutants were significantly defective relative to the H289Q and H289A single
mutants (Fig. 3.11). It is possible that the hydroxyl group of tyrosine contributes a stabilizing
interaction to the transition state of the pNP ligation reaction. In Flp, the H305Q/Y343F mutant
was not as severely defective in ligation with the pNP substrate, but was defective in ligation with
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a substrate containing cresol, which more closely mimics a covalently attached tyrosine with a
pKa of 10 and is more dependent on a proton donor to assist the cresol leaving group (Whiteson
et al., 2007). These results support a role for H289 in ligation.
3.4.4 Summary
H289 may not have a single most important function to explain its conservation in YR active
sites. Although fourteen mutants at 289 retain recombination activity, some of these mutants are
significantly defective at recombination and cleavage. Examination of these mutants and detailed
experiments primarily with the H289Q mutant suggests that H289 has a role in structural support
of the active site, stabilization of the transition state through hydrogen bonding interactions, but is
not important as a proton acceptor to activate Y324 in cleavage. H289 has a significant role in
ligation and is essential for water mediated hydrolysis. In addition cleavage , ligation, and
transition state stabilization, H289 may have important contributions to recombination that are not
directly related to phosphoryl transfer. H289Q and H289A accumulate Holiday Junction
intermediates in recombination, which reduces the amount of recombination product. On nicked
suicide substrates H289Q displayed a TS cleavage preference, which has been previously
observed for mutants at H289 in Cre (Gelato et al., 2005; Martin et al., 2002). This opposite
strand preference may be unique to Cre, but could also be the cause of the HJ accumulation.  
Water mediated hydrolysis by WT Cre but not H289Q indicates that a proton donor must be
present to activate the tyrosine leaving group. Since H289A and H289G are also unable to
generate hydrolysis product, suggesting that water less able to function in proton donation,
arguing for a dual role in catalysis by H289 in proton donation and transition state stabilization.
The mechanism of hydrolysis is similar to mechanism of ligation and the experiments using pNP
modified substrates indicate that H289A and H289Q are partially deficient in ligation. An intriguing
idea based on the rapid rate of hydrolysis in Cre as opposed to TopIBs is that YRs have evolved
to use histidine to accelerate hydrolysis in order to rescue stalled reactions containing trapped
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covalently bound recombinases. Such intermediates may occur at a greater frequency for YRs
due to the increased complexity of recombination, in contrast to more simple mechanism of
relaxation performed by TopIBs. 
3.5 Methods
3.5.1 Cloning and purification of Cre mutants
Cre mutants were subcloned from pBluescriptIIKS+ derived vectors carrying active site
mutants from Chapter 3. The XbaI-HindIII fragment containing Cre was ligated into pET21a.
 Cre protein expression and purification of mutants used for biochemical studies were
modified from previously published procedure(Ghosh & Van Duyne, 2002). Cre expression
vectors were transformed into BL21(DE3). Cells were induced with 0.5 mM IPTG and grown for 3
hours at 37 °C. Cells were harvested by centrifugation at 4000 x g for 30 minutes and
resuspended in 20 mL of lysis buffer (20 mM Tris HCl pH 7.8, 0.5 mM EDTA, 300 mM NaCl, 0.5%
Triton-X100, 10 mM 2-mercaptoethanol, and protease inhibitors). Following cell lysis by
homogenization (Avestin), the crude lysate was clarified by centrifugation at 14,000 x g for 20
minutes. The supernatant of the crude lysate was loaded on Hi-Trap SP-sepharose column (GE
Healthcare Life Sciences). Following extensive washing in buffer (300mM NaCl, 10 mM Na/K
phosphate pH 6.5, 10 mM 2-mercaptoethanol), the protein was eluted in with high salt buffer
(800mM NaCl, 10 mM Na/K phosphate pH 6.5, 10 mM 2-mercaptoethanol) and dialyzed for 16
hours at 4 °C in acetate buffer (20 mM Na acetate pH 5.0, 10 mM 2-mercaptoethanol, 40 mM
NaCl) . The dialyzed protein was loaded directly onto a 10 mL type I hydroxyapetite column
equilibrated in HAP A buffer (10 mM Na,K-phosphate pH 6.8, 10 mM 2-mercaptoethanol). Cre
was eluted with a 40ml 25-40% gradient with buffer HAP B (0.8 M Na/K phosphate pH 6.8, 10
mM 2-mercaptoethanol). Peak fractions were pooled and dialyzed at 4 °C for 16 hours in acetate
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buffer. Dialyzed pooled hydroxyapetite fractions were concentrated using Amicon-30 devices
(Millipore/Amicon) to >10-15 mg/mL. The concentrated protein was buffer exchanged into storage
buffer (20 mM Na acetate pH 5.0, 40 mM NaCl, 2 mM dithiothreitol (DTT)). The resulting protein
was >90% pure as judged by Coomassie Blue-stained SDS-PAGE. Concentrated purified protein
was stored at -20 °C in storage buffer containing 40% glycerol. 
3.5.2 LoxP assay substrate purification 
A table of single-stranded oligonucleotides and the annealed substrates used in Cre assays
is provided in Appendix B. 
DNA oligonucleotides were either purchased from Integrated DNA Technologies (IDT) or the
Keck DNA facility at Yale University, or synthesized with a Mermaid 4 DNA synthesizer
(Bioautomation).  Crude oligonucleotides that had the terminal 5'-DMT (dimethoxytrityl) group
cleaved during synthesis were purified by HPLC anion exchange using a DNAPac column
(Dionex) followed by SepPak C18 cartridge (Waters) to remove trace salts. Oligonucleotides were
then dried down and stored in annealing buffer (10mM Tris pH 7.4, 0.5 mM EDTA, and 100mM
NaCl). 
Oligonucleotides containing a 5'-DMT group following synthesis were purified using Glen-
Pak cartridges (Glen Research).  Oligonucleotides are deprotected with 3 mL of concentrated
ammonium hydroxide at 55 °C for 16 hours. An equal volume of 100 mg/mL NaCl was added and
then loaded on a Glen-Pak cartridge that has been washed with 0.5 mL acetonitrile, followed by 1
mL 2 M TEAA (Triethylamine Acetate pH 7.0). Following loading, the cartridges were washed
twice with 1 mL Salt Wash Solution (5% acetonitrile in 100 mg/mL NaCl) and twice with 1 mL 2%
TFA (Trifluoroacetic Acid). Immediately following TFA, the cartridges were washed twice with 1 mL
water and then eluted with 0.5 mL Elution Solution (50 % acetonitrile in water with 0.5%
concentrated ammonium hydroxide). The eluted oligonucleotides were lyophilized. The dried DNA
is dissolved in annealing buffer and stored at -20 °C. 
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5' bridging phosphorothiolate DNA
5'-bridging phosphorothiolate substrates, loxSS7-8 and loxSS9-10 (Appendix B) were
constructed as previously described (Ghosh et al., 2005a).
Synthesis of pNP-modified DNA
3'-pNP (para-nitrophenol) modified oligonucleotides were synthesized using previously
published methods(Whiteson et al., 2007; Woodfield et al., 2000). loxSS1c and loxSS4c were
synthesized using 3'-PO4 CPG (Glen Research) and standard phosphoramidites on a Mermaid 4
DNA synthesizer (Bioautomation). Following the removal of the 5'-DMT protecting group, the resin
was incubated in concentrated ammonium hydroxide  at 55 °C for 16 hours. The DNA was
precipitated with the addition of 0.1 volume of 3M Na acetate and 3 volumes of absolute ethanol.
The pellet was resuspended in 250 mL of 2 mM MgCl2, 100 mM MES (pH 5.5). Aliquots of 3M
para-nitrophenol (pNP)(Aldrich) in acetonitrile and 0.048 g of 1-[3-(dimethylamino)propyl]-3-
ethycarodiimide hydrochloride (EDC) (Aldrich) were added sequentially in the dark and mixed
vigorously to form an emulsion. After 12-16 hours at 20 °C, 250ul of water was added and the
aqueous layer was extracted three times with 500ul each of ethyl acetate and detritylated with
anion exchange (Waters, QMA Sep-Pak cartridge). The 3'-pNP derivatized oligonucleotide was
purified by reverse phase chromatography with a C18 column (Grace Vydac 218TP C18 5u
(250mm x 4.6 mm)) using a 5-25% acetonitrile gradient at 1ml/min (buffered with 100 mM TEAA
at pH 7.0) over 30 minutes. Peak fractions were pooled, ethanol precipitated and stored in
annealing buffer. 
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DNA 32P-5'end labeling procedure
20 pmol of DNA was end labeled with 32P γATP (3000 Ci/mmol) using 10 units of
polynucleotide kinase (PNK) in PNK reaction buffer (70 mM Tris-HCl pH 7.6, 10 mM MgCl2, 5 mM
dithiothreitol). The reaction was incubated at 37 °C for 1 hour and quenched by addition of
phenol/chloroform. The aqueous layer containing labeled oligonucelotide was purified with a size
exclusion spin column, Centrispin-20 (Princeton Separations) and stored at -20°C in annealing
buffer or annealed with complementary single stranded oligonucleotides in excess by slow
cooling in a thermocycler and stored at -20 °C. 
3.5.3 Cre Binding assay
The probe for electrophoretic mobility shift assays was a 64 bp duplex containing the loxP
site flanked by 10 bp and 20 bp G·C-rich segments (loxSS3/6) (Appendix B).  10 pmol of purified
top strand (loxSS6) was 32P end-labeled with PNK and annealed with a purified, unlabeled bottom
strand. Fixed or varied concentrations of Cre were added to 0.2 nM labeled substrate in binding
buffer (10 mM Tris pH 7.4, 150 mM NaCl, 2mM dithiothreitol, 1 mM EDTA, 50 µg/ml sheared
salmon DNA, 50 ug/mL BSA) and incubated for 30 minutes at 20 °C. Binding reactions were
electrophoresed on a 6% polyacrylamide gel (29:1 acrylamide:bisacrylamide) in TBE that was
pre-run at 10 V/cm for 45 min at  20 °C prior to loading. The gel was run at 13 V/cm for two hours
at 20°C, dried, and analyzed with a phosphoimager. 
3.5.4 Cre Synapsis Assay
Fixed Cre at saturating concentrations, generally 0.5 μM or 1 μM was added to 0.2 nM of
labeled loxSS3/6 substrate and varied amounts of unlabeled loxSS3/6 substrate in 1X NCB buffer
(20 mM Hepes, pH 7.5, 5 mM MgCl2,150 mM NaCl, 2 mM dithiothreitol,  and 50 μg/ml sheared
salmon DNA)  and incubated for 30 minutes at 20 °C. Reactions were electrophoresed on a 6%
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polyacrylamide gel (29:1 acrylamide:bisacrylamide) in buffer containing 50 mM Hepes acid and
25 mM Tris base at pH 7.4 that was pre-run at 10 V/cm for 45 min at 20 °C prior to loading. The
gel was run at 13 V/cm for 2 hours at 20 °C, dried and analyzed with Phosphoimager. 
3.5.5 Cleavage Assays
Cleavage assays measure the accumulation of Cre-DNA covalent intermediate. The use of
three distinct DNA substrates measure Cre cleavage in different ways. Nicked and 5'-bridging
phosphorothiolate (PS) cleavage assays use suicide substrates to trap covalent intermediate by
preventing or slowing ligation. The equilibrium assay uses an intact natural loxP substrate to
measure the amount of covalent product without inhibition of ligation. 
Cre suicide cleavage assay (nicked substrates)
The nicked cleavage assay used a loxP substrate that is composed of three oligonucleotides
that anneal to form a loxP site with a nick 3' of the scissile phosphate. When Cre cleaves the
substrate on the nicked strand, the nucleoside 3' of the scissile phosphate, which is required to
attack the 3'-phosphotyrosine intermediate in ligation, dissociates away, effectively trapping the
covalent intermediate. The nick can be located on either the top strand (loxSS1/2/3) or bottom
strand (loxSS4/5/6) of loxP (Appendix B). 
Unless otherwise stated, cleavage reactions were performed in conditions where Cre is
saturating (500nM). The labeled substrate was added at a fixed and constant low level, ~0.2nM
except where noted. When cleavage was measured in conditions favorable for synapsis, the
reaction was supplemented with 50 nM unlabeled but otherwise identical substrate. 
Reactions were initiated by the addition of Cre to substrate in NCB buffer (unless otherwise
stated), and incubated at 37 °C. Reactions were quenched by the addition of 5X SDS loading
buffer (10% SDS, 312 mM Tris pH 6.8, 100 mM dithiothreitol, 0.002% bromphenol blue and
109
xylene cyanol) and separated by SDS-PAGE (12.5% 37.5:1 polyacrylamide gel) for 1 hour at 20
V/cm. Gels were dried (Thermo-Savant gel drier) and analyzed with a phosphoimager (Storm 800
- GE Healthcare). 
Phosphorothiolate Cleavage 
Top strand (TS) 5'-bridging phosphorothiolate substrate loxSS7-8 was 32P end-labeled and
annealed to either unlabeled BS 5'-bridging phosphorothiolate, loxSS9-10, or unmodified intact
BS (loxSS3). Cre cleavage at the site containing the phosphorothiolate results in release of a 5'-
sulfhydryl group. The sulfhydryl group has a pKa five log orders lower than the hydroxyl and is a
poor nucleophile to attack the 3'-phosphotyrosine intermediate, effectively trapping the covalent
intermediate(Krogh & Shuman, 2000; Krogh & Shuman, 2002). 
Unless otherwise stated, cleavage reactions were performed in conditions where Cre is
saturating (500nM). The labeled substrate is added at  ~0.2nM except where noted. When
cleavage was measured in conditions favorable for synapsis, the reaction was spiked with 50 nM
unlabeled substrate. 
Reactions are initiated by the addition of Cre to substrate in 1x NCB buffer (unless otherwise
stated), incubated at 37 °C and quenched by the addition of 5X SDS loading buffer (10% SDS,
312 mM Tris pH 6.8, 100 mM dithiothreitol, 0.002% Bromphenol blue and xylene cyanol) and
separated by SDS-PAGE (12.5% 37.5:1 polyacrylamide gel) for 1 hour at 20 V/cm. Gels were
dried (Thermo-Savant gel drier) and analyzed with a phosphoimager (Storm 800 - GE
Healthcare). 
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Equilibrium
Cre cleavage on a full loxP site is able to be efficiently ligated, but a small fraction of
covalent intermediate is trapped for wildtype Cre and larger amounts for mutants that are
defective in ligation. This assay is performed in two modes. The first is a simple end-point
cleavage experiment, usually a 60 minute incubation with Cre. More formally however, the assay
can be used to assess covalent intermediate at equilibrium (Keq). For wildtype, this occurs in less
than 60 minutes, but mutants defective in cleavage may take longer. 
Single stranded loxP, loxSS6 (top strand) was 32P end-labeled and annealed with
complementary BS (loxSS3). Cleavage reactions were performed in conditions where Cre is
saturating, generally 500nM. The labeled substrate was added at a fixed and constant low level,
generally ~0.2nM. The cleavage reaction was then spiked with  unlabeled substrate for a total
loxP concentration of 50 nM to promote synapsis. 
Reactions were initiated by the addition of Cre to substrate in 1x NCB buffer (unless
otherwise stated), incubated at 37 °C , quenched by the addition of 5X SDS loading buffer (10%
SDS, 312 mM Tris pH 6.8, 100 mM dithiothreitol, 0.002% Bromphenol blue and xylene cyanol),
and separated by SDS-PAGE (12.5% 37.5:1 polyacrylamide gel) for 1 hour at 20 V/cm. Gels were
dried (Thermo-Savant gel drier) and analyzed with a phosphoimager (Storm 800 - GE
Healthcare). 
pH dependent cleavage assays
Suicide cleavage reactions were performed at 37 °C with the following buffers (50 mM): Na
acetate, pH 4.5-5.5; NaMES, pH 5.5-6.5; Na HEPES, pH 6.5-7.5; Bis-Tris-Propane, pH 7.5-9.5.
Reaction buffers also contained 150 mM NaCl, 5 mM MgCl2, 2 mM dithiothreitol, 50 ug/ml
sheared salmon DNA, and 50 ug/ml BSA. Reactions containing 0.2 nM 32P end-labeled substrate
and 50 nM unlabeled substrate in assay buffer were initiated by addition of Cre to 500 nM.
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Aliquots (20 ul) were taken at appropriate time intervals and quenched by the addition of 5X SDS
loading buffer (10% SDS, 312 mM Tris pH 6.8, 100 mM dithiothreitol, 0.002% Bromphenol blue
and xylene cyanol) and separated by SDS-PAGE (12.5% 37.5:1 polyacrylamide gel) for  1 hour at
20 V/cm.
Equilibrium cleavage was performed with the same buffers and conditions described for
suicide cleavage except an intact, symmetrized loxS2 substrate was used (Appendix B).
Reactions were incubated at 37 °C and aliquots were removed at appropriate time intervals to
determine when the reactions reached equilibrium. 
3.5.6 Ligation assay with pNP substrate
Ligation was measured by initiating a reaction containing 0.2 nM 32P end-labeled pNP
(loxSS1c/2c/3-TS or loxSS4c/5c/6-BS) substrate in NCB buffer and incubated at 37 °C. Reactions
performed under conditions favoring synapsis were supplemented with 50 nM unlabeled but
otherwise identical pNP substrate. Reactions were quenched after 60 minutes by the addition of
0.5% SDS and heated to 70 °C for 1 minute. The quenched reactions were digested with 5 ug of
proteinase K for 1 hour at 37 °C and analyzed on 10% denaturing polyacrylamide gels. 
3.5.7 In vitro Recombination assay
The assay substrate (digested pBG1701) is the same as described  for the in vitro assay in
Chapter 2. Time course reactions were initiated by addition of 50 nM Cre to 0.2 nM 32P end-
labeled substrate in NCB buffer. At appropriate time intervals, 30 ul aliquots were removed and
quenched with an equal volume of phenol/chloroform (Reactions were also commonly quenched
with addition of 0.1% SDS, heat to 70 °C followed by digestion with proteinase K). The extracted
aqueous reactions were analyzed on a 6% acrylamide gel in 1X TBE  for 2 hours at 10 V/cm.
Gels were dried and quantified on a Phosphoimager.  
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Chapter  4. E176 is part of a regulatory switch involving
the general acid K201: characterization of the residues
involved in general acid catalysis
4.1 Introduction
Cre E176 is conserved as an acidic residue in more than 95% of tyrosine recombinases
(YRs). In Cre-DNA complex crystal structures, E176 accepts hydrogen bonds from the catalytic
residues K201 and R173, which activate the O5' leaving group of the scissile phosphoate during
cleavage and activate the incoming 5'-hydroxyl group during ligation (Ghosh et al., 2005a; Krogh
& Shuman, 2000; Krogh & Shuman, 2002; Nagarajan et al., 2005). Sequence alignments of YRs
identified this highly conserved acidic residue many years ago (Abremski & Hoess, 1992; Nunes-
Düby et al., 1998), leading to the characterization of a small number of mutants at the
corresponding D194 in Flp recombinase (Chen et al., 1992a; Friesen & Sadowski, 1992; Lee &
Jayaram, 1993). These mutants were found to be catalytically deficient, but without a clear
understanding of function. The functional role of this residue in catalysis has largely been ignored,
possibly because TopIB enzymes have no analogous residue and instead have a solvent
molecule that interacts with K167 and R130 (Davies et al., 2006; Perry et al., 2010; Perry et al.,
2006). 
In this Chapter I describe the biochemical characterization of E176, R173 and K201 Cre
mutants. The data are most consistent with a structural role for E176 in positioning R173 and
K201. The role of each of these residues in general acid catalysis is examined using 5'-bridging
phosphorothiolate substrates. The resulting thio-effects are different than those measured in
TopIB. Both K201 mutants and mutations that disrupt the position of K201 display a strong
dependence on the concentration of phosphorothiolate substrate for activity. This differs from WT
Cre, which has cleavage activity at all substrate concentrations. This suggests that K201 may act
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as a regulatory switch that is turned on during synapsis. In the absence of synapsis, the active
site exists in a weakly active state. Synapsis positions K201 in the active site for catalysis through
interactions that involve E176. 
4.2 Characterization of E176 mutants
Despite its high conservation, fifteen substitutions at position 176 in Cre were active for
recombination in vivo (see Chapter 2). To better understand the nature of the interactions of E176
with K201 and R173, the E176A, E176D and E176Q mutants were purified. All three mutants
displayed activity in vivo and both E176A and E176D were active in vitro. However, E176Q was
inactive in vitro with soluble lysates.  
Time course experiments to probe the ability of purified E176A, E176D, and E176Q to
mediate recombination in vitro confirmed results from the soluble lysates. Fig.  4.1A shows a
graph of percent excision versus time for in vitro recombination. The product curves for the E176
mutants, particularly E176D and E176Q, are linear. Initial velocities were determined from the
slope in order to compare the rates of recombination for the three mutants to WT Cre (see Table
4.1). E176A is the most robust of these mutants, with nearly 6% of WT recombination activity. The
conservative E176D mutant is less active with 1.23% of WT activity, while E176Q has no
detectable recombination activity in vitro. The results demonstrate that the removal of the entire
E176 side chain is better tolerated by Cre than either of the more conservative substitutions. 
All three E176 mutants were defective in synapsis compared to WT Cre (Fig. 4.1B). E176A
is the most proficient of the mutants, followed by the E176D and E176Q mutants, which are
nearly dead for synapsis. The deficiency in synapsis may explain the poor recombination activity.
However, if the E176 mutants disrupt the positions of K201 or R173, then this would suggest an
additional defect in phosphoryl-transfer activity.  
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Figure 4.1  Catalytic activities of E176 mutants
The alanine, aspartic acid and glutamine mutants at E176 were measured for in vitro recombination (A), Synapsis (B),
and cleavage with a suicide 5'-bridging phosphorothiolate suicide substrate (C). Cleavage was measured in the absence
of synapsis with substrate at 0.2 nM. 
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Table 4.1: Initial velocities of E176 mutants in in vitro
recombination.
Initial velocity is reported at %excised * min-1 and %excised * sec-1. The
third column reports the % of mutant activity relative to WT Cre. 
Initial Velocities
Rel:WT
WT 5.45 0.09 100
E176A 0.32 0.01 5.8
E176D 0.07 0 1.23
E176Q N/A N/A N/A
% * min-1 % * sec-1
E176 mutants were measured for cleavage activity to assess defects in catalysis. In order to
separate cleavage activity from the defects in synapsis, cleavage was measured at
concentrations of 5'-bridging phosphorothiolate substrate (0.2nM) that is 10-fold below the KD of
synapsis(Fig. 4.1C) (Ghosh et al., 2007). At this low concentration of substrate, the Cre-dimer
bound to loxP has been shown to cleave loxP substrate (Ghosh et al., 2005a) (see Chapter 5). All
three E176 mutants showed decreased cleavage of the phosphorothiolate substrate relative to
WT Cre.  This indicates that the E176 mutants disrupt the structure of the Cre active site as
cleavage of this substrate does not require the general acid, K201 (Ghosh et al., 2005a).  The
E176 mutants were then tested for their ability to cleave nicked suicide substrates containing
phosphodiester linkages at the scissile phosphate. In the absence of synapsis (0.2 nM substrate),
E176A and E176D cleave less than 5% of the substrate and E176Q does not produce any
detectable cleavage product. E176A and E176D but not E176Q are rescued for cleavage at
higher substrate concentrations (50 nM), favorable for synapsis formation, where they cleave as
well as WT Cre (~50% cleavage product). Use of the 5'-bridging phosphorothiolate substrate
under conditions favorable for synapsis is able to rescue E176Q for cleavage. The results
suggest that the decreased activity observed for the E176 mutants are likely due to a structural
disruption of R173 or K201. 
4.3 Characterizing the role of R173
As described in Chapter 2, the in vivo characterization of all nineteen substitutions at R173
revealed that R173H, R173K, and R173L mutants retained activity. The conservative R173K
mutant was less active than R173H in vivo. This was confirmed when R173H, and not R173K,
showed recombination activity in vitro in the presence of soluble lysates. In order to understand
the role of R173 in Cre, the R173H, R173K and R173A mutants were cloned into expression
vectors and purified for characterization in vitro.
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The purified R173 mutants were tested for in vitro recombination activity. Portions of the
reaction were removed at 5, 30, 60, and 180 minutes to allow the R173 mutants adequate time to
produce a detectable excision product. As shown in Fig. 4.2, WT Cre efficiently generates
excision product, reaching equilibrium after 30 minutes. R173H excises the 234 bp product with
noticeably reduced activity compared to WT, consistent with the results determined using soluble
lysate. After three hours of incubation, no excision products were observed for either of the
R173K or R173A mutants. Because R173K displayed weak activity in vivo, a longer incubation
may be necessary to produce detectable excision product in vitro. Covalent intermediate
accumulated in the soluble lysate of R173H but this was not observed in the assays using purified
R173H protein (Fig. 4.2). This absence of covalent intermediate was a result of quenching with
phenol/chloroform causing any substrate covalently attached to Cre to partition into the organic
phase. 
The R173K mutant in Cre has been shown to be defective in synapsis (Guo et al., 1999).
The mutants at R173 were therefore, tested for their ability to bind and synapse loxP DNA. WT
Cre binds loxP cooperatively as a dimer with subnanomolar affinity.  As shown in Fig. 4.3A, all
three mutants bound loxP like WT Cre, where protein was titrated in ten fold intervals from 0.5 to
500 nM with 0.5 nM 32P-labeled loxP substrate.  At 500nM Cre, all Cre mutants completely bound
the loxP substrate. During the synapsis assay (Fig. 4.3B), Cre (1μM) was titrated with increasing
concentrations of unlabeled loxP substrate up to 160 nM. R173H and R173A are both competent
in synapsis, while R173K is severely deficient. This suggests that the interactions made by R173
are not requires for synapsis and that R173K may disrupt synapsis through a disruptive
interaction. Although the defect in synapsis could explain the weak recombination activity
observed for R173K, this mutant may also disrupt phosphoryl transfer as was found for the
corresponding mutation in TopIB (Krogh & Shuman, 2000; Krogh & Shuman, 2002; Wittschieben
& Shuman, 1997).  
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To better characterize the functional role of R173 in catalysis, cleavage assays were
performed using both nicked suicide and intact loxP substrates as described in Chapter 3 (Fig.
4.4A). Cleavage reactions were performed with 50 nM total substrate to promote synapsis and
optimize the cleavage activity of Cre. After 1 hour the R173H mutant showed modest cleavage
activity correlating well with recombination activity. However, R173A, which is inactive for
recombination in vivo (Chapter 2) or in vitro, was also able to cleave the nicked suicide substrate.
A weak band corresponding to cleavage of loxP by R713K is visible with the nicked top strand
(TS) substrate (loxSS1/2/3). The R173 mutants cleave the TS preferentially with both the TS and
BS (bottom strand) nicked substrates. WT Cre and R173H accumulate more TS covalent
complex, but R173A accumulates BS covalent complex with intact loxP. The rationale for the
strand bias is unclear, but mutants at H289 also have a strand cleavage preference opposite to
that of WT Cre (see Chapter 4). In the crystal structure of the Cre transition state mimic, R173
and H289 interact with the non-bridging oxygen (O2P) of the scissile phosphate of loxP,
suggesting that this interaction is important for the strand cleavage preference in Cre (Fig. 2.2).  
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Figure 4.2  In vitro recombination assay of the Cre R173 mutants
Cre excision of the 602 bp recombination substrate produces a 234 bp product. Reactions were quenched at 0, 5, 30, 60
and 180 minutes with phenol/chloroform. 
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Figure 4.3  Binding and synapsis of R173 mutants
A. Binding of Cre at 0, 0.5, 5, 50 and 500 nM to 0.5 nM loxP substrate. In addition to monomer and dimer species, the
synapsis band is also visible for WT Cre and the R173H and R173A mutants.
B. Synapsis of R173 mutants at 1μM Cre is measured using 0.2, 10, 40, and 160 nM loxP. 
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Figure 4.4  Cleavage by R173 mutants
A. Schematic showing Cre cleavage of TS-nicked (loxSS1/2/3), BS-nicked (loxSS4/5/6) and intact loxP (loxSS3/6).
B. Gels of Cre R173 mutant cleavage reactions with the Ts, BS and intact loxP substrates. R173 mutants preferentially
cleave the TS substrate(covalent product for loxSS1/2/3, and intact strand product for loxSS4/5/6). However when
tested with the intact loxP substrate(loxSS3/6), R173H accumulates BS covlant product while R173A accumulates TS
covalent product. 
4.4 Thiol rescue of Cre mutants at R173, K201 and E176
Studies of vaccina virus topoisomerase using 5'-bridging phosphorothiolate suicide
substrates suggested that both K167 and R130 (Table 1.1) may function in proton donation to the
5'-hydroxyl leaving group during cleavage in TopIB (Krogh & Shuman, 2001; Krogh & Shuman,
2002). However, it remains unclear which of these two residues is the proton donor, as a second
study suggests that R130 may act as the sole proton donor (Nagarajan et al., 2005). These
experiments rely on the fact that the 5'-thiol leaving group has a pKa 5 units lower than the 5'-
hydroxyl leaving group, and therefore cleavage does not require assistance of a general acid
proton donor. Mutants of residues involved in general acid catalysis with reduced ability to cleave
natural substrates containing a phosphodiester (PO) linkage at the scissile phosphate will be
rescued using a 5'-bridging phosphorothiolate substrate (PS). The thio-effect is a measurement of
this rescue obtained by taking the ratio of the rates of cleavage with the PS substrate and the PO
substrate. A large thio-effect suggests the mutated residue is involved in general acid catalysis,
which was determined for R130 and K167 in TopIB(Krogh & Shuman, 2000; Krogh & Shuman,
2002) and K201 in Cre(Ghosh et al., 2005a). 
To determine the roles of K201 and R173 in general acid catalysis by Cre, the
K201A/R173A, K201A/R173K and K201A/R173H double mutants were purified. Both the single
and double mutants were tested for their ability to synapse loxP sites. As Fig. 4.5 shows, WT Cre
and K201A have the same level of synapsis, but the K201A double mutants are defective in
synapsis. This result suggests that an interaction from R173 or K201 with O5' of the scissile
phosphate is necessary for efficient synapsis. K201 likely satisfies this requirement when R173 is
mutated to alanine or histidine, and R173 is capable of fulfilling these interactions with the scissile
phosphate in the absence of K201. However the R173A, R173H and presumably even R173K
mutants are unable to interact with O5' and are therefore unable to efficiently mediate synapsis in
the absence of K201. 
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WT Cre has been shown to cleave low concentrations of the PS DNA efficiently(Ghosh et al.,
2005a). At 0.1 nM substrate, which is nearly 100-fold below the KD for synapsis, Cre exclusively
cleaves the TS of the phosphorothiolate substrate. As the substrate concentration is increased,
cleavage of the BS becomes preferred in an apparent correlation with formation of synapsis. To
determine if the cleavage activity of K201A and the mutants at R173 are similar to that of WT Cre,
cleavage of 6 pM to 100 nM PS DNA was measured. The  reactions were analyzed by SDS-
PAGE and quantitated for TS, BS and total cleavage (Fig. 4.6). Only R173H displayed a cleavage
profile resembling that of WT Cre.  K201A and R173K do not cleave the PS substrate on either
strand at low concentrations of PS, but are able to cleave at higher concentration of substrate.
This suggests that these mutants are unable to cleave in the absence of synapsis and the
formation of synapsis rescues the cleavage defect of the Cre-loxP dimer. The R173A mutant
shows reduced cleavage activity at low substrate concentrations. Based on these results,
concentrations of loxP substrate greater than 20 nM are optimal for measuring thio-effects, as all
mutants show cleavage of the phosphorothiolate substrate at these concentrations. 
To quantify a thio-effect, the mutants must be capable of cleaving a phosphodiester (PO)
linkage at the 5' position of the scissile phosphate. Since the R173 mutants were more active in
cleaving the top strand of loxP(Fig.  4.4), the TS-nicked substrate (loxSS1/2/3) was used in order
to give weakly active mutants such as R173K and R173A a chance to cleave the phosphodiester
bond. The TS-nicked substrate contains an intact, natural BS where cleavage and ligation of this
strand is in equilibrium. To compensate for this, the same natural BS (loxSS3) is paired with a
suicide 5'-bridging phosphorothiolate TS substrate (loxSS7-8). Fig. 4.7 shows these substrates
schematically and an example of a 60 minute cleavage reaction using both nicked and
phosphorothiolate substrates for the mutants at R173 and K201. A 50 nM substrate concentration
was used in these assays to promote synapsis dependent cleavage. WT Cre efficiently cleaves
both substrates. However, K201A and the R173 mutants are defective in cleaving the PO
substrate. The PS substrate rescues cleavage activity of all mutants with the exception of the
K201A/R173A double mutant. 
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Figure 4.5  Synapsis of R173 and K201A mutants
Synapsis of 1μM Cre with 0.2, 10, 40, and 160 nM loxP.  Gel showing synapsis of WT, R173H, R173A and R173K is
duplicated from Fig. 4.3 for comparison.
Figure 4.6  Concentration dependence in cleavage of 5'-bridging phosphorothiolate substrates
A. Schematic of TS and BS cleavage by Cre with 5'-bridging phosphorothiolate substrates.
B. Gels of PS cleavage reaction at 1 hour. Lanes: 0, 6, 22, 66, 200, 2,000, and 20,000 pM loxP-PS substrate. K201A, R173K, and A36V have an additional lane
containing 100,000 pM loxP-PS substrate.
C. Plots of the fraction of TS, BS and Total cleavage product as a function of concentration of substrate.
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Figure 4.7  Rescue of cleavage activity with 5'-bridging phosphorothiolates
A. Schematic of TS nicked (loxSS1/2/3) cleavage by Cre. Cre cleavage at the TS nick is irreversible but cleavage on
intact BS is in equilibrium. B. Schematic of Cre TS-phosphorothiolate suicide cleavage. Cre cleavage of TS-PS is
irreversible but cleavage on intact natural BS substrate is in equilibrium. 
C. Cleavage of nicked versus phosphorothiolate substrate after 60 minute incubation of Cre with 50 nM substrate. 
D. Example of time course of cleavage with WT Cre using nicked and phosphorothiolate substrate. Cleavage of
nicked DNA is about 2x faster than phosphorothiolate (PS) DNA. Thio-effect = ~0.5.
Time course experiments were performed to estimate the rate of cleavage for the Cre R173
and K201 mutants. Reactions with the nicked TS substrate were incubated for 126 hours to
obtain measurable cleavage for the weakly active R173K and K201A mutants. Fig. 4.8 shows
graphs of the cleavage products of TS-nicked and phosphorothiolate substrates versus time.
With the exception of WT Cre, all mutants cleave the phosphorothiolate substrate faster than the
nicked substrate. The K201A/R173A is less able to cleave the PS substrate than the other
mutants. This demonstrates that Cre requires an interaction from K201 or R173 with either the
O5' or O2P of the loxP scissile phosphate in order to cleave the PS substrate.  K201A generates
1-3% cleavage product after 126 hours of incubation. Therefore, to determine the thio-effects for
the panel of R173 and K201A mutants the initial velocities of cleavage were measured. 
Initial velocites were determined in triplicate.  The reactions for fast mutants such as WT Cre
were quenched in under a minute. Weakly active mutants like K201A, were incubated for up to
140 hours to generate measurable cleavage product with the TS-nicked substrate. Table 4.2
shows the measured initial velocities and calculated thio-effects for Cre compared to those
determined for vaccinia virus topoisomerase (Krogh & Shuman, 2002). WT Cre has a thio-effect
less than 1, as it cleaves the nicked substrate faster than it does the phosphorothiolate substrate.
All single mutants of R173 have thio-effects that agreed with each other within 5-fold, where
R173H had the smallest thio-effect and R173K the largest. K201A showed the largest rescue with
a 1300-fold thio-effect. The thio-effects for the K201A:R173A and K201A:R173K double mutants
are unable cleave the PO linkage of the nicked substrate. The large thio-effects for the K201A
and R173 mutants are consistent with both K201A and R173 having a role in general acid
catalysis, but the larger thio-effect for K201A indicates that K201 is more likely the proton donor
responsible for activating O5' of the loxP scissile phosphate at cleavage.
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Figure 4.8  Cleavage time course with nicked and phosphorothiolate substrates
Top: Gels for WT cleavage time course reactions with TS-nicked and phosphorothiolate (PS) substrates. Graph of total
cleavage as a function of time(top right). Graphs of similar cleavage reactions for other mutants below and set to the
same scale (%cleavage on the y-axis and time in hours on the x-axis). 
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Table 4.2: Thio-effects for Cre and vaccinia virus topoisomerase
O: initial velocity of cleavage of the nicked TS substrate (loxSS1/2/3) as %TS*sec-1
S: initial velocity of cleavage for the TS-phosphorothiolate substrate (loxSS7-8/3) as %TS*sec-1
S/O: Thio-effect is ratio of initial velocities in Cre. Reported thio-effect in V. topo (Krogh & Shuman, 2002)
Cre
O S S/O S/O
WT 1.62E-01 8.37E-02 0.52 WT 0.67
R173H 3.18E-03 4.60E-02 14
R173A 3.35E-04 9.63E-03 28 R130A 190
R173K 1.45E-04 1.17E-02 80 R130K 2600
K201A 2.91E-06 3.88E-03 1333 K167A 370
K201A_R173A 6.10E-07 N/A N/A
K201A_R173K 8.70E-07 N/A N/A K167A_R130K 2000
V. Topo
 E176Q and R173K mutants share a similar deficiency in recombination, cleavage and
synapsis, suggesting that E176Q and R173K mutants may disrupt catalysis in a similar manner.
Perhaps E176Q introduces an unfavorable interaction, which forces R173 to adopt a non-catalytic
conformation. To further examine the role of E176 in general acid catalysis, several R173/E176
and K201A/E176 double mutants were constructed and purified. The cleavage activity of all of the
mutants was tested using nicked and phosphorothiolate suicide loxP substrates. One hour
cleavage reactions with PO and PS substrates were measured at low (0.2 nM) and high (50 nM)
concentrations to study the effect of synapsis on cleavage. The cleavage activity (plotted in Fig.
4.9) was determined from two or three independent measurements for all but the E176A/R173K
and E176A/R173A double mutants. Although the rate of cleavage can not be determined based
on the 1 hour cleavage assay, a qualitative assessment of the rescue activity is instructive in
understanding the functional relationship between R173, K201 and E176 in general acid
catalysis. The cleavage values plotted in Fig. 4.9 are consistent with results obtained from the
concentration dependence of phosphorothiolate cleavage (Fig. 4.6) and experiments measuring
thio-effects (Fig. 4.7 and Fig. 4.8). 
E176Q, but not E176D or E176A,  has a substantial thio-effect under conditions favoring
synapsis. The E176Q/R173H double mutant has cleavage activity equivalent to that of the R173H
single mutant. This suggests that the mechanism of disruption by E176Q may involve Nη of
R173, since R173H would not interact with E176Q in this manner (Fig. 2.2). The E176Q/R173K
double mutant behaves like the R173K single mutant, showing substantial rescue with
phosphorothiolate, but only under conditions favoring synapsis. The E176A/R173A double mutant
is active for cleavage on the nicked substrate and displays a cleavage profile similar to that of
both the E176A and the R173A single mutants. This double mutant demonstrates that the
catalytic defects caused by E176Q and R173K are due to disruptive effects rather than the loss of
an important interaction. The K201A/E176Q double mutant has a cleavage profile identical to that
of the K201A/R173K double mutant, where a substantial rescue of cleavage activity is observed
with the phosphorothiolate substrate, but only under conditions favoring synapsis. This contrasts
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with the K201A/R173A mutant, which is deficient at cleavage of the phosphorothiolate substrate
in conditions favoring synapsis. These results suggest that an interaction from either K201 or
R173 with the scissile phosphate is required to stabilize the transition state during cleavage of the
phosphorothiolate substrate. Taken together, these results from the cleavage assays provide a
more complete set of data that probe the interactions made between E176, R173 and K201 as
they pertain to cleavage within a Cre-loxP dimer and within the synaptic complex. 
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Figure 4.9  Cleavage by Cre mutants on nicked and phosphorothiolate substrates
60 minute endpoint cleavage reactions with nicked (O) and phosphorothiolate (S) substrates.  Plotted cleavage is the
average of two or three independent measurements except for the  E176A/R173K and E176A/R173A double mutants,
which were only measured once.
A. Cleavage measured in conditions favorable for synapsis formation. Substrate was at 50 nM to promote synapsis. 
B. Cleavage independent of synapsis. Substrate at 0.2 nM to measure cleavage of the Cre dimer bound to loxP in the
absence of efficient synapsis.
Table 4.3: Summary of activities of mutants at E176, R173 and K201
Name notes
WT +++ +++ +++ +++ +++ +++ +++
K201A 0* 0 +++ + +++ 0 0 minimal in vivo activity at detection lim it (Chapter 2) 
R173H ++ ++ +++ +++ +++ +/0 TS cleavage preference on nicked substrate
R173A 0 0 +++ ++ +++ 0 TS cleavage preference on nicked substrate
R173K + 0 + + +++ 0 +/0 minimal cleavage on nicked substrate w ith TS preference
E176A +++ ++ ++ + +++ + +++
E176D +++ ++ + + +++ + +++
E176Q ++ 0 + + +++ 0 ++
K201A/R173H + + +++ 0 0
K201A/R173A + 0 + 0 0
K201A/R173K + + +++ 0 0
E176Q/R173K + +++ 0 0
E176Q/R173H +++ +++ 0 TS cleavage preference on nicked substrate
E176Q/K201A + +++ 0 0
E176A/R173A ++ +++ + ++ (*) TS cleavage preference on nicked substrate
 in vivo 
activity
 in vitro 
excision Synapsis
PS no 
synapsis
PS + 
synapsis
PO no 
synapis
PO + 
synapsis
++ (*)
+ (*)
++ (*)
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4.5 Discussion
4.5.1 E176 in general acid catalysis
These studies demonstrate an important but non-essential structural role for E176 in
positioning K201 and R173 in the active site of Cre. The E176A mutant is  catalytically competent
for cleavage, synapsis and recombination in vitro. The E176Q mutant is considered to be a
conservative mutation, but was found to harbor catalytic deficiencies far greater than those of the
E176A mutant. E176Q introduces a disruptive interaction, presumably with Nη1 of R173. The
phenotype of the E176Q mutant is equivalent to that of the R173K mutant, where both mutants
are severely defective in synapsis and cleavage, and inactive for recombination in vitro. 
Biochemical characterization of the R173A and R173H mutants demonstrated that the
interactions made by arginine to O5' and O2P of the scissile phosphate in the transition state are
not required for cleavage or synapsis. Therefore, like E176Q, R173K must introduce a disruptive
interaction that results in deficiencies in recombination, cleavage and synapsis. 
To determine if the R173K and E176Q altered the activity via the same mechanism, a series
of double mutants were constructed and studied for cleavage of 5'-bridging phosphorothiolate
substrates. The results from these cleavage experiments suggested that R173K directly, and
E176Q indirectly via R173, disrupts the position of K201. Indeed, studies with non-bridging
phosphorothiolate substrates in TopIB suggest that in the transition state, the proximity of R130 to
K167 introduces electrostatic repulsion between R130 and K167(Nagarajan et al., 2005). In the
transition state mimic structure of Cre the amino group of K201 is 4.55 Å and 4.66 Å from the Nε
and Nη2 atoms of R173, respectively. Similar R130-K167 distances are observed in the transition
state structures of trypanosomal and vaccinia virus TopIB(Davies et al., 2006; Perry et al., 2010).
Disruption of R173 by E176Q could push the Nη of R173 closer to K201, increasing the
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electrostatic repulsive forces felt by K201 and thereby disrupting the ability of K201 to effectively
interact with O5' of the scissile phosphate and function in acid/base catalysis. Studies of R130K in
TopIB with non-bridging phosphorothiolate substrates demonstrated that the lysine is too short to
efficiently interact with the O5' of the scissile phosphate and too long to be able to adopt a
conformation allowing for favorable bonding interactions with the non-bridging oxygen, O2P
(Nagarajan et al., 2005). This is likely also true for R173K in Cre given the similarity of active sites
of Cre and TopIB. Because the ε-amino group of R173K does not make efficient contact with the
scissile phosphate, the lysine side chain likely experiences greater conformational freedom than
the arginine residue and therefore disrupts K201 in a manner similar to that of E176Q. This is
consistent with observations from the R173K synaptic structure where K173 is pointed directly at
K201, and the ε-amino group of K201 is oriented away from O5' (see Fig. 4.10) (Guo et al., 1999).
E176 is well conserved in YRs as an acidic residue. Both λ integrase and Flp recombinase
have an aspartic acid in this position. However in the crystal structures of λ int (Biswas et al.,
2005) and Flp (Chen et al., 2000; Conway, Chen & Rice, 2003) DNA complexes, the aspartic acid
residue interacts with the β2-β3 region and the conserved arginine in a different manner than
E176 does in Cre (discussed in Chapter 2). The glycine and asparagine mutants at D194 in Flp
are defective in recombination and cleavage, which suggests that the interactions made by
aspartic acid may fulfill a similar structural role as observed in Cre (Chen et al., 1992a; Lee &
Jayaram, 1993).  E176 in Cre functions as a structural bridge that positions R173 and K201 so
that their electrostatic repulsive forces are minimized. TopIBs function robustly without an
equivalent residue at this position. Instead, TopIB relies on water to make a similar set of
interactions with R130 and K167. This evolutionary difference between Cre and TopIB may be
explained by the different regulatory mechanisms used to position the lysine and arginine in the
active site. 
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Figure 4.10  Disruption of K201 by R173K
Views of the active site in the 'activated' Cre subunits of (A) the transition state mimic  structure (pdb 3MGV) and (B)
the synaptic structure determined with Cre mutant R173K (pdb 4CRX). K173 does not engage the scissile phosphate at
either O5' or nonbridging oxygen O2P, but instead the amino group is oriented in the direction of K201. Although the
shift is small, the amino group of K201 is pointed away from the active site and O5'. 
Although R173 of Cre and R130 of TopIB are nearly superimposable in the transition state
structures, the primary and secondary structures surrounding each arginine are very different in
the two enzymes (Fig. 4.11A). In Cre, R173 is located at the N-terminus of helix H, three residues
away from E176. In variola topoisomerase, R130 is located in a loop, which extends away from
the active site. Upon DNA binding, a portion of this loop forms a short helix (α5), which makes
specific interactions in the major groove of DNA (Perry et al., 2010; Perry et al., 2006). The
formation of α5 may act as a regulatory switch that prevents R130 from effectively interacting with
the scissile phosphate in the absence of DNA binding. Although α5 is unique to the viral
topoisomerases (Dong & Berger, 2008; Perry et al., 2006), the loop region proximal to the
catalytic arginine in cellular and bacterial TopIBs forms a different set of interactions that may act
in a similar manner to the viral TopIBs in regulating activity through modulation of the position of
the catalytic arginine (Patel, Shuman & Mondragón, 2006; Redinbo et al., 1998; Stewart et al.,
1998).  
This model is consistent with the thio-effects measured in vaccinia virus topoisomerase,
which indicated that mutants of R130 have a larger thio-effect than those of K167(Krogh &
Shuman, 2002). However, the thio-effects from the equivalent substitutions in Cre are different
than those observed in TopIB. K201A has a much larger thio-effect than the mutants at R173,
which suggests that the cleavage activity of Cre depends more on K201 than on R173. These
differences in the thio-effects for arginine may be due to interactions between the ε-nitrogen of
R173 and the non-bridging oxygen, O2P, in the transition state. H289 also hydrogen bonds to the
O2P scissile phosphate of the Cre transition state mimic. When R173 is mutated to an alanine,
H289 can still stabilize the negative charge at O2P in the transition state. TopIB does not have a
histidine at this position, so the stabilization of negative charge on O2P relies entirely on R130.
This interaction is lost when R130 is mutated to either an alanine or lysine residue, resulting in
the observed drop in cleavage activity with the natural substrate. The R130 interaction with O2P
appears to be dispensable with 5'-bridging phosphorothiolate substrates, as both R130A and
R130K are capable of cleavage resulting in the large thio-effect observed in TopIB. 
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The difference in thio-effects for the catalytic lysine in Cre and TopIB may be explained by a
difference in the mechanism of positioning the lysine in the active site, as shown in Fig. 4.11B.
K201 in Cre is located on the flexible β2-β3 loop, which makes a salt bridge interaction with
another Cre dimer across the synaptic interface between R199 on β2-β3 and D126 on helix E of
the synaptic partner. This suggests that synapsis has a role in positioning K201 in the active site.
TopIB functions as a monomer, so the equivalent beta hairpin (β7-β8) inserts K167 into the active
site without any assistance from inter subunit interactions.  
The conformational flexibility of the loop carrying K201 is best depicted by comparing the
positions of K201 and the β2-β3 hairpin in the active and inactive subunits of a Cre synaptic
complex with the crystal structure of Cre monomer complex (Yuan, 2008) (Fig. 4.12). The overall
structures are nearly identical with an average Cα rmsd of 1.6 Å, but deviate at the β2-β3 loop
carrying K201. In the Cre half site complex, K201 is completely removed from the active site.
R173 of the half site complex is also reoriented and does not form any interactions with the
scissile phosphate. The comparison supports a mechanism of Cre regulation where synapsis
formation facilitates the placement of K201 in the active site. This model of regulation agrees with
the phenotypes observed for the E176Q and R173K mutants, which likely disrupt activity by the
partial or full displacement of K201 from the active site via electrostatic and/or steric repulsion
with R173 or K173.  
The concentration dependence of phosphorothiolate substrate cleavage provides an
interesting depiction of the differences between the active sites of Cre in dimeric and Cre in
synaptic complexes. Synapsis is dependent on the loxP concentration under conditions where
Cre is saturating. At concentrations of substrate well below the KD of synapsis Cre exists almost
exclusively as a dimeric complex in solution(Ghosh et al., 2007).  Cleavage of the
phosphorothiolate substrate by WT Cre was used to show that at low loxP concentrations, the
Cre dimer preferentially cleaves the TS, but at higher concentrations BS cleavage becomes
favored corellating with the formation of the synaptic complex(Ghosh et al., 2005a). 
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Figure 4.11  Variation in the position of catalytic arginine and lysine in Cre and
TopIB
A. The position of R173 in Cre relies on E176. TopIB has no equivalent residue to E176 and instead relies on its close
proximity to α5, which forms specific contacts in the major groove of DNA to dock R130.
B. The β2-β3 loop containing K201 in Cre forms interactions with αE of a neighboring Cre subunit across the synaptic
interface. These interactions anchor K201 in the active site of the cleaving subunit. Because TopIB functions as a
monomer, K167 is more rigidly packed in the active site. 
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Figure 4.12  K201 is on a mobile structural element in Cre
A. Overlay of the active (Green) and inactive (Purple) subunits of Cre from the transition state structure(3MGV) with
the structure of the Cre half site complex (Cyan). The structures overlay well with an average RMSD of 1.6 Å, except
for the region containing K201, which is on the bottom of the image and highlighted in C.
B. Cartoon representation of the position of K201 in the mobile loop. The β2-3 loop of the active subunit of Cre
(Green) interacts with the inactive Cre subunit across the synapsis interface, which helps to position K201 in the active
site. The β2-β3 loops of the inactive subunit (purple) and Cre monomer (cyan) do not form the same interactions
resulting in the removal of the loop containing K201 from the active site.
C. Views comparing the position of K201 and the β2-β3 loop of the active, inactive and monomeric Cre structures.
The fraction of total cleavage product remained nearly constant, even though the proportions of
TS and BS cleavage changed with substrate concentration. The K201A and R173K mutants were
unable to cleave the phosphorothiolate substrate at low loxP concentrations, indicating that these
mutants are unable to cleave as a dimer. However, R173H has a cleavage profile similar to that of
WT Cre, cleaving the TS efficiently at low concentrations of phosphorothiolate substrate. Cre
R173A has cleavage activity at low substrate concentrations, but at a level significantly lower than
that of either WT or R173H Cre. These results are perplexing in that they suggest that the general
acid, K201, is essential for the cleavage activity of the Cre dimer but not for the activity of the
synaptic complex. Because cleavage of the 5'-bridging phosphorothiolate substrate does not
require a proton donor, K201 must have some other role in cleavage catalyzed by the Cre dimer,
which becomes unnecessary upon formation of a synaptic complex. 
Without a crystal structure, the positions of the active site residues of the Cre dimer in
complex with DNA are unknown. However, the position of K201 within the Cre-dimer is likely to be
similar to that observed in the Cre-DNA half site structure as the half site complex was
crystallized in the absence of a synaptic partner. The active site of the Cre-dimer likely exists in a
partially activated state due to misoriented active site residues, reduced intersubunit interactions
and reduced DNA bending (Chapter 5). Perhaps K201 associates with the scissile phosphate in
the Cre dimer in some manner that stabilizes the transition state enough to allow efficient
cleavage of the phosphorothiolate substrate and limited cleavage of nicked DNA containing a
phosphodiester linkage (Fig. 4.13A).  In the absence of K201 association with the scissile
phosphate, Cre is unable to cleave the phosphorothiolate substrate as a dimer. This is observed
with the K201A mutant, which eliminates the lysine side chain, and the R173K and E176Q
mutants, which block association of K201 with the scissile phosphate through electrostatic and/or
steric repulsion. The R173H mutant is too short to disrupt the position of K201, and therefore
cleaves the phosphorothiolate substrate as a dimer more efficiently than WT Cre. The partially
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deficient cleavage activity of the R173A dimer suggests that the Cre active site benefits from the
stabilizing interaction between Nε of R173 and the non-bridging oxygen, O2P, of the scissile
phosphate. 
Several results provide insight into how synapsis alleviates the requirement for K201 to
cleave the phosphorothiolate substrate. The crystal structure of the K201A mutant in a synaptic
complex shows that the removal of the lysine side chain does not affect the position of the β2-β3
loop or the interaction of the 201 amide nitrogen with E176 (Ghosh et al., 2007). The formation of
the synaptic complex primes the active site for cleavage activity through DNA bending (Ghosh et
al., 2007; Guo et al., 1999), intersubunit interactions (see Chapter 6), and possibly the
interactions within the β2-β3 loop with αE via a salt bridge. In this primed state, K201 is not
needed to provide any stabilizing contacts to the scissile phosphate for cleavage of the
phosphorothiolate substrate. Evidence supporting this hypothesis comes from the concentration
dependent cleavage assays of phosphorothiolate substrates by the E176, R173 and K201 Cre
mutants. The K201A/R173A double mutant did not show significant cleavage activity with the
phosphorothiolate substrate under conditions favoring synapsis, which demonstrates the
importance of interactions of both R173 and K201 with O2P and O5' groups of the scissile
phosphate.  
The behavior of K201 as a catalytic switch (Fig. 4.13) that is turned on at synapsis highlights
the importance of E176 in Cre. This switch is only effective if the lysine is able to efficiently
interact with the O5' group of the scissile phosphate upon formation of a synaptic complex. E176
facilitates the orientation of K201 by serving as an anchor point via the hydrogen bonding
interaction between the carboxylate sidechain of E176 with the amide nitrogen of K201, while
minimizing the electrostatic repulsion between K201 and R173. The lysine switch likely evolved in
Cre and other YRs as a way to restrict cleavage and possibly ligation activity to the synaptic
complex. TopIB acts as a monomer, so the corresponding lysine is always placed in the active
site.
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Figure 4.13  Model for regulation of Cleavage in Cre by a K201 switch
A. Cre dimer bound to loxP. The β2-β3 loop containing K201 is mobile so that K201 is displaced from the active site
some fraction of the time (cyan), but is also able to make productive interactions with the scissile phosphate that allow
for cleavage of loxP in the absence of synapsis (green). 
B. Under conditions favorable for synapsis, two Cre dimers bound to loxP (cyan) form a synaptic complex where two
subunits (green) are active and two are inactive (purple). The interactions made by β2-3 with the synaptic partner
anchor K201 in the active site of the cleaving subunit.
4.6 Methods
4.6.1 Cloning and Cre purification
Method details described in Chapter 3
4.6.2 EMSA assays
Binding and synapsis assays performed as described in Chapter 3.
4.6.3 In vitro recombination
R173 mutants were measured for in vitro recombination using an assay described in
Chapter 3.The E176 mutants were measured for in vitro recombination activity using a different
substrate than the one described in Chapter 2 and 3. For this reason, the method details are
described below. 
In vitro recombination assay: E176 mutants
pGV257, a 3kB plasmid containing two loxP sites in direct repeat flanking a 314 bp spacer
was linearized by digestion with BSRG-1, dephosphorylated and 32P end-labeled with
polynucleotide kinase. Reactions were carried out in NCB  buffer ( 20 mM Hepes, pH 7.5, 5 mM
MgCl2,150 mM NaCl, 2 mM dithiothreitol, and 50 μg/ml sheared salmon sperm DNA) with
substrate at 0.2nM and initiated by the addition of Cre to 50 nM. At appropriate time intervals, 20
ul aliquots were removed and quenched with and equal volume of phenol/chloroform. The
extracted aqueous layer contains unreacted substrate, and product. The products of the reaction
145
are a 315 bp linearized product, which carries the 5'-32P and an unlabeled 2.8kb circle. Reactions
were run on a 6% acrylamide gel in 1x TBE for 2 hours at 10V/cm. Gels were dried and analyzed
with a phosphoimager.
4.6.4 Concentration dependent cleavage with 5'-bridging
phosphorothiolate substrate
5'-bridging phosphorothiolate substrate preparation and cleavage assay described in
Chapter 3. See Appendix B for details of loxSS7-8 and loxSS9-10 oligonucleotides.
20 ul reactions containing 0.006 nM 32P end-labeled 5'-bridging phosphorothiolate substrate
(loxSS7-8/9-10) and varied amounts of unlabeled but equivalent substrate (0 – 100 nM) in 1X
NCB were initiated by the addition of 500 nM Cre and incubated for 60 minutes at 37 °C. The
reactions were quenched by addition of 5ul of 5X SDS loading buffer and run on 12.5% SDS-
Page for 1 hour at 20 V/cm. The dried gels were quantified with a phosphoimager. 
4.6.5 Cleavage assays for thio-effect
 Cleavage reactions with nicked TS (loxSS1/2/3) and 5'-bridging phosphorothiolate substrate
performed as described in Chapter 3 with following modifications. 
Reactions containing 0.2 nM 32P-end labeled substrate and 50 nM unlabeled substrate were
incubated by addition of Cre to 500 nM and incubated at 37 °C. At appropriate time intervals, 20
ul aliquots were removed and quenched in 5X SDS loading buffer. 
Endpoint-cleavage assays
Cleavage was measured with either TS nicked (loxSS1/2/3) or 5'-bridging phosphorothiolate
(loxSS7-8/9-10) substrates.
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Reactions in the absence of synapsis contained 0.2 nM 32-P end labeled substrate in 1X
NCB and were initiated by the addition of 500 nM Cre. After 60 minutes at 37 °C, the reactions
were quenched with 5X SDS loading buffer, and run on a 12.5% SDS-Page gel at 20 V/cm for 1
hour.
Reactions performed in conditions favoring synapsis were identical to those described above
except the reaction was spiked with 50 nM unlabeled substrate to promote synapsis. 
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Chapter  5. Allosteric Regulation of Cleavage in Cre
5.1 Introduction
Crystal structures of Cre bound to DNA in tetrameric complexes revealed extensive
protein:protein contacts at the dimer and synaptic interfaces (Van Duyne, 2001). The N-terminal
and C-terminal domains of each Cre subunit bury nearly 3500 Å2 of surface in the tetramer (Fig.
5.1). The packing interactions formed in the Cre tetrameric complex may be necessary to activate
Cre for cleavage of DNA. Large protein interfaces are also observed in crystal structures of
tetrameric complexes of λ-int and Flp, however the interfaces are less extensive, burying less
surface area than Cre (Fig. 1.8) (Biswas et al., 2005; Chen & Rice, 2003c).  
A striking feature of the Cre tetramer is that the C-terminal tail forms an alpha helix (hN) that
exchanges in trans to bind in a hydrophobic pocket of a neighboring subunit (Fig. 5.1). hN
consists of the last twelve amino acids (E331 to D343). A short 5 amino acid linker from R326 to
E331 connects hN to the preceding helix (hM), which carries the catalytic tyrosine (Y324). The
exchange of hN with partner subunits and the proximity to Y324 has led to the suggestion that
this region is involved in regulating recombination activity in Cre (Gopaul et al., 1998; Van Duyne,
2001). The sequential exchange of the C-terminal domain is believed to be a common feature of
most tyrosine recombinases despite the lack of sequence and structural conservation (Fig. 5.2)
(Hallet et al., 1999; Kazmierczak et al., 2002; Spiers & Sherratt, 1999; Tekle et al., 2002). Unlike
Cre, the C-terminus of λ-int forms a β-strand that binds a neighbor subunit in trans (Fig. 5.3)
(Biswas et al., 2005). Flp recombinase differs from other tyrosine recombinases in that the helix
containing the catalytic tyrosine is exchanged with the partner in trans and the C-terminal helix
returns to bind in cis (Chen & Rice, 2003b). Though no equivalent tetrameric structure of XerC/D
bound to DNA has been determined, sequence and structural comparisons between the unbound
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XerD structure to various Cre tetrameric structures suggest that the C-termini of XerC and XerD
should resemble Cre more than λ-int (Fig. 5.2)(Hallet et al., 1999; Spiers & Sherratt, 1999;
Subramanya et al., 1997).
Cre is a monomer in solution and forms stable complexes as a monomer and dimer bound to
loxP (Ghosh et al., 2007). The structures of tetrameric Cre-DNA complexes do not accurately
represent the structure of Cre in any of these pre-synaptic states because the protein:protein
interfaces have not formed. Recently, a crystal structure of a Cre monomer bound to a loxP was
determined (Yuan, 2008). This is the first structure that captures Cre in a pre-synaptic state. The
DNA substrate used in the crystallization was designed to force formation of a crystal lattice
where adjacent Cre monomers would be 180° out of phase, to prevent protein:protein interactions
like those observed in the tetrameric structures. Despite the inability to form native protein:protein
interactions, the core of the Cre monomer in the half site structure superimposes well with the
core of Cre in the tetrameric complex structures. Interestingly, the largest differences are at the N-
terminus and the C-terminus. Helix A (hA) forms part of the dimer and tetrameric interface in
tetrameric structures, but is shifted by nearly 90° in the half site structure. Interestingly, hN from
the half site structure manages to bind in a hydrophobic pocket of a neighboring Cre subunit as a
crystal packing artifact. Although the conformation of hN bound in the pocket is similar, the linker
connecting hM and hN (hM-hN) adopts a radically different conformation to allow hN to reach the
pocket of an adjacent molecule in the crystal. The half site structure suggests that the Cre
monomer bound to loxP is poised to bind hN in trans, but does not provide information about the
position and structure of hN in the Cre monomer in solution. 
Modeling has suggested that hN may be able to bind in the hydrophobic pocket in cis.
Crystal structures have been determined for λ-int as an unbound monomer, monomer bound to
DNA, and a tetrameric complex bound to DNA. 
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Figure 5.1  Intersubunit interactions formed by Cre in the tetrameric-DNA complex
Cartoon and surface representation of Cre tetramer bound to loxP viewed from the C-terminal, catalytic domain (A and
C, and the N-terminal domain (B and D). The N-terminal and C-terminal domains both make extensive interactions in
the tetramer at both the dimer and synaptic interfaces.
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In all three structures the C-terminal β-strand binds in a similar orientation against conserved β-
strands that contain the catalytic lysine, except that the binding is in cis for the unbound structure
and in trans for the DNA bound complexes (Aihara et al., 2003b; Biswas et al., 2005; Kwon,
Tirumalai, Landy & Ellenberger, 1997) (see Fig. 5.3). Interestingly, the C-terminal β-strand of λ-int
in the monomer complex binds in trans through a crystallographic neighbor. To determine if hN of
a Cre monomer is able to bind the hydrophobic pocket in cis, a cysteine was engineered into both
hN and the binding pocket to measure hN binding through crosslinking. Although this  mutant
readily formed crosslinks in the presence of loxP corresponding to dimers, trimers and tetramers
of Cre, no crosslinks corresponding to unbound monomer or bound monomer were detected
(Yuan, 2008). If hN does not bind Cre in cis, perhaps the C-terminus adopts a different structure
like that observed for XerD where the C-terminal tail forms a larger helix that docks against the
catalytic domain (Subramanya et al., 1997). This idea is appealing because Cre binds loxP
cooperatively to form a dimeric species, suggesting the protein:protein contacts formed at this
interface are strongly favored. Presumably, hN from one Cre subunit is capable of binding in the
hydrophobic pocket of the second subunit in the dimer, although it seems unlikely that hN of the
second subunit will be able to bind in the pocket of the first without the protein unfolding.
In addition to structural questions pertaining to assembly of the tetrameric complex, the
activity of Cre in pre-synaptic states is also unknown. Given the evolutionary relationship to
topoisomerases, the Cre monomer may have cleavage activity. Indeed, studies have
demonstrated that λ-int, XerC and XerD monomrs have topoisomerase activity on supercoiled
plasmid DNA containing recognition sites (Cornet et al., 1997; Craig & Nash, 1983; Kikuchi &
Nash, 1979). Further work has shown that the λ-int monomer is capable of cleaving a linear
substrate in the absence of the regulatory N-domain (Lee, Whang, Lee & Jayaram, 1994). The
trans cleavage mechanism used in Flp precludes it from acting as a monomer under normal
conditions, but studies have shown that providing the nucleophile exogenously as tyramine (a
tyrosine mimic) or as a peptide that contains the tyrosine allows Flp to cleave DNA as a monomer
and relax DNA supercoils (Whiteson et al., 2007; Xu et al., 1998).  
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Figure 5.3  C-terminal elements and binding compared in Cre and λ-integrase
Comparison of the tetrameric structures of Cre (A) and λ-int (B). Isolated view of active subunit, showing docking of
hN in Cre (C) and β9 in λ-int (D). Close-up view of linker region of an active subunit connecting the catalytic tyrosine
to hN of Cre (E) and β9 of λ-int (F).   NOTE: hK and hL in Cre (and equivalent helices in λ-int) hidden from view in (E
and F). Active subunits colored in green, blue; inactive subunits colored in magenta, yellow; active site tyrosine and its
helix colored in red.
Topoisomerase activity in Cre has not been reported under natural conditions, although studies
have demonstrated that Cre can exhibit relaxation activity on a plasmid substrate containing a
wildtype loxP site and a mutant loxP site carrying a deletion in the crossover region (Abremski,
Wierzbicki, Frommer & Hoess, 1986). This activity is more likely a consequence of a failed
recombination reaction involving the Cre tetramer rather than cleavage activity of Cre as a
monomer.
Structures of Cre have suggested that hN has a role in regulating recombination activity.
Mutants of Cre at G333 on hN are defective in recombination, but retain the ability to bind loxP
(Wierzbicki, Kendall, Abremski & Hoess, 1987). Mutations or deletions in the C-terminal regions
of λ-int and XerCD disrupt recombination activity but can increase their topoisomerase activity
relative to wildtype protein (Hallet et al., 1999; Kazmierczak et al., 2002; Spiers & Sherratt, 1997;
Spiers & Sherratt, 1999; Tekle et al., 2002). This suggests a regulatory role for hN in preventing
cleavage prior to tetramer formation. In Cre, Y324 is separated by a short linker connecting Y324
and hN (hM-hN linker). In tetrameric structures of Cre, the linker adopts an extended
conformation in the active subunit relative to the linker in the inactive subunit suggesting a role for
hN in positioning Y324 in an active conformation (Fig.  5.1). The binding pocket for hN in Cre is
formed by several helices that contain active site residues H289, R292 and W315. Binding of hN
may be necessary to stabilize the active site. 
In this chapter the requirements for the formation of an active Cre-DNA complex are
investigated with a focus on the regulatory role and function of hN.  Studies of pre-synaptic
complexes show that Cre is unable to cleave DNA as a monomer but the protein interfaces
formed in the Cre-loxP dimeric complex are sufficient for a low level of activity in the absence of
synapsis. Deletion of hN results in Cre, which is incapable of recombination, cleavage or
synapsis.  Investigation into how hN regulates Cre cleavage activity suggests that having hN
bound in the hydrophobic pocket is insufficient to activate Cre for cleavage and that the length of
the hM-hN linker is essential for synapsis and positioning Y324. 
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5.2 Minimal complex for cleavage of loxP
Synapsis stimulates two of the four Cre subunits for cleavage of loxP (Ghosh et al., 2005a).
The protein:protein interactions formed in this tetrameric complex likely facilitate the cleavage
activity (Ghosh et al., 2007), but it is not known if these contacts are required for Cre to cleave
DNA.
The cleavage activity of the Cre monomer bound to loxP half site was studied by Peng Yuan,
a former graduate student. At high concentrations (4uM complex), Cre was capable of cleaving
the half site, trapping approximately 50% of Cre in a covalent intermediate (Yuan, 2008).
Although Cre was capable of this cleavage in solution, no evidence for covalent intermediate
formation was observed in the crystal structure. At such high concentrations, extensive
protein:protein interactions are likely formed, thereby activating Cre for cleavage. The cleavage
activity was measured as a function of Cre-loxP complex concentration. Cleavage increased with
complex concentration, indicating that the observed cleavage was likely due to protein:protein
interactions, and not to the Cre monomer acting on an isolated loxP substrate. Additional
experiments with a Cre mutant (A36V) that is known to be partially defective in synapsis (Hoess
et al., 1987; Wierzbicki et al., 1987), further supported the conclusion that Cre requires
intersubunit interactions for cleavage. 
The dimeric Cre-loxP complex might be better suited to have cleavage activity considering
the Cre dimer forms protein:protein interactions, and hN from one or both subunits will be able to
bind the hydrophobic pocket of the partner subunit. The formation of synapsis has been shown to
accelerate cleavage (Ghosh et al., 2005a; Guo et al., 1999; Hoess, R H, Wierzbicki A, Abremski
KE, 1990), so in order to be able to determine if Cre is cleaving as a dimer, the reaction must be
performed under conditions where synapsis does not occur. Assuming Cre is at saturating
concentrations, the KD of synapsis of Cre with loxP is approximately 10nM (Ghosh et al., 2007).
Previous work examined cleavage using 5'-bridging phosphorothiolate suicide substrates at
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concentrations of substrate nearly 100 fold below the KD of synapsis, and found that cleavage of
the bottom strand (GC half site) approaches zero, but the cleavage of the top strand (AT half site)
is robust even at the lowest substrate concentrations (Ghosh et al., 2005a). The results suggest
that the Cre dimer is capable of cleaving the top strand of loxP, but cleavage of the bottom strand
appears to require synapsis.  This set of experiments was repeated with Cre A36V, a synapsis
defective mutant, to determine if a low level of synapsis is responsible for the previously
measured cleavage activity (Fig. 5.4). Wildtype Cre robustly cleaved the top strand of the
phosphorothiolate substrate. Surprisingly, cleavage of the bottom strand does not go to zero, but
instead reaches a plateau of about 12% at concentrations 1000 fold below the KD for synapsis.
Interestingly, A36V displays a steady basal level of cleavage for almost the entire concentration
range tested, which supports the idea that the Cre dimer is active for cleavage. However, the
phosphorothiolate substrate is an unnatural substrate that alleviates the need for a general acid
to assist the leaving group during cleavage, therefore the requirements to cleave
phosphorothiolate DNA are less stringent than those for a  natural substrate.
To eliminate the possibility of the that cleavage by the Cre-loxP dimer is an artifact of the
artificial phosphorothiolate substrates, cleavage was measured with a suicide substrate that
contained a natural phosphodiester linkage at the scissile phosphate. Cleavage was assayed at a
concentration of loxP ranging from 2 pM to 2000 pM. The lowest concentration was 5000 fold
below the KD of synapsis (Ghosh et al., 2007). Reactions with wild type Cre were incubated for 1
hour at 37 °C.  At the lowest concentration, cleavage was measured to be 10% of total counts
and remained nearly constant over a sixty fold increase in substrate concentration before
increasing significantly at concentrations close to the KD of synapsis. The trend was the same for
cleavage of both top and bottom strands. The increase in cleavage near the end of the measured
concentration range of the assay is consistent with stimulation from the formation of synapsis.
The concentration dependence of synapsis in Cre has been studied and modeled (Ghosh et al.,
2007). Using this model, the approximate amount of synapsis formed can be calculated for the
concentrations of substrate used in the cleavage experiment (Fig. 5.4). At 2pM substrate, less
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than 0.03% Cre bound loxP is in a synaptic complex, and while this amount will increase with
concentration, the cleavage product does not. This indicates that the observed cleavage is
independent of synapsis suggesting that observed cleavage is from the Cre-loxP dimer complex
(Fig. 5.5). 
The ability of the dimeric Cre-loxP complex to cleave but not the Cre monomer to cleave
DNA substrate suggests that intersubunit protein contacts must be made to activate Cre for
cleavage. It is unclear, however, if one or both Cre subunits in the dimer are capable of cleavage.
Although the use of nicked suicide substrates allows cleavage to be measured at a normal
phosphodiester linkage, the presence of the nick may influence bending of the loxP site, which is
known to be important in regulating the activity of Cre in the synaptic complex (Ghosh et al.,
2005a; Guo et al., 1997; Guo et al., 1999). Without structural information for the Cre-dimer, it is
unknown what role DNA bending plays in the cleavage activity of this complex.
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Figure 5.4  WT Cre cleaves the TS of loxP preferentially as a dimer.
Cre cleavage as a function of loxP concentration for wildtype (A) and A36V (B). Use of a suicide phosphorothiolate
substrate was used to trap Cre-loxP in a covalent complex. Reactions were separated by SDS-PAGE after 60 mins.
Concentrations of substrate used were, 6, 22, 66, 200, 2000, 20,000, and 100,000(A36V only) pM A. Bottom strand
product (BS) runs with slower mobilty than top strand covalent product (TS). Graphs on bottom show fraction cleaved
vs. fraction synapsed. The fraction synapsed was calculated using a published model for Cre (Ghosh, Guo & Van
Duyne, 2007). The x-axis is plotted on a log scale to show the entire concentration range clearly. 
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Figure 5.5  WT Cre cleaves nicked substrates as a dimer bound to loxP
Cre cleavage as a function of loxP concentration for substrates with a nick on the top strand or bottom strand.
Reactions were separated by SDS-PAGE after 60mins. Concentrations of substrate used were, 2, 6, 22, 66, 200, and
2000 pM.  Bottom. Graph of fraction cleaved vs. fraction synapsed. The fraction synapsed was calculated using a
published model for Cre (Ghosh et al., 2007). X-axis plotted on a log scale to show entire concentration range clearly. 
5.3 Characterization of the Cre C-terminal deletion mutant
To determine if hN has an important function in Cre, a deletion mutant lacking the last 12
amino acids in Cre was studied. This mutant (ΔC) lacks hN but retains the hN-hM linker. CreΔC
was found to be inactive for recombination by both in vivo and in vitro assays (Table 5.1). This
result clearly demonstrates that hN is essential for Cre activity. In order to understand this defect,
assays to assess various activities at specific steps in the recombination pathway were
performed. 
loxP binding assays of purified CreΔC showed that ΔC is partially defective. Unlike WT Cre,
which shows strong cooperative binding to populate the Cre-loxP dimer complex, CreΔC formed
the dimer complex in an uncooperative manner (Fig. 5.6A).  This result demonstrates that hN is
important for cooperative binding, and suggests that hN participates in the Cre dimer interface as
observed in tetrameric DNA complex structure of Cre (Ghosh et al., 2007; Guo et al., 1997; Guo
et al., 1999). CreΔC was unable to form measurable synaptic complex in the EMSA assay(Fig.
5.6B). This is with consistent with  the crystal structure of the Cre synaptic complex, which shows
that hN forms extensive interactions at the synaptic interface (Ghosh et al., 2007; Guo et al.,
1999). Interestingly, the dimeric complex formed by ΔC displayed slower mobility than the WT
Cre-loxP dimer complex. This could be caused by a defect in bending loxP, resulting in an
elongated complex that would migrate more slowly in a native gel relative to a smaller complex
formed from a sharply bent loxP observed in the Cre tetrameric crystal structures. This is the
opposite of what would be expected with bending experiments using long DNA substrates.
To determine if CreΔC is capable of cleaving loxP, cleavage assays with both a nicked and a
phosphorothiolate loxP suicide substrates were performed. CreΔC was incapable of cleaving a
natural loxP site after 60 minutes at 37 °C, but did have weak activity on a phosphorothiolate
substrate. To be certain that ΔC was inactive in cleavage, a second set of reactions was
incubated for 140 hours at 37 °C. CreΔC accumulated no covalent product on the nicked suicide
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substrate but did build up nearly 50% total covalent product with the 5'-bridging phosphorothiolate
substrate with a strong bias for cleavage of the top strand as would be expected for a mutant
defective in synapsis (Ghosh et al., 2005a) (Fig. 5.7). 
Requirements for cleavage of the 5'-bridging phosphorothiolate substrate are less stringent
than the natural loxP site (Ghosh et al., 2005a; Krogh & Shuman, 2000). As discussed in Chapter
4, the general acid lysine appears to be displaced from the active site of the Cre-loxP dimer. The
increased mobility of Y324 in CreΔC means that the nucleophile and general acid will be less
likely to occupy positions compatible with cleavage activity at the same time. Since the 5'-bridging
phosphorothiolate substrate alleviates the need for the general acid, K201, cleavage only
depends on the ability of Y324 to attack the scissile phosphate. Cleavage of the
phosphorothiolate substrate by ΔC indicates that Y324 is able to attack the scissile phosphate
without hN. This cleavage activity is weak, which indicates that Y324 of ΔC does not efficiently
attack the scissile phosphate. 
5.4 Mechanism of regulation by hN
The C-terminal helix of Cre is essential for recombination, synapsis and cleavage. Two
possible mechanisms for regulation were tested. hN binds in a hydrophobic pocket near active
site residues W315, R292 and H289 and may support a competent active site. In this model, a
Cre monomer must have a neighbors' hN docked in the hydrophobic pocket in trans to be
capable of cleavage. Alternatively, hN may regulate Cre by acting as a tether between monomers,
where the docking of hN into a neighboring pocket causes a tension on Y324 of the donor just
seven amino acids away from the beginning of hN, and locks it in a position favorable for attack
on the scissile phosphate. 
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Figure 5.6  Binding and Synapsis of CreΔC
A. Binding of Cre to 200pM 64 bp loxP (loxSS3/6, see appendix B). Cre concentrations tested were, 0, 0.5, 5, 50, 500
nM. B. Synapsis by 500 nM Cre as a function of loxP (loxSS3/6) LoxP concentrations tested were  0.2, 10, 40, 160 nM.
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Figure 5.7  CreΔC cleaves phosphorothiolate substrates.
Cleavage of nicked bottom strand (A) or phosphorothiolate (B) loxP substrate after 140hour incubation at 37 °C. ΔC is
incapable of cleaving nicked substrate containing natural phosphodiester linkage, but is able to cleavage the unnatural
phosphorothiolate substrate. Note: A36V has low activity on both substrates, and WT hydrolyzes the phosphotyrosine
linkage of both substrates. 
5.4.1 Helix-N binding pocket occupancy is insufficient for Cre
activity
If Cre requires binding of hN in the hydrophobic pocket to stabilize the activite site, CreΔC
ought to be capable of cleavage when hN is docked. To test this idea, a two sets of experiments
were performed. The first experiment tested if CreΔC could be complemented by active site
mutants K201A and Y324F, which are incapable of cleavage but contain an intact C-terminus.
CreΔC was mixed at varied ratios with K201A or Y324F and incubated with either a nicked loxP
suicide substrate or a phosphorothiolate suicide substrate. After one hour at 37 °C, no cleavage
product was visible for any protein mixture using the nicked substrate. However CreΔC with
K201A  was capable of cleaving the phosphorothiolate substrate. The K201A mutant is capable of
cleaving the phosphorothiolate substrate alone (Chapter 4) (Ghosh et al., 2005a), so it is
impossible to determine if CreΔC had any role in the observed cleavage (Fig. 5.7). Much weaker
cleavage activity was observed with the CreΔC/Y324F mixture on the phosphorothiolate
substrate. This was also not surprising since CreΔC has weak activity on this substrate (Fig. 5.8).
Although the effect was small, the amount of cleavage product decreased as the ratio of CreΔC
increased. Since Y324F is unable to cleave this substrate alone, Y324F must stimulate CreΔC
activity. The maximum stimulation was observed when the ratio of CreΔC:Y324F was 1:3. This
suggests that Y324F may stimulate the formation of synapsis where the active complex is a
tetramer of Cre consisting of three Y324F monomers and one CreΔC monomer (Fig.  5.8A model
VI).  The  stimulatory effect is small because Y324F is partially defective in synapsis.  If the
formation of synapsis is the cause of observed increase in CreΔC activity, then it is difficult to
identify the role of hN in this experiment.
To eliminate some of the issues of the complemention experiment and isolate the effect of
hN docking into the hydrophobic pocket, a peptide of hN was used in place of active site mutants.
If hN binding in the pocket is required for the formation of a competent active site, then it should
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be possible to provide the helix in trans as a peptide, assuming that the affinity is high enough for
binding to occur.  Since this 13 amino acid peptide contains no aromatic residues, the 83% pure
dry peptide was dissolved in water the concentration was measured using aborbance at 214 nm
(Kuipers & Gruppen, 2007). The peptide was added in 200 fold excess(>100uM) to a solution of
0.5 μM CreΔC and then measured for cleavage activity. The high concentration of peptide was
used to promote binding, though binding of the peptide to Cre was not experimentally measured
at this concentration. No stimulation of cleavage was observed when the hN peptide was added
to reactions with either nicked or phosphorothiolate DNA suicide substrates (Fig. 5.10). The
inability of Y324F or K201A to complement ΔC on the nicked substrate shows that hN binding to
the ΔC pocket is not sufficient to activate ΔC subunit. 
5.4.2 Helix-N as a tether for Y324
Crystal structures of Cre tetrameric complexes bound to loxP show that hN binding in the
hydrophobic pocket is nearly identical for active and inactive subunits, but the orientation of hM
and the linker connecting hM and hN are quite different (Ghosh et al., 2007; Guo et al., 1997;
Guo et al., 1999). In active subunits, hN exchanges across the dimer interface and the hM-hN
linker region forms an extended conformation with a N327-E331 Cα distance of 11 Å. The inactive
subunits of Cre exchange hN as part of the synaptic interface and have a compressed linker with
a N327-E331 Cα distance of 7 Å. Y324 and hM are also in different positions for active and
inactive subunits (Fig. 5.11). 
 If Cre uses a tethering mechanism to control activity through the orientation of Y324, then
changing the length of the hM-hN linker between Y324 and hN should disrupt the tether and have
an affect on activity. A series of Cre mutants containing one, two or three glycine insertions before
hN at E331 were constructed and purified (pGV1014, pGV1015, and pGV1015; see table 5.1). 
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Figure 5.8  ΔC complementation assay
ΔC(Gray) containing an intact active site is mixed at varied ratios with active site mutants Y324F and K201A (Black)
that are incapable of cleavage but carry hN. 
A) Cartoon depicts possible interactions formed in solution. 
B) Cleavage reactions were incubated for 60 min at concentrations favorable for synapsis (500 nM Cre/50 nM DNA
substrate) with either phosphorothiolate substrate(PS) (left) or nicked suicide substrate (right). Note: K201A has near
WT cleavage activity on PS substrate. Cleavage product for ΔC:Y324F on PS-substrate decreases as a function of
Y324F indicating that a tetrameric complex similar to VI (A) may form and have greater activity than others. No
cleavage was observed on nicked suicide substrate. hN donated from K201A or Y324F to CreΔC is unable to rescue the
ΔC cleavage defect.
The glycine insertion mutants were all found to be inactive for recombination in vivo (data not
shown).  In order to determine which step in recombination is disrupted by the glycine insertions,
the mutants were tested for binding, synapsis and cleavage.
The Cre glycine insertion mutants are able to bind loxP cooperatively, whereas CreΔC is
defective in cooperative binding to loxP. A minor difference in cooperativity is observed for the
glycine insertions that increases with the length of the hM-hN linker (Fig. 5.9A). All three glycine
insertion mutants are severely defective in synapsis formation. A minimal amount of product is
visible for the Cre mutant containing one glycine, but no synapsis is visible for the Cre mutants
with two or three glycines (Fig. 5.9B). These results suggest that the longer linker between hM
and hN is more disruptive to the interactions formed by Cre at the synaptic interface than at the
dimeric interface.
The Cre glycine mutants were then tested for cleavage activity (Fig. 5.10). Using a nicked
suicide substrate, the mutants show cleavage activity that decreases with increasing linker length.
At conditions unfavorable for synapsis, the cleavage product is barely detectable for the +2 and
+3 glycine mutants. As expected, these mutants show little stimulation when cleavage is
performed under conditions favorable for synapsis. The +1 glycine mutant has a modest increase
in cleavage activity followed by a nearly undetectable increase in cleavage activity of the +2
glycine mutant with no increase observed for the +3 glycine mutant. When cleavage was
measured using the phosphorothiolate suicide substrate, all glycine insertion mutants were
deficient in cleavage compared with WT Cre, with all three glycine insertion mutants displaying a
similar extent of cleavage and little to no stimulation when assayed in conditions favorable for
synapsis. All three glycine insertion mutants were better able to cleave than CreΔC. In the
absence of synapsis, the glycine insertion mutants are severely deficient in cleavage, directly
demonstrating a role for hN through the hM-hN linker in positioning Y324 for cleavage.
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The glycine insertions disrupt synapsis formation without having a significant effect on the
ability to form the dimeric complex. This contrasts with ΔC, which is defective in both cooperative
binding and synapsis. In the WT Cre-DNA tetramer, the linker at the synaptic interface is
compressed relative to the linker at the dimer interface (Fig. 5.11). The compressed linker at the
synaptic interface may not be able to accommodate the additional amino acids, or may prevent
necessary synapsis contacts from forming. 
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Figure 5.9  Binding and Synapsis of Glycine Insertion Mutants
A. Binding of Cre to 200pM 64 bp loxP (loxSS3/6). Cre concentrations tested, 0, 0.5, 5, 50, 500 nM. B. Synapsis by
Cre as a function of loxP (loxSS3/6) at constant Cre concentration of 500nM. LoxP concentrations tested were, 0.2, 10,
40, 160 nM.
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Figure 5.10  Cleavage activity of glycine insertion mutants
Cleavage activity after 60 mins of ΔC with hN peptide and glycine insertion mutants. Assays performed using nicked
suicide substrate (left) and phosphorothiolate suicide substrate (right). Reactions performed at 0.2nM substrate and
50nM substrate to measure effects of synapsis on cleavage. Activity reported as the ratio of mutant cleavage to WT at
50nM for each substrate. hN peptide is unable to stimulate  ΔC for cleavage. The glycine insertion mutants are severely
defective in cleavage with a trend of gly+1>gly+2>gly+3. Synapsis is partially able to rescue gly+1 cleavage defect,
most notable on the nicked suicide substrate. The severe deficiency of all these mutants indicate a role for hN in
positioning Y324 for activity.
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Figure 5.11  The hM-hN linker conformation in active and inactive Cre subunits
A) A cartoon representation of Cre-DNA tetramer highlighting hN. B) Surface representation of Cre-DNA tetramer
viewed from the C-terminal domain. hN of active and inactive subunits bind the receptor pocket in a similar manner,
however the linker of active subunits of Cre (green, shown in C), is in an extended conformation relative to the linker
of the inactive subunit (purple, shown in D). The conformation of the linker alters the position of hM (red) containing
the tyrosine nucleophile, Y324 (red spheres).  
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Table 5.1: Summary of activities for mutants characterized in study of hN
Description ID Binding Cleavage Recombination
WT pGV15 +++ +++ +++ +++ +++
Y324F pGV31 +++ +++ ++ 0 0
ΔC ++ + 0 0 0
pGV1014 +++ +++ + + 0
pGV1015 +++ +++ 0 + 0
pGV1016 +++ ++ 0 + 0
Cooperativity Synapsis
+1 Gly
+2 Gly
+3 Gly
5.5 Discussion
5.5.1 Assembly of an active Cre-loxP complex
Crystal structures of the Cre-loxP synaptic complex (Ghosh et al., 2007; Guo et al., 1999),
covalent intermediate (Guo et al., 1997), HJ intermediate (Gopaul et al., 1998) and the transition
state mimic (this work, Chapter 2) suggest that the C-terminus of Cre has a role in the assembly
of the synaptic complex and the regulation of activity. The studies presented here shed futher light
on these roles.
Determination of the Cre half site structure captured the first view of Cre in a pre-synaptic
state (Yuan, 2008). The structure and position of the C-terminus was a primary interest in
capturing this structure. Despite attempts to prevent intermolecular exchange of hN, Cre
monomers were able to exchange hN in trans with a neighboring Cre monomer in the crystal
lattice. The interactions formed by hN in the half site structure were similar to those observed in
the tetrameric complexes. However, the hM-hN linker was in an entirely different conformation in
the half site structure to allow this docking of hN, which demonstrated the flexibility of the linker.
The structure is consistent with crosslinking studies which were unable to detect hN of the Cre
monomer binding in cis (Yuan, 2008). This suggests that upon Cre binding to DNA, hN is poised
to bind in the hydrophobic pocket of a neighboring Cre monomer. However, the structure does not
explain how hN of the Cre monomer is oriented or where it is binding in solution. The Cre
monomer bound to DNA is unable to satisfy intermolecular interactions. The demonstration that
Cre is unable to cleave linear substrates as a monomer indicates that these intermolecular
interactions are required for activity. This result is consistent with the observation that Cre does
not function as a type I topoisomerase under normal conditions (Abremski et al., 1986). 
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Cre cooperatively binds loxP to form the dimeric complex. Since there are no crystal
structures of the Cre dimer bound to DNA, structural information about this state is inferred from
the Cre-DNA structures of tetrameric complexes and the Cre half site structure (Ghosh et al.,
2007; Guo et al., 1999; Yuan, 2008). The synaptic complex is two-fold symmetric where each half
corresponds to a Cre dimer bound to loxP. The Cre dimer interface is composed of extensive
interactions between  N-terminal and  C-terminal domains, which includes hN of the active
subunit exchanged in trans with the inactive subunit. hN of the inactive subunit is donated across
the synaptic interface into a hydrophobic pocket of an active subunit of the second Cre bound
dimer. In solution, an isolated Cre dimeric complex is unlikely to have this precise organization.
One possibility is that both Cre subunits in the dimer participate in a reciprocal exchange of hN.
Modeling suggests that the hM-hN linker is of insufficient length to accommodate such an
interaction without partial unfolding of hM. Synapsis also likely aids in the distinctive asymmetric
bend of loxP that is observed in the Cre tetrameric-DNA complex structures. If so, then the Cre
dimeric complex will likely experience greater conformational freedom in bending of loxP where
the average state is less bent than observed in the crystal structure of the synaptic complex.
Although significant differences are likely to exist between the dimeric complex observed as half
of the Cre-DNA tetrameric complex crystal structure and the dimer complex in solution, the
cooperative binding of Cre to loxP signifies that contacts responsible for the Cre dimer interface in
the synaptic complex are also important for formation of the dimer. 
The intermolecular contacts formed by the dimeric complex are sufficient to activate Cre for
cleavage on an isolated loxP site. Cleavage product was detected at loxP concentrations 5000x
below the KD for synapsis (10nM) and remained nearly constant over a 100 fold increase in loxP
concentration before increasing in a manner consistent synapsis formation. At saturating
concentrations of Cre, synapsis is a function of loxP concentration. Using a previously published
model that describes this relationship (Ghosh et al., 2007), the fraction of synapsis formed in the
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cleavage reactions at loxP concentrations below 10 pM is less than 0.1%.  Data from assays
using nicked suicide and phosphorothiolate suicide substrates agree well with a conclusion that
Cre is capable of cleaving loxP as a dimer in the absence of synapsis. 
Unexpectedly, wildtype Cre displayed greater activity on the top strand (AT half site) of the
loxP phosphorothiolate substrate than on the top strand of the nicked loxP substrate at
concentrations of loxP well below the KD of synapsis. This difference was only observed on the
top strand, as bottom strand (GC half site) cleavage products were similar for both substrates.
This effect appears to be isolated to cleavage at low concentrations of loxP, since wildtype Cre
displays a faster rate of cleavage on nicked loxP substrates than the phosphorothiolate
substrates at conditions favorable for synapsis (see Chapter 4:  thio-effect experiments). The
phosphorothiolate substrate is unique because it abrogates the need for a general acid during
cleavage. This suggests that the active site of the cleaving subunit in the dimeric complex is not
the same as the active site of the tetrameric complex. Cre active site residues K201 and R173
are involved in general acid catalysis and slight variations in their position will have a significant
impact on the ability of Cre to cleave the phosphodiester linkage of the nicked substrate but less
impact on the phosphorothiolate substrates because this substrate does not require a general
acid (See Chapter 4). The effect was observed only for top strand cleavage, which suggests that
in the absence of synapsis, the active site is primed for cleavage on the top strand but lacks the
general acid to catalyze the cleavage reaction. 
The Cre A36V mutant was included in these experiments as a control for synapsis. A36 is
located on a loop at both the dimeric and synaptic interfaces in the tetrameric Cre structures. The
A36V mutation caused a severe defect in synapsis without affecting binding. Since A36V does
not synapse, it offers an excellent control for synapsis independent cleavage. Indeed, cleavage
by A36V remained at a low level for both top and bottom strands of phosphorothiolate substrate
over the entire concentration range studied, indicating that no stimulation from synapsis was
occurring. However, cleavage of the top strand by Cre A36V was much lower than cleavage of
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the top strand by WT Cre at the lowest concentrations measured. This might suggest that
synapsis is the cause of the high level of top strand cleavage for WT Cre. Alternatively, A36V may
disrupt the dimeric interface in ways that are not detectable in a binding experiment. From the
structure, A36 is at the center of the N-terminal intermolecular interface. Mutation to valine will
certainly disrupt this interaction potentially causing a defect in the dimeric complex as well as the
documented defect of synapsis (Hoess et al., 1987; Wierzbicki et al., 1987). The active site of the
cleaving subunit of wild type Cre in the dimeric complex is already partially compromised (See
Chapter 4), so any disruption of the dimeric interface will likely further reduce activity. Therefore,
A36V may not be an appropriate control for synapsis independent cleavage if this mutant also
disrupts the dimer interface that has already been shown to be crucial for Cre activity. 
All tyrosine recombinases mediate recombination through a tetrameric complex similar to
that of Cre, but the assembly and activation of the recombinase tetramers differ. For simple
systems such as Cre, tetramer formation through synapsis results in activation of Cre for
recombination, and depends solely on Cre and loxP (Van Duyne, 2008). More complex systems
such as λ-integrase and XerCD employ accessory domains or rely on interactions with additional
proteins or regions of DNA for activation and control of recombination. Although recombination is
tightly regulated in these complex systems, the cleavage activity of pre-tetrameric states is not.
For example, λ-integrase, XerC and XerD have been shown to cleave their recognition sites as
monomers and were found to have topoisomerase I like activity (Cornet et al., 1997; Craig &
Nash, 1983; Kazmierczak et al., 2002; Kikuchi & Nash, 1979; Lee, Aihara, Ellenberger & Landy,
2004; Tekle et al., 2002). Flp recombinase is unable to cleave DNA as a monomer under normal
conditions, but this is in large part due to the trans cleavage mechanism that requires two
subunits to construct a complete active site (Lee et al., 1994). 
Simple recombinase systems such as Cre appear to more tightly regulate cleavage activity
than more complex recombinase systems such as λ-integrase and XerC and D (Azaro & Landy,
2002; Barre & Sherratt, 2002; Van Duyne, 2008). The complex systems have evolved a
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dependence on accessory regulatory elements to control recombination activity. Cre and Flp do
not require accessory regulatory elements in recombination, so all regulatory control of activity is
provided by the protein and recombination site. Attempts to build λ-like regulation into Cre have
been successful, but only after Cre binding was disrupted by altering the Cre binding element in
loxP and adding an extra base in the crossover region to make loxP more like the λ-integrase
recognition site, attP (Warren, Laxmikanthan & Landy, 2008). These data support a model where
tyrosine recombinases with extra regulatory elements such as λ-int and XerCD, evolved from a
common precursor like Cre. If such an evolutionary path did exist, perhaps recombinases such as
λ-int and Xer were originally more tightly controlled to prevent topoisomerase activity as
monomers similar to Cre. Incorporation of accessory regulatory elements comes at a price for
these systems. In order to become sensitive to regulatory cofactors, the recombinases have
weakened protein:protein interfaces and as well as binding to their recognitions sites causing
them to become somewhat leaky. 
5.5.2 Regulation of Cre activity by the C-terminal helix
Biochemical studies of Cre ΔC showed that this mutant is defective in cooperative binding,
synapsis and cleavage. This is consistent with results showing that mutation of G333 of hN to
tryptophan, arginine or glutamic acid, caused severe defects in recombination without disrupting
binding (Wierzbicki et al., 1987). The C-terminal domains of tyrosine recombinases are not well
conserved (Fig. 5.2), and not surprisingly the C-terminal deletions of other tyrosine recombinases
behave differently than those in Cre.
The C-terminal truncation mutant in λ-int, W250ter, removed the last six amino acids and has
greatly reduced recombination activity but enhanced cleavage and topoisomerase
activities(Kazmierczak et al., 2002; Lee et al., 2004; Tekle et al., 2002). λ-int is unique in that it is
the only system for which structures have been determined for the unbound protein (Kwon et al.,
1997), bound monomer (Aihara et al., 2003b), and tetrameric complexes (Biswas et al., 2005).
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The C-terminus adopts a different conformation in each of these structures. The equivalent region
of hN from Cre forms a beta strand (β9) in λ-int. The beta strand binds against the conserved β-
sheet structure containing the catalytic lysine in tyrosine recombinases. This is quite different in
Cre, where hN binds in a primarily α-helical hydrophobic pocket. The tetrameric structures reveal
that the C-terminal β-strand is exchanged with a partner subunit in trans similar to Cre and Flp
(Biswas et al., 2005; Chen & Rice, 2003b; Van Duyne, 2001) (Fig. 5.3). The structure of unbound
λ-int reveals that β9 binds the β-sheet in cis (Kwon et al., 1997), which differs from crosslinking
studies in Cre that were unable to detect hN binding in cis (Yuan, 2008). β9 in the half site
structure binds in trans through a crystallographic neighbor much like the Cre half site structure
(Aihara et al., 2003b). Mutations in the C-terminal β-strand (I353M and I353A) or at the receptor
strand (A241V) of λ-int disrupt the interactions formed by the C-terminus and display a phenotype
similar to the C-terminal deletion mutant, W350ter (Kazmierczak et al., 2002; Tekle et al., 2002).
The structures and biochemical characterization of the W350ter, I353M and A241V mutants
suggest that the C-terminal region of λ-int functions as a conformational switch that acts to
prevent cleavage in the absence of a tetramer and stimulates strand exchange and Holiday
Junction isomerization in the context of the tetrameric complex during recombination (Aihara et
al., 2003b). However, the mechanism of regulation by the C-terminus of λ-int is likely different
from Cre (Kazmierczak et al., 2002). 
Sequence and structural comparisons between the unbound XerD structure to various Cre
tetrameric structures suggest that the C-termini of XerC and XerD should resemble Cre more
than λ-int (Hallet et al., 1999; Spiers & Sherratt, 1999; Subramanya et al., 1997). The C-terminal
region of XerC is five amino acids longer than XerD, with an appended sequence 'KRGK' (Fig.
5.2). C-terminal deletion mutants lacking the last 5 or 10 amino acids of XerD are generally
inactive for recombination but retain topoisomerase activity and cooperative binding with XerC
(Spiers & Sherratt, 1997). The XerCΔ5 mutant (which has an equivalent C-terminal length as
XerD) was capable of recombination, while XerCΔ10 was inactive for recombination. Both XerC
deletion mutants retain topoisomerase activity, but are diminished in cooperative binding with
178
XerD (Ferreira et al., 2003; Spiers & Sherratt, 1999).  The results here suggest a role for the C-
terminal ends of XerC and XerD in recombination and that the C-terminus of XerC has a larger
role in cooperative interactions with XerD to form the dimer than does the C-terminus of XerD
with XerC. Interestingly, the interaction with regulatory protein FtsK has been mapped to the C-
terminus of XerD where it stimulates XerD for cleavage at recombination site dif (Yates et al.,
2006).
Examination of the tetrameric Cre structures offered two models for functional control of Cre
activity by hN. Although hN binds the pocket of active and inactive subunits in a similar manner,
the hM-hN linker has an altered conformation. In the active subunit this hM-hN linker adopts an
extended conformation, while the linker in the inactive subunit adopts a compressed
conformation. This has led to the suggestion that hN binding in the active subunit communicates
with hM through the linker to position Y324 in an active conformation (Gopaul et al., 1998; Van
Duyne, 2001). Alternatively, hN binding may stabilize the active site of the cleaving subunit. The
hydrophobic pocket of Cre that hN binds in consists primarily of α-helices. H289 and R292 are
located on αK with W315 in a loop between αL and αM. The interactions formed by hN binding
may be necessary to form a competent active site.  
To examine if hN is necessary for a competent active site, a series of experiments were
performed with CreΔC where hN was provided as a peptide or from an active site mutant
incapable of cleavage (K201A or Y324F). In both cases, hN was unable to stimulate ΔC for
cleavage suggesting that hN binding the hydrophobic pocket was insufficient to activate Cre for
cleavage. 
Glycine insertions in the hM-hN linker were constructed to determine if hN binding
communicates with Y324 to adopt an active position. All three glycine insertion mutants were
competent for cooperative binding, but defective for synapsis. This contrasts with Cre ΔC, which
is defective in both cooperative binding and synapsis, suggesting that exchange of hN is critical in
cooperative binding at the dimer interface and is tolerant of the insertions in the linker. The
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synaptic interface requires hN as well, but the interface is not able to tolerate the insertions in the
linker. Examination of Cre synaptic structure reveals that hM-hN linker adopts an extended
conformation across the dimer interface while forced to compress at the synaptic interface
(Ghosh et al., 2007; Gopaul et al., 1998; Guo et al., 1997; Guo et al., 1999). Since the hM-hN
linker is compressed at the synaptic interface, perhaps the insertions in the hM-hN linker are
unable to be accommodated due to potential steric clashes with a synaptic partner. 
Increasing the hM-hN linker by a single glycine results in more than a five fold drop in
cleavage activity. Extending the linker by two or three glycines results in mutants that are
essentially inactive for cleavage. Therefore, the hM-hN linker has evolved a specific length to
function as a sensor. hN binding in the hydrophobic pocket of a neighboring subunit on the same
loxP site communicates a change in position of Y324 on hM that is permissive for cleavage
activity. This demonstrates a dual role for hN and the associated linker by directly affecting
cleavage in the active site through modulation of the position of Y324 as well as being essential in
the formation of synapsis to permit recombination. 
The regulation of hN in Cre may be similar to the C-terminal regions of XerC and XerD.
Studies in XerC and XerD relied on Cre structures to aid in the identification of regions
responsible for a C-terminal interaction in a Cre-like hydrophobic pocket (Hallet et al., 1999;
Spiers & Sherratt, 1999). The C-terminal regions and receptor pockets in XerC and XerD were
found to exhibit recombinase specificity where the C-terminal region of XerC will only bind in the
pocket of XerD and vice versa (Ferreira et al., 2003; Hallet et al., 1999). On DNA substrates
where XerC is favored for cleavage, a C-terminal deletion mutant of XerC(Δ289-298) disrupts
cleavage by XerC with an observable stimulation of cleavage by XerD. However, when wildtype
XerC is mixed with a C-terminal deletion of XerD (Δ294-298) on the same substrate no change in
cleavage is observed (Ferreira et al., 2003). This suggests that like Cre, the donation of the C-
terminal region in the cleaving subunit is more important than receiving a C-terminal region to
stabilize the active site. When the equivalent of the hM-hN linker region was shortened in either
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XerC or XerD, the recombinase with an unperturbed C-terminal region was activated for cleavage
(Ferreira et al., 2003). This demonstrated that like Cre, the length of the linker region connecting
the catalytic tyrosine nucleophile with the C-terminal helix has evolved a specific length and is
critical for activity. 
The C-terminal regions of tyrosine recombinases are poorly conserved despite close
proximity to the catalytic tyrosine. However, structures of tyrosine recombinases demonstrate that
the C-terminal regions are intimately involved in protein:protein interactions that form the dimer
and tetramer complexes and are important for coordinating subunit activity in recombination. Flp
recombinase is unique from most tyrosine recombinases in that the helix containing the catalytic
tyrosine is exchanged with the partner in trans and the C-terminus returns to bind in cis. For other
tyrosine recombinases, the functional consequence of mutation or deletion in the C-terminal
region vary considerably, suggesting that the mechanism of regulation in recombination has not
been conserved in the family. In Cre, hN is an essential regulatory switch that mediates formation
of the dimer and tetramer and directly impacts catalytic activity by positioning the catalytic
tyrosine for cleavage. The importance of hN in regulating Cre activity relative to equivalent C-
terminal domains in λ-int and XerCD agrees well with the previous conclusion that complex
tyrosine recombinase systems reliant on accessory regulatory elements have reduced built-in
regulation that mediate activities such as cleavage and cooperative binding in favor of regulating
recombination. 
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5.6 Chapter specific methods
5.6.1 Cloning and Cre purification
Method details described in Chapter 3
5.6.2 EMSA assays
Binding and synapsis assays performed as described in Chapter 3.
5.6.3 Concentration dependent cleavage as dimer
Assay as described in Chapter 3 except the concentration of radiolabeled substrate was held
fixed at a low concentration 2 pM (nicked suicide substrate; loxSS4/5/6 and loxSS1/2/3) or 6 pM
(5'-bridging phosphorothiolate substrate; loxSS7-8/9-10) and spiked with unlabeled substrate to
fill out the concentration range.
5.6.4 Complementation cleavage assay
ΔC was premixed with either K201A or Y324F at ratios of 1:3, 2:2, and 3:1. The cleavage
reaction was initiated by addition of a master mix containing assay buffer, radiolabeled and cold
DNA substrate. Final assay concentrations were 1 μM Cre, 0.2nM radiolabeled substrate, and 50
nM cold substrate. The procedure was performed with both nicked and phosphorothiolate DNA
substrates (loxSS4/5/6 and loxSS7-8/9-10). 
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5.6.5 hN peptide cleavage
The C-terminal 13 amino acid peptide corresponding to hN was ordered from Genscript and
determined to be 83% pure by mass spectral analysis. 500 mg of hN peptide was dissolved in
200ul of dH2O and confirmed soluble by measurement of backbone absorbance at 214 nm
(Kuipers & Gruppen, 2007). hN peptide was added to a standard one hour cleavage assay
reaction with ΔC at a final concentration of approximately 120 μM. Reactions performed with both
nicked BS and phosphorothiolate substrates, with and without extra cold DNA to stimulate
formation of synapsis. 
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Chapter  6. Conclusions and Perspectives
6.1 Summary of conclusions
Decades of genetic, biochemical and structural studies have advanced the understanding of
site-specific recombination mediated by YRs and the mechanistic relationship to TopIB enzymes.
Cre and a handful of other YRs have been at the forefront of most of this research (Van Duyne,
2008). The relative simplicity of Cre-loxP recombination compared to the more complicated YRs
systems such as λ-integrase and XerC/D, has made it an excellent model for understanding the
mechanism of recombination (Sauer, 2002). The simplicity of the system has proved
extraordinarily useful the application of Cre as a tool in genomic manipulations in vitro  and in
vivo. However, the simplicity of the system also exposes at least three weaknesses when used in
this context. First, Cre has a predilection for the excision reaction rather than integration.
Therefore, Cre is less efficient when used to introduce genes rather than catalyzing their removal.
Secondly, Cre-loxP recombination is a reversible reaction that rarely converts 100% of substrate
to product creating a mosaic effect. Lastly, Cre is as a single protein that recognizes a specific
sequence, restricting the number of simultaneous DNA manipulations that can be performed
(Buchholz & Stewart, 2001). Therefore, the generation of novel Cre-like recombinases with
unique specificity, improved directionality and altered reaction preference will have a tremendous
impact on the application of site-specific recombinases as genomic tools. Although the
engineering of Cre has been partially successful (Buchholz & Stewart, 2001; Livet et al., 2007;
Sarkar, Hauber, Hauber & Buchholz, 2007), a fundamental understanding of the requirements for
catalysis and the regulatory mechanisms that control activity is a prerequisite for any rational
protein design. The work described in this dissertation builds on the fundamental understanding
of the requirements for Cre activity.  
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6.2 Tolerance to change in the active site
The construction and characterization of the library of active site mutants discussed in
Chapter 2 is the most comprehensive compilation of activities of any YR or TopIB system. The in
vivo recombination assay proved to be a powerful tool to characterize Cre mutant excision
activity. Of the seven conserved active site residues in YRs, H289 and E176 are the most tolerant
to change in Cre. These residues have no corresponding residue in TopIBs. The understanding of
these results was facilitated by the determination of a Cre-loxP-vanadate transition state mimic
complex structure, which is analogous to similar intermediates captured in TopIBs (Davies et al.,
2006; Perry et al., 2010). The active sites of Cre and TopIB in the transition state are essentially
superimposable, with the lone exceptions of H289 and E176. In this structure H289, interacts with
the phenolic oxygen of Y324 and the non-bridging oxygen of O2P (Fig. 2.2), which had led to
speculation that the histidine functions as a base responsible for activation of the tyrosine
nucleophile (Van Duyne, 2001; Whiteson et al., 2007). Fourteen different substitutions at 289 in
Cre were active, which argues against H289 having an essential catalytic role. E176 accepts
hydrogen bonds from K201 and R173, which are two residues involved in general acid catalysis.
In TopIB, the corresponding spaces are filled by two well ordered water molecules that mediate a
similar set of interactions. The similarity in position of the other shared active site residues,
highlights the evolutionary relationship in phosphoryl transfer mechanism between YRs and
TopIB. 
6.3 H289 accelerates water mediated hydrolysis
YR-DNA complex structures and biochemical studies of several point mutants in Flp
implicated the conserved histidine in general base catalysis that activates the tyrosine for
nucleophilic attack on the scissile phosphate (Pan, Luetke & Sadowski, 1993a; Whiteson et al.,
2007). The results from the in vivo characterization of mutants at H289 in Cre argues against
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such a role. All nineteen single site mutants at H289 were purified and tested for in vitro
recombination, cleavage, binding and synapsis. Most mutants with activity in vivo had correlating
activities in vitro. The H289A mutant, which is the structural equivalent of TopIB has decreased
activity. The conservative H289Q mutant was the most active with nearly 50% of WT Cre activity.
In addition to H289Q, the H289L and H289M mutants accumulated covalent intermediates at
levels higher than WT Cre. This suggested a possible deficiency in ligation, but the accumulation
of covalent intermediate was not a general property of mutants at H289. Perhaps water is able to
functionally replace the histidine in ligation as observed in TopIB. The H289L, H289M and H289Q
mutants are excellent structural mimics for histidine that would exclude water from being able to
effectively participate in ligation. Smaller amino acids at position 289 would allow water to access
the scissile phosphate in a manner similar to that observed in TopIB and the H289A structure. If
water is acting in place of these mutants, then they should produce a measurable solvent kinetic
isotope effect with D2O. 
The pH rate profile experiments on cleavage activity demonstrated that H289 is not required
to function as a catalytic base to activate Y324 for nucleophilic attack on the scissile phosphate.
Surprisingly, these pH experiments revealed that WT Cre efficiently hydrolyzes the 3'-
phosphotyrosine covalent intermediate as a function of pH, but H289Q does not. In fact, none of
the H289 mutants have any measurable hydrolysis activity even after 24 hours, where WT Cre
had converted 100% of the substrate to hydrolysis product. The rate of hydrolysis by WT Cre was
more than 600 times faster than TopIB, suggesting that H289 may be conserved to accelerate
hydrolysis of the covalent intermediate. Although hydrolysis of the covalent intermediate would
appear to be counterproductive, this activity may be a rescue mechanism for stalled
recombination reactions. The resulting 3'-phosphate containing nick is then able to be corrected
with host enzymes. The recombination mechanism is far more complex than relaxation, so YRs
are more likely to stall as a covalent intermediate during recombination. 
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The use of substrates containing a methylphosphonate at the scissile position to study the
rate of hydrolysis may be instructive to understanding the evolutionary relationship between Cre
and TopIB. This substrate alleviates the needs for charge stabilization in the transition state at the
methyl group, partially alleviating the need for Cre Arg292. In Cre and Flp, the rate of hydrolysis
with the methylphosphonate substrates does not change, however TopIB experiences at 103
increase in the rate of hydrolysis (Ma et al., 2009a; Ma et al., 2007; Ma et al., 2009b; Tian et al.,
2003). This effect may be explained in part by H289 in Cre, and the corresponding H305 in Flp.
Without a corresponding histidine, Arg223 in TopIB could adopt a conformation similar to the
histidine in Cre, capable by catalyzing hydrolysis. The histidine in Cre and Flp prevents the
corresponding arginine from adopting a similar conformation. Cre H289A is unable to hydrolyze
covalent intermediate of substrates containing normal phosphate (Chapter 3). However H289A
should be capable of hydrolyzing covalent intermediate with the methylphosphonate substrate by
a similar mechanism to that proposed for TopIB via the arginine. Likewise, the incorporation of
histidine into the active site of TopIB by mutating K220 of Vaccinia topoisomerase, may
accelerate the rate of hydrolysis of covalent intermediate using natural substrates.
6.4 E176 plays a structural role
To investigate the functional role the conserved Glu/Asp residue, I studied three mutants at
E176 in Cre and found that E176A is better tolerated than either of the more conservative
mutants E176Q and E176D. The biochemical properties of the E176Q mutant were identical to
the catalytically defective R173K mutant. By measuring cleavage activity with 5'-bridging
phosphorothiolate substrates for mutants at E176, R173 and K201, I proposed a model where
E176Q disrupts the orientation of R173 such that the arginine displaces K201 from the active site
through electrostatic and/or steric repulsion. The characteristics of the R173K mutant suggest a
similar mode of disruption. This is supported based on modeling that suggests that the lysine is
187
too short to interact with O5' and too long to interact with O2P of the scissile phosphate of the
transition state. This is also supported by the crystal structure of the R173K synaptic complex,
where the ε-nitrogen of K201 is oriented away from O5'. 
TopIB has no equivalent Glu/Asp residue, but two well ordered water molecules form a
similar set of interactions with K167 and R130. Investigation of TopIB structures shows that R130
is located on a loop that may play a role in orienting R130 in the active site. A Glu/Asp residue in
a similar position in TopIB would likely help anchor R173 and limit the effectiveness of any
regulatory role that the loop may have. 
6.5 K201 as a regulatory catalytic switch
The concentration dependence of cleavage by mutants at E176, R173 and K201 with 5'-
bridging phosphorothiolate substrates demonstrated that K201 has an additional role in stabilizing
the scissile phosphate of the Cre-dimer bound to loxP. When cleavage was measured under
conditions favoring synapsis, cleavage no longer required K201. The loop containing K201 in Cre
forms synapsis dependent interactions and is displaced from the active site in the absence of
these interactions. These data demonstrated a model for lysine as a regulatory switch that limits
cleavage and possibly ligation activity in Cre until the synaptic complex forms.  This highlights the
structural role of E176, which will helps orient the mobile lysine in the active site through the
carboxylate hydrogen bonding interaction with the amide nitrogen of K201 and by restricting
mobility of the R173 sidechain, which minimizes the electrostatic and/or steric repulsion at the ε-
nitrogen of K201. 
This form of regulation is unique to Cre and possibly other YR systems because TopIB does
not form higher order complexes. This region of YRs is variable, which suggests that other YR
systems may rely a set of different interactions, possibly with accessory proteins to orient K201 in
the active site. Disruption of the β2-β3 loop containing K201 in Cre could help confirm this model
by disrupting the interactions formed at synapsis. 
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6.6 Cre cleaves loxP as a dimer
Cre forms extensive protein:protein interactions in the synaptic complex burying nearly 3500
Å2 of surface area (Van Duyne, 2001). Other YRs systems such as λ-int and Flp form less
extensive interactions in the recombinase tetramer-DNA complex structures (Grindley et al.,
2006). Synapsis had been shown to have a stimulatory effect on cleavage activity in Cre, but it
was unclear if synapsis was required for cleavage. Work performed with 5'-bridging
phosphorothiolate substrates suggested that Cre could cleave as a dimer bound to loxP, however
this substrate has reduced requirements, which may not reflect Cre activity on a natural loxP
substrate.  I demonstrated that Cre could cleave a natural phosphodiester linkage at substrate
concentrations more than 1000-fold below the KD of synapsis.  This demonstrated that Cre could
cleave as a dimer bound to loxP. Cleavage as a dimer indicated that the protein:protein contacts
formed by the Cre dimer are enough to support a low level of catalysis and indicates that K201 is
able to populate the active site long enough to catalyze cleavage by the Cre-dimer without the
interactions formed through synapsis.
6.7 The C-terminus of Cre regulates activity through Y324
The C-terminal helix (hN) of Cre is swapped to a neighboring monomer in the tetrameric-
DNA complex structures of Cre. I demonstrated that hN is essential for Cre activity in cooperative
binding, synapsis and cleavage. In the Cre dimer, hN of at least one monomer is able to bind the
partner, which could explain the cleavage results described above. By altering the length of the
hM-hN linker, I showed that hN regulates Cre activity by acting as a tether, which modulates the
position of Y324. These insertions maintained cooperative binding at the dimer interface, but were
defective in synapsis, which demonstrated the sensitivity of the linker length to the synaptic
interface. An interesting question is whether or not Cre is able to cleave loxP as a monomer.
Evidence suggests that Cre does not cleave as a monomer (Abremski et al., 1986), which
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contrasts with λ-integrase (Craig & Nash, 1983; Kikuchi & Nash, 1979)and XerCD(Cornet et al.,
1997), which were shown to cleave as monomers and have topoisomerase activity. This led to a
model where Cre, and other 'simple' recombinases have tighter built-in regulatory mechanisms to
control activity than these other complex systems. The complex YR systems rely on accessory
proteins and DNA binding domains to regulate activity of the tetramer(Azaro, M A, Landy, A, 2002;
Barre & Sherratt, 2002). In order to be able to respond to these accessory regulatory proteins, the
'complex' YR systems had to become less tightly regulated as monomers and dimers. This meant
that the built in mechanisms like those described in Cre were not needed and likely in competition
to the accessory factors.  
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Appendix A. Cre Mutant Reference Table
System Mutant Binding Cleavage Ligation HJ resolution References
176 P2(E197) K + 28
G 0 0 0 0 26
N 0 + 0 + 0 Poor binding; defective ligation 26,58
G 0 + + + 26
Y + + + 19,28
D 0 + + 1
S + + + + 1,2,3
A + + + + 2
173 Q 0 0 + 0 0 25,20,21
Cre (R173) C/K 0 + + 0 0.2 WT recombination 24,27,34
K + 0 + + + 0 26,19,23,22,52
Q/E 0 + + 0 0 weak cleavage 26,58
S/P 0 + 0 0 0 26,58
K + + 55
C + 55
A 0 + + + 2,8,15,4
K 0 + + + 2,8,15,4
201 A 0 43
R + defective recombination 43
A + + 0 defective strand exchange/ no relaxation 35,29
Cre(K201) A 0 + 0 0 31,32,33
A + + + + 15,2,7,8,14
R + + + + 2,7
D + + + + 5
E + + 0 7
289 L 0 0 + 25
Cre (H289) Y + + + 24
A 0 37
Q + + + + ligation defective 36,41,37
L/P 0 0 + + + + defective ligation 36,44,40,22,41,52,59,60,58,37
Cre (H289) A,N + + 38,39
L + 55,56
L + + 57
A + + 9
D 0 + 0 6
I,N + + + 6
Cre 
Res
In vivo 
activity
In vitro 
activity Notes  (†)
Flp(D194)
Flp(D194)
R (Z.rouxii) (D194) Defective HJ res_strand transfer rxn; WT binding
Flp (D194)
Topo(G132) Relaxation 10-2 /  kcl 10-3 / klig 10-1 
Topo(G132) kcl 10-2 / klig 10-2
Topo(G132)
λint (R212)
Flp(R191) accum cov int./weak cleavage/ligation deficient
Flp(R191)
Flp + R (R191)
Xer(R148) Minimal cov formed on HJ sub
Xer(R148)
Topo(R130) kcl 10-5 / klig 10-5
Topo(R130) kcl 10-4  / klig 10-5
Flp (K223)
Flp (K223)
Xer (K172)
Topo(K167) relaxation 10-2 / kcl 10-4 / klig 10-5
Topo(K167) relaxation 1/3 / kcl 10-2 / klig 10-2
Topo(K167) relaxation 10-1 / binding 10-1
Topo(K167) relaxation 10-2 
λint (H308)
recombination (in vitro 10-3 ; in vivo 20%)
Flp (H305)
Flp (H305)
Flp (H305)
accum HJ, opp strand bias
Xer(H244L) buildup cov intermediate
TnpI(H234) buildup cov intermediate
Topo(K220) in vitro relaxation 20% / cleavage 10%
Topo(K220)
Topo(K220)
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Appendix A. Continued.
† Activities relative to wildtype enzyme
System Mutant Binding Cleavage Ligation HJ resolution References
292 C/H 0 0 + 0 0 25,20,48,49
Cre (R292) C 0 + + 24
P2 (R272) K + + 28
G/P/Q 0 0 + + 0 0 36,40,41,42,58
K 0 + + + 22,42,52
Q 0 + + + 30,55
K + + 55
K + + + + 9,10,17,15,14,18
A 0 + + + 9,15,18
E,G 0 + 0 6
Q 0 3
315 A 0 0 + 0 + 43,54
Q 0 + 44
H + + + + 45,54
F + + + + WT recombination; cleavage 5x less 46,54
Cre(W315) H + 54
Cre(W315) F + 54
Cre(W315) A 0 54
C + 55
A + + + 10,17,15,14
N,Q + + + 10
324 F 0 0 + 0 0 50, 51 49, 25
Cre (Y324) C 0 + + 24
F 0 0 + 0 0 44,22,41,46,58
S 0 0 + 0 0 44,46,40,41,22
F 0 + 30
A 0 + 0 4
F,K 0 + 0 11,12,15,16,13
C 0 + + 13
H,E 0 + 13
Cre 
Res
In vivo 
activity
In vitro 
activity Notes  (†)
λint (R311)
recombination in vitro 10-3 / defective binding
Flp (R308)
Flp (R308)
XerC(R243)/XerD(R247)
XerC(R243)/XerD(R247) cov formed on HJ sub
Topo(R223) Kcl(eq) = >60% / relaxation and binding 10%/ cleavage 2%
Topo(R223) Kcl(eq) = 1/ kcl 10-4 / klig 10-5
Topo(R223)
Topo(R223)
Flp (W330)
Flp (W330) kcl 10-2
Flp (W330) defective recombination / kcl 10-3
Flp (W330)
Xer(H270)
Topo(H265) Kcl(eq) = 5x WT / kcl 10-2 / klig 10-2
Topo(H265) Kcl(eq) = 5x WT
λint (Y342)
Flp (Y343)
Flp (Y343)
XerC(Y275)/XerD(Y279)
Topo(Y274)
Topo(Y274)
Topo(Y274) Endo cleavage
Topo(Y274) Endo cleavage
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System Ref
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
Recombinase 19
Recombinase 20
Recombinase 21
Recombinase 22
Recombinase 23
Recombinase 24
Recombinase 25
Recombinase 26
Recombinase 27
Recombinase 28
Recombinase 29
Recombinase 30
Recombinase 31
Recombinase 32
Recombinase 33
Recombinase 34
Recombinase 35
Recombinase 36
Recombinase 37
Recombinase 38
Recombinase 39
Recombinase 40
Recombinase 41
Recombinase 42
Recombinase 43
Recombinase 44
Recombinase 45
Recombinase 46
Recombinase 47
Recombinase 48
Recombinase 49
Recombinase 50
Recombinase 51
Recombinase 52
Recombinase 53
Recombinase 54
Recombinase 55
Recombinase 56
Recombinase 57
Recombinase 58
Recombinase 59
Recombinase 60
Num
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Table 6.1: Single stranded oligos that are annealed to form assay substrates
Single stranded oligo substrates
Name Length Sequence (5'‐3') Description
loxSS1 27 TTCGAGTGGCCGATAACTTCGTATAAT TS‐nicked cleavage  substrate
loxSS2 39 GTATGCTATACGAAGTTATGCAGATCTCAGCGGCGTGAC TS‐nicked cleavage  substrate
loxSS3 64 GTCACGCCGCTGAGATCTGCATAACTTCGTATAGCATACATTATACGAAGTTATCGGCCACT intact BS
loxSS4 37 TTGTCACGCCGCTGAGATCTGCATAACTTCGTATAGC BS‐nicked cleavage  substrate
loxSS5 29 ATACATTATACGAAGTTATCGGCCACTCG BS‐nicked cleavage  substrate
loxSS6 64 CGAGTGGCCGATAACTTCGTATAATGTATGCTATACGAAGTTATGCAGATCTCAGCGGCGTG intact TS
loxSS7‐8 66 TTCGAGTGGCCGATAACTTCGTATAATGTATGCTATACGAAGTTATGCAGATCTCAGCGGCG PS‐TS cleavage  substrate
loxSS9‐10 66 TTGTCACGCCGCTGAGATCTGCATAACTTCGTATAGCATACATTATACGAAGTTATCGGCCA PS‐BS cleavage  substrate
26 TTCGAGTGGCCGATAACTTCGTATAA
loxSS2c 40 TGTATGCTATACGAAGTTATGCAGATCTCAGCGGCGTGAC TS‐l igation substrate
36 TTGTCACGCCGCTGAGATCTGCATAACTTCGTATAG
loxSS5c 30 CATACATTATACGAAGTTATCGGCCACTCG BS‐l igation substrate
loxS2AL 58 TTTTGTCACGCCGCATAACTTCGTATAATGTACATTATACGAAGTTATCGGCCACTCG Symmetric intact TS
loxS2BL 58 TTTTCGAGTGGCCGATAACTTCGTATAATGTACATTATACGAAGTTATGCGGCGTGAC Symmetric intact TS
loxSS1‐pNP TS‐pNP modified l igation substrate
loxSS4‐pNP BS‐pNP modified l igation substrate
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Table 6.2: Annealed DNA substrates for Cre assays constructed from single stranded oligonucleotides
Annealed assay substrates
Name Purpose Sequence
loxSS1/2/3 TS‐nicked suicide  cleavage
loxSS4/5/6 BS‐nicked suicide  cleavage
loxSS3/6
loxS2
loxSS7‐8/9‐10
loxSS7‐8/3
TS‐l i gation
BS‐l igation
  GTCACGCCGCTGAGATCTGCATAACTTCGTATAGC-ATAC-ATTATACGAAGTTATCGGCCACTCG
  CAGTGCGGCGACTCTAGACGTATTGAAGCATATCG-TATG TAATATGCTTCAATAGCCGGTGAGCTT
TTGTCACGCCGCTGAGATCTGCATAACTTCGTATAGC ATAC-ATTATACGAAGTTATCGGCCACTCG
  CAGTGCGGCGACTCTAGACGTATTGAAGCATATCG-TATG-TAATATGCTTCAATAGCCGGTGAGC
Eq‐cleavage, binding and 
synaps is
  GTCACGCCGCTGAGATCTGCATAACTTCGTATAGC-ATAC-ATTATACGAAGTTATCGGCCACTCG
  CAGTGCGGCGACTCTAGACGTATTGAAGCATATCG-TATG-TAATATGCTTCAATAGCCGGTGAGC
Eq‐cleavage
TTTTGTCACGCCGCATAACTTCGTATAATGTACATTATACGAAGTTATCGGCCACTCG
    CAGTGCGGCGTATTGAAGCATATTACATGTAATATGCTTCAATAGCCGGTGAGCTTTT
TS/BS‐ Phosphorothioate  
cleavage
TTGTCACGCCGCTGAGATCTGCATAACTTCGTATAGpCATACAoTTATACGAAGTTATCGGCCACTCG
  CAGTGCGGCGACTCTAGACGTATTGAAGCATATCoGTATGTpAATATGCTTCAATAGCCGGTGAGCTT
TS – phosphorothioate  
cleavage
  GTCACGCCGCtGAGATCTGCATAACTTCGTATAGoCATACAoTTATACGAAGTTATCGGCCACTCG
  CAGTGCGGCGACTCTAGACGTATTGAAGCATATCoGTATGTpAATATGCTTCAATAGCCGGTGAGCTT
TS‐pNP
  GTCACGCCGCtGAGATCTGCATAACTTCGTATAGCATACA-----TTATACGAAGTTATCGGCCACTCG
  CAGTGCGGCGaCTCTAGACGTATTGAAGCATATCGTATGT PNp-AATATGCTTCAATAGCCGGTGAGCtt
BS‐pNP
ttGTCACGCCGCTGAGATCTGCATAACTTCGTATAG-pNP CATACATTATACGAAGTTATCGGCCACTCG
  CAGTGCGGCGACTCTAGACGTATTGAAGCATATC-----GTATGTAATATGCTTCAATAGCCGGTGAGC
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